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Approximately 1.5 wt. % of bone is comprised of citrate molecules bound to the 
surface of apatite crystals. Furthermore, 80 to 90% of physiological citrate is contained 
within bone. Recently, interest in citrate has increased due to the potential of a citrate 
based method for estimation of postmortem intervals, time since death, of skeletal 
remains. The broad objective of this research was to develop and validate a High-
Performance Liquid Chromatography (HPLC) method for quantitative and qualitative 
analysis of citrate in bone.  
An appropriate HPLC column and operating conditions for the detection of citrate 
were selected and subsequently used to analyze standard solutions consisting of sodium 
citrate dihydrate in water from 0 to 2.5 mM, a physiological range, for linearity, impact 
of storage time, and intra-day test method precision. After testing on simple matrices, an 
existing bone processing protocol was optimized by determining the optimal mass of 
sample, presence of matrix effects, and most suitable bone type to sample (cortical or 
trabecular). Finally, the HPLC method and optimized processing method were combined 
to analyze the impact of short term (14 day) storage conditions, intra-bone factors 
associated with sampling at different anatomical locations, and applicability to a model 
for the determination of postmortem interval (PMI).  
The HPLC method developed in this study demonstrated acceptable linearity over 
a physiological range of standards (0 to 2.5 mM) in all sets of standards analyzed (n =11). 
Also, the method provided repeatable results under normal operating conditions. Analysis 
of three bone masses (50, 75, and 100 mg) and different bone types (cortical and 
iii 
 
trabecular) demonstrated 75 mg, cortical only bone samples were most suitable for 
analysis. Furthermore, standard addition and recovery tests indicated the presence of 
matrix effects within the processing protocol of the bones samples. Finally, a total of 36 
bone specimens were prepared with the optimized processing protocol and analyzed for 
citrate. Chromatograms of each sample were analyzed for peak resolution and separation, 
as well as used to calculate the normalized concentration of citrate (wt. %.). Postmortem 
intervals were then calculated using a previously published citrate degradation model by 
Schwarcz et al. in order to assess precision. The mean concentration of citrate in all 
samples analyzed in this thesis was 1.12 ± 0.6 wt. %, which translated into a mean 
calculated PMI of 7.93 ± 13.72 years. The results from this thesis demonstrate the need 
for a better model of PMI estimation, as well as further research on the distribution of 
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Estimation of the postmortem interval (PMI), or time elapsed since death, can be 
critical in cases involving decomposed human remains. Having a reliable and accurate 
estimation of PMI can help identify the individual by narrowing the pool of decedents to 
which the remains might belong [40]. In cases where homicide is suspected, PMI can be 
used to eliminate suspects and corroborate witness testimony. Furthermore, having a 
reliable PMI can help to better account for natural and events and environmental forces 
that may have occurred, allowing a more complete taphonomic analysis [40]. Methods 
for estimation of PMI by forensic anthropologists and pathologists have traditionally 
been highly qualitative in nature. Among these techniques is the use of gross observations 
of soft tissue decay help to provide a general time estimate. Anthropologists also rely on 
their knowledge of the environmental region to help determine a more narrow range of 
PMI [40]. Finally, specific benchmarks can he used to establish or verify maximum or 
minimum time estimates [40].  
While the techniques described above are well established and accepted, an urgent 
need for quantitative methods of PMI estimations using skeletal remains has been 
recognized by the Scientific Working Group for Forensic Anthropology (SWGANTH) 
housed in the National Institute for Standards and Technology and the Technology 




innovative, and useful approach for the determination of time since death of an 
individual. SWGANTH stress the necessity of systematic studies determining the key 
environmental variables on the decomposition process of skeletal remains. In particular, 
they identified two needs of interest: (1) studies that rely on skeletal material instead of 
the taphonomic environment and (2) critical review of existing forensic anthropology 
methods.  
Alternative methods using skeletal remains have been investigated as a means to 
circumvent the limitations of the tissue decomposition techniques. One of the most 
promising and recent techniques of PMI estimation using skeletal remains has sought to 
utilize the degradation of citrate [16, 32, 49].  
Each of these studies on citrate degradation has primarily utilized absorption 
spectroscopy for analysis of citrate concentrations. In order to make this technique work, 
specialized kits for citrate detection are necessary. The results from these kits have not 
been shown to be repeatable [16]. In addition, the chemistry involved requires a pH level 
where hydroxyapatite precipitation is thermodynamically favored as indicated by the 
presence of a precipitate in the sample [16, 21]. Overall, a need was apparent for a better 
analytical technique to measure citrate concentrations within bone samples.  
The overall objective of this thesis was to develop and validate an HPLC method 
for quantitative and qualitative analysis of citrate in bone. In order to achieve this 
objective, experiments were developed to achieve three main aims. First, an HPLC 
method was developed and tested on a physiologically relevant range of citrate standards. 




preparation and sampling of bone samples using HPLC. Third, bone samples were 
prepared and tested to evaluate the qualitative and quantitative analysis provided by the 
HPLC method developed in aim one.  
Chapter 2 presents a comprehensive overview of the current research on citrate in 
bone. A review of the literature demonstrated the need for better testing methods, as most 
of the research to date has relied on the unreliable enzymatic assay kits. Chapter 3, 
presents a comprehensive list of the methods and materials used throughout the thesis in 
order to achieve the aims of this thesis. Chapter 4 presents the results associated with 
each of the three aims defined in this thesis. Chapter 5 contains a discussion of the results 
and their significance. Finally, Chapter 6 contains the conclusion and brief discussion of 








LITERATURE REVIEW AND RESEARCH OBJECTIVE 
 
2.1 Bone 
Bone comprises the largest percentage of connective tissue mass in the body, and 
unlike other connective tissue matrices, is physiologically mineralized and constantly 
regenerated as a consequence of bone turnover throughout its life [47]. Lamellar (Mature) 
bone is typified by s well-organized arrangement of collagen fibers, lamellae arranged in 
circumferential as well as tubular arrangements (osteons), and strong mechanical 
properties [33]. Furthermore, lamellar bone can be classified into two primary types: 
cortical or compact, and trabecular or cancellous as seen in Figure 2.1 below [33, 51].   
 
 
Figure 2.1: Identification of Cortical (Compact) and Trabecular (Cancellous) 
Bone in Porcine Rib Specimen 
 
The adult human skeleton is approximately comprised of 80% cortical and 20% 
trabecular bone [51]. While this ratio holds true for the overall skeletal structure, some 
bones and skeletal sites have different ratios of trabecular to cortical. In the femoral head, 







of 75/25 [9]. Ultimately, the architecture and amount of cortical bone at any site relate to 
the function of the bone in that area [26].  
 
2.1.1 Cortical Bone 
Cortical or compact bone is a calcified hard, dense bone that forms the outer layer 
of bone around the marrow cavity and the trabecular bone [33, 51]. It is porous but it has 
a high ratio of solid tissue to space compared to trabecular bone indicating a higher 
porosity in trabecular bone compared to cortical [17, 51, DUTTA]. Furthermore, pores in 
trabecular bone are easily visible under the microscope, while pores in cortical bone (10-
20 μm) are not visible to the naked eye [17].  Adult cortical bone is comprised of a 
collection of cylindrical units known as the osteon or Haversian system that run parallel 
to the outer surface of the bone [33, 39, 51]. A central canal containing a neurovascular 
bundle is found in each Haversian system and is known as a Haversian canal. These 
canals contain one or more blood vessels that carry blood to and from the osteon [39]. 
Perforating canals, also known as Volkmann’s canals, extend perpendicular to the 
surface. Blood vessels in these canals, supply osteons deeper in bone with blood. Small 
spaces known as lacunae separate lamellae, and are connected to each other and the 
central Haversian canal by channels known as canaliculi [39, 51].  Cytoplasmic processes 
are extended into the canaliculi by osteocytes that are found in the lacunae [51].  
A series of nested cylinders around the central canal are formed by lamellae of 
each osteon. When these sections are cut transversely, a target like pattern is formed by 




collagen fibers in each of the lamellae which adds both strength and resiliency to the 
bone. Cement lines separate osteons, have a high content of inorganic matrix, and 
correspond to areas of bone resorption and deposition [51]. 
 
2.1.2 Trabecular Bone 
Trabecular or cancellous bone consists of a honey-comb like structure that is 
commonly found at the ends of long bones and in the middle of bones in the pelvis, 
vertebrae, and other flat bones [51]. Within this type of bone, lamellae are not arranged in 
osteons. The matrix of the bone form supporting bundles of fibers in a meshwork known 
as trabeculae [39]. A network of rod-and-plate-like elements are formed by trabeculae 
and act as scaffolding for the marrow cavity, lighten bone, and allow room for blood 
vessels and bone marrow [33]. Neither capillaries nor venules are found within the 
trabecular matrix. As a result, nutrients diffuse along canaliculi that open onto the surface 
of trabecular in order to reach the osteocytes. Furthermore, blood vessels within the tissue 
deliver nutrients and remove waste produced by the osteocytes, and red bone marrow is 
distributed between the trabeculae [39]. 
Trabecular bone is typically located in areas of low stress or in places where 
stresses arrive from many directions. In addition, trabecular bone can withstand stresses 
applied from many directions, and is much lighter compared to cortical bone. From a 
functional standpoint, the lighter weight of trabecular bone reduces the weight of the 




framework provides protection and support to the cells of the bone marrow contained 
within the bone.    
 
2.2 Chemical Composition of Bone 
Bone is a heterogeneous composite material consisting of (in descending order) a 
mineral or inorganic phase, an organic phase, and water [7].  The inorganic phase is 
comprised of hydroxyapatite (Ca10(PO4)6(OH)2) that is analogous to geologic 
hydroxyapatite [7]. The organic phase is comprised primarily of type I collagen, 
noncollagenous proteins, and lipids. Furthermore, bone contains proteins in the 
extracellular matrix of bone that can be categorized as follows: (a) structural proteins 
(collagen and fibronectin) and (b) proteins with specialized functions [7]. Relative 
amounts of these constituents have been noted to vary with age, site, gender, ethnicity, 
and health status [7]. Properties of bone are defined by the amount and proper 
arrangement of each of these components (quality and quantity) [7]. In general, dry bone 
is reported to be anywhere from 30 to 40% organic by weight with the rest, 60 to 70%, 
being inorganic components [33, 39]. The inorganic or mineral portion gives rigidity to 
the bone, while the organic components provide a slight resilience, which accounts for its 








2.2.1 Inorganic Matrix 
The inorganic matrix is an important factor in the rigidity and hardness of bone 
and consists primarily of calcium phosphate [7, 51, 53].  Also, it contains small but 
significant amounts of calcium carbonate, as well as very small quantities of ionic 
components such as Mg2+, Na+, K+, Cl-, F-, and citrate [53]. However, it must be noted 
that citrate is an organic molecule, and is only included under the inorganic matrix as it is 
attached to Hydroxyapatite.  
A number of techniques including gravimetric analyses, analysis of calcium and 
phosphate contents, bone mineral density (BMD), and micro-computed tomography 
(micro-CT) have been used to quantify the mineral present in bone (6). Such analyses 
have shown that mineral content of bone ranges from approximately 30% dry weight to 
98% dry weight. Most bones have approximately 60 to 70% mineral/dry weight 
depending upon site, species, and stage of development [10, 12].  
X-ray diffraction studies have determined that a proportion of the calcium 
phosphate exists in crystalline form with a three-dimensional atomic configuration 
(crystal lattice) similar to geological calcium phosphate minerals, commonly known as 
the apatites [53]. Bone apatites are truly hydroyapatites having a lattice structure, poor 
crystallinity, and smaller crystal size [53]. The ratio of calcium: phosphorous in these 
crystals can vary, and contain besides calcium, the other ionic components listed 
previously [53]. Due to the small size, apatite crystals have the property of chemisorption 
of excess phosphates and other ions, which leads to absorption of water and the forming 




shell between Ca2+ ions of the apatite crystal surface and Na+ ions of the extracellular 
fluid is believed to account for the significant sodium content in bone [53]. 
 
2.2.2 Organic Matrix 
The organic matrix is primarily comprised of Type I Collagen that consists of a 
repeated tripepetide sequence, which form a left handed helix [33]. These collagen fibers 
constitute about 95% of the organic matrix and approximately 40% of the total body 
collagen [53]. Bone collagen fibers increase in diameter and become more closely packed 
with increasing age [53]. Glycine comprises one-third of the total amino acid content of 
bone collagen, while alanine, proline, and hydroxyproline together constitutes one-third 
combined [53]. In addition, hydroxylysine, a unique amino acid, is significant within 
collagen and is believed to play an important role in ensuring stable interchain linkage 
between tropocollagen moieties in bone.  
One of the more distinct physical properties of collagen in bone is the extreme 
insolubility in reagents which easily solubilize collagen from other sources [53]. A key 
example of this can be seen in mineral solutions, as less than 0.5% of the total collagen of 
bone is soluble in neutral salts [24]. Furthermore, less than 1% is dissolved in dilute acid 
solutions, 0.5 M acetic acid [24, 41]. Although, it has been demonstrated that as much as 
30% of bone collagen can be dissolved by repeated freezing and thawing in 3% acetic 
acid [24, 53].  
The remainder of the organic matrix is comprised of small quantities of complex 




bone tissue by weight and are extremely complex in chemical structure and physical 
properties [53]. Glycosaminoglycan, sialic acid, etc. are contained within the 
carbohydrate portion of these protein polysaccharides while the protein portion contains 
40% acidic amino acids. Chondroitin 4 sulphate, chondroitin 6 sulphate and keratin 
sulphate are included in the other muco-polysaccharids of bone [53]. The exact 
biochemical role of the compounds is not clear, but they are believed to be of significance 
in the dynamic functions of bone such as mineralization of the matrix, bone resorption, 
and regulation of bone remodeling and morphogenesis of bone [53].  
 
2.2.3 Mineralization of Bone Matrix 
Calcification, the hardening of organic tissue due to the deposition of calcium 
salts within the tissue substance, of the bone matrix is a distinct characteristic of bone. 
Currently, several hypothesis have been developed to explain the calcifiability of bone, 
but none seem to be satisfactory [53]. However, the following three facts are well 
understood and worth stressing. First, bone mineral crystals are arranged parallel to the 
long axis of bone collagen fibrils, suggesting specific structural elements that occur 
repeatedly along the collagen fibrils, initiate mineral nucleation and crystal formation. 
Second, optimal concentrations of the main ionic components of bone mineral should 
occur locally in matrix before mineral nucleation and crystallization occur. Third, 
glycolytic enzymes and ATP are essential for mineralization to occur [53].  
These facts demonstrate that mineralization of bone matrix is a complex physic-




molecules, optimal ionic environment, and ATP. The requirement of ATP appears to 
suggest that mineral nucleation is an energy consuming process. This mechanism remains 
unknown, however, once this process is initiated, crystal growth proceeds forming the 
characteristic hydroxyapatite crystals along the collagen fibrils. These crystals then give 
rigidity and strength to bone.  
  
2.2.4 Cellular Regulation of Mineralization Process 
The organic matrix that is mineralized is produced by cells, which also control the 
flux of ions into the extracellular matrix and register signals that mark the starting and 
stopping of the mineralization process. The extracellular matrix surrounding these cells 
define both the sites where mineralization will commence and the size to which the 
crystals should grow, in addition to providing an oriented surface for mineral deposition 
[6]. The size and organization of the collagen fibrils limits the dimensions mineral 
crystals can obtain, but without the noncollagenous proteins, mineralization will not 
occur in a measurable time period [6].    
The main cells involved in the mineralization process of bone are the following: 
osteoblasts, osteocytes, and osteoclasts. A summary of the properties and functions of 
each of these cell types is provided below and is followed by a more thorough discussion 







Table 2.1 Primary Cells Mineralized in Vertebrate Bone (adapted from Boskey6) 
Cell Type Properties and Function 
Osteoblast Orchestrates coupling of bone formation and bone remodeling and 
synthesizes matrix; round or flat-bone forming cell 
Osteocyte Linked to other similar cells by canaliculae; osteoblast surrounded by 
mineral 
Osteoclast Binds to bone surface and releases acid and enzymes that respectively 
remove mineral and matrix in response to signals; multinucleated large-
bone resorbing cell 
 
 
Ostoeoblasts are the differentiated bone-forming cells that secrete bone matrix 
and are versatile secretory cells while retaining the ability to divide.  These cells secrete 
the collagen and ground substance that comprise the initial unmineralized bone or 
osteoid. Osteoblasts are also responsible for calcification of the matrix [48]. Calcification 
of the matrix is believed to be initiated by osteoblasts through the secretion of small, 50-
250 nm, membrane-limited matrix vesicles into the matrix. The vesicles are rich in 
alkaline phosphatase and are only secreted during the periods in which cells are 
producing the bone matrix [48].   
Osteocytes are the mature bone cells that are enclosed by the bone matrix that it 
previously secreted as an osteoblast. These cells have the ability to synthesize matrix, as 
well as resorb it to a limited extent, which is important in the homeostasis of blood 
calcium [48]. Death of osteocytes causes a resorption of the bone matrix by osteoclast 
activity, followed by remodeling or repair of the bone tissue by osteoclasts. Osteocytes 





Osteoclasts function to resorb bone and are large multinucleated cells that when 
active rest directly on the surface of bone where resorption is to occur. The portion of 
these cells in direct contact with bone is commonly divided into two parts, the ruffled 
border and clear zone. The ruffled border is the central region that contains numerous 
plasma membrane infoldings forming micro-villous type structures. The clear zone is a 
ring like perimeter of cytoplasm that serves to demarcate the limits of the bone area being 
resorbed [48]. In addition, osteoclasts contain vesicles that contain hydrolytic enzymes 
such as collagenase, which digest the organic components of the bone matrix. Prior to the 
start of this process, the bone matrix must be decalcified [48]. The prevailing theory is 
that dissolution of the calcium salts occurs through the secretion of organic acids by the 
membranes of the ruffled border, which is also aided by low pH favoring the action of 
acid hydrolyses [48]. This process creates a local acidic environment in the clear zone 
adjacent to the ruffled border that creates a compartment at the site of the ruffled border 
where focal decalcification and degradation of the matrix occurs [48].     
 
2.3 Citrate 
 In general, citrate is any anionic form, salt, or ester of citric acid with a chemical 
formula of C6H5O7
3-, and a structure as seen in Figure 2.2. It is historically known as an 






Figure 2.2 Chemical Structure of Citrate 
 
2.3.1 Kreb’s Cycle 
 The Kreb’s Cycle, also known as the citric acid cycle or tricarboxylic acid (TCA) 
cycle, is a series of reactions used by all aerobic organisms to completely oxidize glucose 
derivatives to carbon dioxide. Its overall function is to harvest high-energy electrons from 
carbon fuels, but it does not generate a large amount of ATP or oxygen as a reactant [3]. 
Overall, it involves a number of oxidation-reduction reactions that result in the oxidation 
of an acetyl group into two molecules of carbon dioxide. In eukaryotes, these reactions 
occur within mitochondria. The following chemical reaction (Eq 2.1) summarizes the 
cycle [46]: 
 
𝑎𝑐𝑒𝑡𝑦𝑙 𝐶𝑜𝐴 + 3𝑁𝐴𝐷 + 𝐹𝐴𝐷 + 𝐴𝐷𝑃 + 𝐻𝑃𝑂4
−2 → 2 𝐶𝑂2 + 𝐶𝑜𝐴 + 3𝑁𝐴𝐷𝐻
+ + 𝐹𝐴𝐷𝐻+ + 𝐴𝑇𝑃    Eq 2.1 
 
Ultimately, the citric acid cycle serves as a final common pathway for the 
oxidation of fuel molecules including amino acids, fatty acids, and carbohydrates. It also 
serves as an important source for precursors for many building blocks of molecules 




2.3.2. Citrate in the Kreb’s Cycle Pathway 
 Citrate is historically known as one of the early intermediates in the Kreb’s cycle 
[11]. In the Kreb’s Cycle, Acetyl-CoA undergoes condensation with oxaloacetate giving 
up its acetyl group and forming the six carbon molecule citrate. Citrate is then undergoes 
a reversible isomerization to form isocitrate. The formation reaction (Figure 2.3) is 
catalyzed by citrate synthase, while the reversible degradation reaction (Figure 2.4) is 
catalyzed by aconitase. 
 
 
Figure 2.3 Formation of Citrate in the Kreb’s Cycle. Reaction is catalyzed by citrate 
synthase, which causes condensation of acetyl-CoA and oxaloacetate 
 
 
Figure 2.4 Degradation of Citrate in the Kreb’s Cycle. Reaction is catalyzed by 






 All mammalian cells produce citrate, as it is important within the Kreb’s Cycle 
[11]. The sum amount of citrate produced consists of the existing concentration of citrate 
plus the citrate that was utilized by cells, commonly referred to as “gross citrate 
production”. Another useful measurement is “net citrate production” which is the 
component of synthesized citrate not utilized by cells, remaining as accumulated citrate. 
In normal cellular metabolism, citrate produced is usually utilized in order to avoid a high 
degree of citrate accumulation [11].  
   
2.4 Citrate in Bone 
Citrate levels in bone and teeth are roughly 100 to 400 times greater than soft 
tissues and plasma, with the only exception being the prostate. As seen in Table 2.2 
below, citrate levels in bone and teeth are generally accepted to be in the 20 to 80 
μmols/gram range.  
 
Table 2.2 Citrate Concentrations in Tissues (adapted from Costello11). Calculated 
Concentrations in wt.% are based around 75 mg sample with the average value for citrate 
in the range when provided. 
 
Location Citrate (μmols/gram) 
Average Calculated 
Concentration (wt.%) 
Bone / Teeth ~20-80 0.946 
Cartilage ~1 0.019 
Blood Plasma ~0.2 0.004 
Other Soft Tissues ~0.2-0.4 0.006 
Prostate Tissue ~10-15 0.236 





Approximately 80 to 90% of all citrate within the body is contained within bone. 
Furthermore, a number of studies have reported citrate concentrations in bone from 1.09 
to 2.0 dry wt. % of bone [14, 16, 20, 21, 28, 34, 49]. A table is provided with a list of 
these studies and the weight percent obtained, as well as the types of bone used (Table 
2.3).  
 
Table 2.3 Literature Values of Citrate Concentration (wt. %) in Bone. The measurement 







Dickens14 1941 1.60 Cortical 
Knuuttilla34 1985 1.09 Cortical 
Gibbs21 1991 1.50 Trabecular 
Schwarcz49 2010 2.00 Cortical 
Hu28 2010 1.20 Cortical 
Dunphy16 2014 1.69 Cortical 












2.4.1 Early studies on citrate in bone 
The presence of citrate in vertebrate bone was first reported almost 75 years ago 
[11, 14]. Initially, there was a great deal of research in this area, but starting in the mid-
1970s, interest in the topic waned and the topic was rarely studied [11, 49]. Recently, 
interest in citrate has resurfaced thanks to technological advances which have allowed for 
a better understanding of its importance in the bone matrix. Early literature on the topic is 
still important and has proven critical in driving current research. Below is an overview 














N/A Van Slyke manometric apparatus 
Citrate, calcium, and phosphate 
form an insoluble complex 
 




method of Pucher 
Reported 1.61 % of dry, fat, and protein 
free weight; bone contains approximately 
70% of total citrate in body 
Dixon and 
Perkins15 
1953 Bone Rats Colorimetric Enzyme Reaction 
 
Amount of citrate in bone regions 
are in inverse ratio to metabolic activities 
Knuttila34 1985 Cortical Bone 
Human Iliac 
Crest 
Enzymatic Assay Kit 
 
Reported mean citrate concentration of 1.09 
wt.%; 
carbonate concentration dependent on citrate 
metabolism 
 
Hu28 2010 Cortical Bone 
Cow and 
Chicken 
Nuclear Magnetic Resonance (NMR) Citrate is critical for the stabilization of the 




Human Fluoroenzymatic Method 
 
Citrate is produced by primary human 
osteoblasts 
 
Davies13 2014 Bone 
Rabbit and 
Horse 







2.4.1.1 Precipitation of Citrate in Presence of Phosphate and Calcium  
 Kupyer (1938) was attempting to identify information on the nature of the 
unidentified constituents of urine through an analysis of its titration curve [35]. 
Throughout this process, he determined that it was advantageous to remove citrate from 
the urine samples by pretreating the solutions. In aqueous solutions, the precipitation was 
found to be incomplete, but in urine it was found to be more complete [35]. This more 
complete precipitation was later discovered to be attributed to phosphate present in urine. 
Subsequent experimentation determined that citrate, calcium, and phosphate formed a 
precipitate under alkaline conditions (base was added to turn litmus blue; pH > 8.3).  
Furthermore, this study demonstrated that the concentrations of calcium and of phosphate 
in the solutions determine the amount of citric acid precipitated. This was determined by 
producing solutions which contained various amounts of calcium chloride, potassium 
acid phosphate, and citric acid in centrifuge tubes. Citrate was measured by determining 
the amount of CO2 liberated when the solutions were oxidized with KMnO4 in the Van 
Slyke manometric apparatus. The study also demonstrated that when no phosphate was 
present, practically no citrate was precipitated, while increased amounts of phosphate 
corresponded to increased precipitation all the way until complete precipitation. Calcium 
was also shown to be necessary in concentrations higher than the amount needed to react 
with phosphate and citrate [35]. This study was the first to indicate the potential 






2.4.1.2 High Levels of Citrate in Bone 
Dickens followed Kupyer’s findings by being the first to report extremely high 
levels of citrate in bone [14]. In Dickens’ study, citric acid was estimated by the 
colorimetric pentabromoacetone method of Pucher et al. with dioxan instead of pyridine 
as the final diluent [14, 45]. Both ox bone and steamed bone meal were analyzed in the 
study for citrate content, but ox bone was believed to be underestimated due to 
difficulties in the crushing of the bone [14]. Steamed bone meal was shown to be 
analogous to bone, as the overall mineral composition closely resembled typical values of 
human bone. Analysis of the bone meal showed citrate concentrations of 1.61% of dry, 
fat, and protein free weight in the bone meal.    
Ultimately, this study provided a resource on citrate concentrations in a variety of 
solid tissues. Furthermore, Dickens determined that the hard substance of bone contains 
citric acid, and hypothesized that it may constitute approximately 70% of the total 
concentration of citrate in the body. In addition, he documented lower citrate 
concentrations in the marrow and cartilage, as well as variations believed to be caused by 
hormonal and dietary conditions. [14].  
 
2.4.1.3 Citrate in Circulating Fluids and at Site of Calcification 
Eventually, early research in the field gave way to a study by Dixon and Perkins 
in 1952 in which they studied the influence of citrate concentrations present in circulating 
fluids and at the site of calcification on calcification mechanisms [15]. Bone of the 




citric acid in the tissues. Thus, enzymes contributing to the formation and conversion of 
citric acid, namely citrogenase, aonistase, and isocitric dehydrogenase, were analyzed in 
different regions. The impact on calcification in tibia slices from achitic rats was also 
studied [15].  
Tibiae from rats were cut into thin sections and used as the animal model in this 
study. Citrogenase activity was estimated by using the enzyme system which forms 
citrate from oxaloacetate and acetate based upon the technique of Stern and Ochoa [50]. 
The reaction involves the conversion of acetate to acetyl phosphate, the transfer of the 
acetyl group to form acetyl-coenzyme A, and the final condensation of the acetyl group 
with oxaloacetic acid to form citric acid. Citric acid was then determined in TCA extracts 
by the colorimetric method of Weil-Malherbe and Bone [59]. A standard curve was used 
and a standard included with each determination.  
The authors determined that a mechanism for high local concentrations of citric 
acid within bone existed due to activities of citrogenase and aconitase much greater than 
isocitric dehydrogenase when compared to other tissues. Also, citric acid may be co-
precipitated with calcium phosphate during its deposition, and thus may hold calcium in a 
complex form [44]. Furthermore, it was determined that high citrate concentrations may 
help to reverse the process of calcification and solubilize bone salt already produced. 
Finally, the authors suggested that citrate concentrations were in an inverse ratio to the 
metabolic activities of the bone region [44]. This research would suggest that citrate 
concentrations would vary based on the metabolic activity of the region where bone 




postmortem intervals, as there would be uncertainty associated with the sampling of 
bone, as bone taken from regions with low metabolic activity would have higher citrate 
concentrations and those taken from regions with high metabolic activity would have 
lower citrate concentrations.  
 
2.4.1.4 Relation between Citrate and Carbonate in Human Cortical Bone 
Knuuttila investigated the correlation between citrate and carbonate in bone 
specimens from the iliac crest whose death had been caused by acute coronary disease or 
accidents [34]. Cortical bone was separated using a dental drill and analyzed for citrate 
content using a citrate enzymatic kit. Carbonate in the samples were also analyzed using 
a microdiffusion method. Analysis of the bones yielded a mean citrate concentration of 
1.09 wt% (10.9 ±3.1 mg/g) in the 128 samples tested and was found to not depend on 
subject age. Further analysis of the correlation between citrate and carbon dioxide yielded 
a statistically significant negative correlation, confirmed by regression analysis. 
Ultimately, this study suggested citrate had an impact on the binding of carbonate to 
apatite structures or that carbonate concentration is dependent on citrate metabolism [34].  
 
2.4.1.5 Citrate Stabilization of Apatite Nanocrystals in Bone 
 Hu et al. (2010) demonstrated that citrate molecules are strongly bound to and 
cover the surface of apatite nanocrystals and are highly conserved across fish, avian, and 
mammalian bone [28]. Nanocrystals of apatitic calcium phosphate impart the organic-




thickness of the Nanocrystals (approximately 3-nm) provides the advantageous 
mechanical properties and likely help to prevent crack propagation. The authors sought to 
obtain a better understanding of the factors controlling the nanocrystals in bone in order 
to prevent and treat diseases including osteoporosis that lead to millions of fractures each 
year. Nuclear Magnetic Resonance (NMR) was used to show that surfaces of the apatite 
crystals in bone are studded with strongly bound citrate molecules.  Analysis of the data 
produced in this study revealed that bound citrate comprises 5.5 wt% of organic matter in 
bone, which allows it to bind more calcium than all noncollagenous proteins in bone due 
to more COO- groups. They were further able to demonstrate that the area density of 
citrate on bone apatite was around 1/(2 nm)2 [28]. Also, it was shown that bound apatite 
interferes with nanocrystal thickening as seen in a wide range of vertebrate orders, 
indicating its importance in stabilizing nanocrystal size at the thickness for advantageous 
mechanical properties and for fast resorption during bone remodeling.   
 
2.4.1.6 Osteoblasts produce Citrate in Bone 
Franklin et al. (2014), sought to demonstrate that osteoblasts are specialized cells 
that produce citrate which the bone incorporates into its structure, in contrast to the 
prevailing view that citrate in bone is derived from blood [19]. The authors argued that 
this was a specialized metabolic capability not commonly occurring in other cells as they 
use citrate via the Kreb’s cycle for bioenergetics / metabolic requirements. In osteoblasts, 
net citrate production demands mitochondrial citrate oxidation is inhibited so that citrate 




extracellular environment. Furthermore, it was believed that osteogenic differentiation of 
mesenchyme stem cells (differentiation of stem cells into osteoblasts) was responsible for 
osteoblasts capable of producing citrate [19].  
 In the study, human mesenchymal stem cells (MSC) and osteoblasts were 
obtained and studied. Citrate production by the cells was determined by using a 
specialized cell culture method followed by a fluoroenzymatic method. Ultimately, the 
results demonstrated that citrate is produced by primary human osteoblasts, but not by 
undifferentiated mesenchyme cells. The authors determined that osteogenic 
differentiation was responsible for citrate producing osteoblasts [19]. Plasma was 
eliminated as a source of citrate, making this the first study to demonstrate that 
osteoblasts are capable of producing citrate that is incorporated into the bone matrix [19]. 
In summary, this study brought about the new view that citration by citrate producing 
osteoblasts occurs at the same time as mineralization throughout the process of bone 
formation. 
 
2.4.1.7 Citrate Bridges between Mineral Platelets in Bone 
 Davies et al. determined that citrate anions help to bridge mineral platelets and 
bone [13]. They further hypothesized that the presence of the anions serves to separate 
platelets that have disordered regions in between them rather than stepped 
transformations into more ordered regions of mineral. Octacalcium phosphate citrate was 





 Using a number of techniques including NMR, X-ray diffraction, and electronic 
structure calculations, the authors worked to establish a quantitative structure for the 
material. The model was compared with fresh rabbit and horse bone to validate the OCP-
Citrate model. Overall, the authors were able to compare the models, and felt that the 
model of citrate ions incorporated as hydrated layers into the mineral structure was fairly 
analogous to the results obtained from the bone samples. Furthermore, the authors 
believed that the incorporation of citrate into an OCP-like structure could act to restrict 
the growth of mineral crystals and produce a plate-like morphology similar to what is 
seen with bone. This architecture works to prevent the formation of large crystals that 
would have deleterious mechanical properties; therefore, the authors claim that citrate in 
the bone mineral may explain changes in crystallinity for individuals with metabolic 
diseases, while also making sense of molecular level bone mechanics [13].   
 
2.5 Weathering of Skeletal Remains Post Mortem 
Later stages in decomposition of human remains include skeletonization followed 
by extreme skeletonization [30]. At these stages, little or no soft tissues are present on the 
skeletal remains. The exposure of these remains to an outdoor context initiates changes in 
physical and chemical features through a weathering cascade. Key parameters of bone 
weathering are similar to those found in body decomposition, and ultimately lead to loss 
of collagen and dissolution of bone mineral [57]. Weathering of bone is best described as 
a cascade during which collagen is degraded by microorganisms in the present of water 




and calcium ions in bone mineral that are highly dependent on acidic and calcareous soils 
occur [36, 61].  
 
2.6 Postmortem Interval Estimation  
Estimation of the postmortem interval (PMI), or time elapsed since death, can be 
critical in cases involving decomposed human remains. Having a reliable and accurate 
estimation of PMI can help identify the individual by narrowing the pool of decedents to 
which the remains might belong [40]. In cases where homicide is suspected, the PMI can 
be used to eliminate suspects and corroborate witness testimony. Furthermore, having a 
reliable PMI can help to better account for natural and events and environmental forces 
that may have occurred, allowing a more complete taphonomic analysis [40]. As 
discussed in Chapter 1, PMI estimations by forensic anthropologists and pathologists 
have traditionally been highly qualitative in nature, but a need for a more quantitative 
approach has been well documented.  
This section will discuss studies on the newly emerging quantitative technique for 
estimation of PMI based upon degradation of citrate as first described by Schwarz. A 












Gibbs21 1991 Trabecular Bone Human  
Enzymatic Assay 
Kit 
No difference in citrate content between 
sexes; 1.5 wt %  
Schwarcz49 2010 Cortical Bone Porcine 
Enzymatic Assay 
Kit 
Limit of 100 years with 1% error; 2 wt. % 
Kanz32 2013 Cortical Bone Human  
Enzymatic Assay 
Kit 
Accuracy of PMI was "unsatisfyingly low"; 
Absolute difference between known and 
calculated PMI was 19.5 years 
Dunphy16 2014 Cortical Bone Porcine 
Enzymatic Assay 
Kit 
High standard deviations and variance in 
samples; 1.69 wt.% 
Froome20 2014 Cortical Bone Porcine 
U-V Vis Assay 
and HPLC 





2.6.1 Investigation of Differences in Citrate Content for Determination of Sex  
 Citrate content of trabecular bone was analyzed in both archaeological and 
modern specimens of unknown origin to determine if variation in time of citrate content 
could be used to determine sex of human skeletal remains [21].  Differences in citrate 
content of trabecular bone samples were analyzed with U.V-enzymatic citrate lyase 
spectrometry at a pH of approximately 7. Results demonstrated that differences in 
trabecular citrate content in bone were not due to the testing of different parts of the 
body. It was also shown that no significant differences in citrate content between sexes 
was obtained to justify the use of this method as a means to determine sex of skeletal 
remains. The analysis of citrate content in trabecular bone of recently embalmed 
individuals had citrate contents of 1.5 ± 0.1 wt. % [21]. Furthermore, the formation of a 
precipitate of some bone in all samples analyzed was reported as the pH approached 7 
[21].  
 
2.6.2 Potential of Citrate Degradation Model for Estimation of Post Mortem Interval 
 Schwartz et al. took the work of Gibbs and applied it to demonstrate a correlation 
between citrate degradation and PMI. Portions of rib bone, either pig or human, were 
analyzed for citrate content with a citrate lyase method in the form of a colorimetric 
enzyme assay kit (Xygen Diagnostics, Burgesssville, ON). This study found that citrate 
concentration of bone decreased with remarkable regularity in a number of diverse 
environments [49]. Furthermore, results indicated that storage environment had minimal 




below 0° C.  Results from this study also indicated that citrate levels would reach zero 
around 95 years from time of death. Schwarz et al. go on to clarify that this lifetime is 
only applicable to samples stored at temperatures greater than 0° C. Samples stored 
below this temperature, T<0° C, would be expected to have longer lifetimes. Ultimately, 
the authors argue that storage conditions make it hard to predict very long-term behavior 
of citrate, but they seem to believe that the rate of decline may demonstrate some increase 
[49].  
When analyzing the study, it appears the authors believe their data demonstrates a 
high degree of correlation between citrate content and PMI once soft tissues had fully 
decayed. The method was believed to have an error of approximately 1% of age based on 
the only error being an analytical error in the detection of citrate (±0.003%). An equation 
was developed to determine the PMI interval based on the calculated citrate level as seen 
below (Eq. 2.2). 
 C(t) = -0.673 x log(t) +3.021 Eq. 2.2 
 
In this equation, C(t) is the citrate content in wt% and t is the time since death in 
days [49]. The equation was determined to have an r2 value of 0.986. However, when this 
technique was applied to three exhumed human remains to compare calculated values 
with known values of PMI, each of the samples exceeded the reported precision of one 
month (Table 2.6). Furthermore, one sample had a much higher citrate level than 






Table 2.6 Determination of Error (days and % of age) in Exhumed Human Remains 











(% of age) 
52-04 1.12 556 692 + 136 24.5 
57-05 1.48 1010 198 - 812 80.4 
85-06 1.38 324 280 - 44 13.6 
  
Another potential problem with this study was the use of six different porcine ribs 
for determination of citrate degradation in porcine rib samples. When the concentrations 
obtained in the study (Table 2.7) is plotted (Figure 2.5) it shows a fairly high degree of 
linearity (r2= 0.981), but there is no evidence provide that this is not variation between 
bones in each individual rack.  
 
Table 2.7 Citrate Concentrations in Porcine Ribs Analyzed at Various Time Points 
Adapted from Schwarcz et al.49 
 
Sample Time (days) Citrate (wt.%) 
Tennessee 0 0 1.974 
Tennessee 1 30 1.945 
Tennessee 2 60 1.821 
Tennessee 3 90 1.745 
Tennessee 4 120 1.702 
Tennessee 5 150 1.590 











Schwarz et al. documented the use of an enzyme based colorimetric method for 
the determination of citrate concentration in bone. Also, the authors believed their study 
demonstrated the ability to use citrate content of bone to estimate PMI up to about 100 
years with a 1% error in the age determination. The error in estimation of the three 
samples demonstrated the need for a better model to ensure more precise PMI 
estimations. Furthermore, it appeared that this study was limited by a small sample size 
































2.6.3 Attempt to Validate PMI Estimation with Citrate Method Developed by Schwarcz 
 Kanz et al. produced a study in 2013 that utilized the citrate method developed 
and identified by Schwarz et al. to evaluate the citrate concentrations of human remains. 
In the study, temporal bones and femora of 20 individuals buried in wooden coffins and 
body bags were subjected to the citrate detection method described by Schwarcz [32]. 
Namely, enzymatic assay kits were obtained from R-Biopharm AG (Darmstadt, 
Germany) that utilized a citrate lyase method. In this method citrate lyase converts citrate 
to oxaloacetate and pyruvate; the mixtures react with nicotinamide-adenine dinucleotide 
(NADH) to form L-malate and L-lactate. The amount of citrate consumed is equivalent to 
the amount of NADH consumed and can be measured at 340nm with a photometer [32]. 
The use of the buried individuals allowed a direct comparison of the PMI estimate 
produced by citrate degradation methods to known PMI.  
 The results in the study demonstrated a marked difference between the temporal 
and femur bone samples of the same individuals from the body bag test group, while 
differences were insignificant for those buried in wooden coffins [32]. Furthermore, 
similar levels of underestimated in PMI were seen with the analysis of the femora for 
both the body bag and wooden coffin test groups. Finally, femurs showed slight 
differences between body bag and wooden coffin degradation rates of citrate when 
compared to the temporal bone population. From this, it was surmised that cortical bone 
from long bones should be preferentially used in citrate-based PMI estimations [32].   
 In comparing the results of this study with those in Schwarcz, Kanz et al. 




calculated PMI was 19.5 years. Thus, the accuracy obtained from the Schwarcz equation 
was “unsatisfyingly low”. Second, Schwarz et al. plot the data in their study on a log time 
scale, then concludes a linear relationship between citrate concentration (wt. %) and PMI 
(days). When this data is plotted in a more straightforward manner, citrate concentration 
vs. PMI (days) (Figures 2.6 – 2.7) with raw data from both studies included, the 
relationship is more difficult to see. The data demonstrate decay in the first 180 days that 






Figure 2.6 Plot of all citrate concentration versus known PMI (days) using the data 
obtained in the Schwarcz and Kanz Studies (Schwarcz49 and Kanz32). 
 
 
Figure 2.7 Plot of all citrate concentration versus calculated (predicted) PMI (days) 
using the Schwarcz model for data obtained in the Schwarcz and Kanz Studies 
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2.7 Analytical Techniques Used to Measure Citrate Concentration 
Analysis of techniques used to measure citrate concentrations demonstrated that 
the most prevalent technique is the enzymatic assay kit method as used in both the 
Schwarcz et al. and Kanz et al. studies [32, 49]. Literature further indicated the need for 
alternative methods of citrate detection due to precipitation and reliability issues with the 
method [32, 49]. This section will briefly introduce the use of the enzymatic assay kit and 
issues associated with the method presented by Dunphy [16]. Then a brief survey of 
analytical techniques commonly used to measure citrate concentrations will be provided 
in order to demonstrate three alternative techniques to enzymatic assays that would be 
suitable for the measurement of citrate. The three methods discussed are: Capillary 
Electrophoresis, Nuclear Magnetic Resonance, and High-Performance Liquid 
Chromatography. 
. 
2.7.1 Evaluation of Enzymatic Assay Kit Performance 
In this study, Dunphy set out to further evaluate the potential of enzymatic based 
citrate detection using absorption spectroscopy and high-performance liquid 
chromatography [16]. Bone solutions were prepared using the method developed by 
Schwarcz et al. and analyzed using both the enzymatic assay kits and HPLC. Citrate 
concentrations of 1.26 and 1.39 wt. % were reported with the colorimetric assay kits, 
while a concentration of 1.69 wt. % was found using HPLC. These values, when 
compared to the 2010 study Schwarz et al., were not as high with the best recovery, 85%, 




and intra-sample variance indicating the need for a more thorough investigation of the 
sample preparation techniques, as well as the need for critical evaluation of the enzymatic 
assay kits compared to other techniques to quantify citrate concentrations. 
 
2.7.2 Alternative Methods for Measurement of Citrate 
The first alternative method investigated was the use of capillary electrophoresis. 
In this technique anions are injected into a thin capillary glass tubing in the form of a 
small plug that moves rapidly toward an anode generated by a negative power supply. 
Capillary electrophoresis is sensitive, reproducible, and rapid [26]. In a study by Holmes 
et al. citrate concentrations in urine were investigated using capillary electrophoresis; 
however, this analytical technique has not been used in regards to citrate in bone. 
The second technique identified was Nuclear Magnetic Resonance (NMR) 
spectroscopy. NMR spectroscopy uses electromagnetic radiation to cause transitions 
between energy levels. The range of NMR transition frequencies is typically anywhere 
from 10-1000 MHz. NMR signal intensities depend upon differences in the populations 
of energy levels [27].  
Hu et al used NMR to investigate citrate bonded to apatite surfaces. According to 
the study, NMR was able to unambiguously identify the signals generated by citrate in 
bone. This study was able to determine that citrate accounts for 5.5 wt% of the organic 
matter in bone [28]. An example NMR spectra of bone obtained in the study is provided 






Figure 2.8 13C NMR Spectra of Bone, of Organic Residues at the Interface with 
Apatite, and of 13C-labeled Citrate in Bone. (A) Fish bone (B) avian bone (C) Bovine 




2.7.3 High Performance Liquid Chromatography 
The third and final analytical technique investigated was the use of High-
performance liquid chromatography (HPLC). HPLC is an analytical technique that 
utilizes a high pressure to force solvent through closed columns containing very fine 
particles that give high-resolutions separations [23].  
Dunphy, et al. demonstrated that HPLC had a higher recovery rate when detecting 
citrate in bone compared to absorption spectroscopy. The study also demonstrated that 
HPLC was able to detect citrate levels that were closer to those reported in literature by 







2.7.4 Method Comparison 
 A thorough evaluation of these techniques showed HPLC to be the best of the 
aforementioned analytical methods for this particular purpose.  This was confirmed in 
literature, in particular Dunphy who highlighted a number of advantages with HPLC for 
citrate detection in bone compared to absorption spectroscopy [16]. Furthermore, it was 
determined to be a widely available analytical tool, and one commonly used in forensic 
investigations. In addition, HPLC equipment was available for use in this thesis, while 
both NMR and capillary electrophoresis equipment were unavailable. As such, HPLC 
was selected for use throughout this thesis as an alternative analytical technique for the 
determination of citrate content in bone. 
 
2.8 High-Performance Liquid Chromatography 
 In general, chromatography has been accepted to universally cover the science of 
separations. Essentially, the term is used to describe techniques that enable samples of 
chemical mixtures to be separated by exploiting differences in physical or chemical 
properties [42]. These differences govern the rate of migration of the components within 
the mixture that are being influenced by a moving fluid a “bed” of stationary phase [42]. 
Finely ground solids or liquid coating on the solids may form this stationary phase and 
are contained within a tube of metal or glass which is known as the chromatographic 
column [42]. 
 Column chromatography deals with the separation of a mixture of components by 




through the packed column. A mobile phase is used to flow the sample through the 
column, and is known as elution of the sample from the column [42].    
 Differential rates of elution arise from the interaction between the components of 
the sample and the material or coating used to pack the column. In general, there are four 
principles by which components of a sample are selectively retained [42]. The first of 
these is liquid-liquid chromatography, which exploits differences in the partition 
coefficients. The second is liquid-solid chromatography that utilizes absorption effects on 
surfaces such as silica gel. The third principle is ion-exchange chromatography, which 
takes advantage of dissociation of weak or strong electrolytes. The final principle is steric 
exclusion chromatography, which is based on molecular size or shape [42].  
 Retention is defined to be the interaction of a sample with the column packing. In 
any chromatographic system, the degree of retention of a compound is a characteristic of 
that sample as it depends on the size, solubility, absorption, and ionization characteristics 
of that compound in the specific environment in which the system is set up [42].  
 HPLC is the most employed chromatographic technique due to its importance in 
the pharmaceutical industry. It is estimated that HPLC accounts for 60% of the 
worldwide separation science market, while Gas Chromatography (GC) accounts for 35% 
[38]. Overall, HPLC is the most powerful of all the chromatographic techniques as it is 
able to perform analyses and separations that would be challenging or impossible for 






2.8.1 High Performance Liquid Chromatography Systems 
A typical HPLC system consists of a solvent delivery system, an autosampler 
with an autoinjector, a detector, a high-pressure column, and a computer control system 
with integrated software to control the system and data output as seen below (Figure 2.9). 
An oven to control the column temperature is also included with many commercial 


















Figure 2.9 Diagram of a High-Performance Liquid Chromatography System. The main elements of HPLC systems are 























2.8.2 High-Performance Liquid Chromatography Method Development 
 Prior to carrying out quantitative experiments on an analyte in a set of samples, it 
is necessary to develop a suitable method. The problem addressed by the method needs to 
be clear defined, then all available information regarding that problem need to be 
collected. Information that is typically gathered includes the details of the physiochemical 
properties of the analyte, the physiochemical properties of other components in the 
matrix, and the features both good and bad of the available methods [38].  
 In some ways, method development is considered an art that can only be mastered 
through years of experience, but in reality, a simple thought process could be used [38]. 
In the case of citrate, this process revealed the need for an ion-exchange column. 
Following the identification of a column type, testing parameters for the HPLC need to 
be selected [38]. 
 After the column and testing conditions have been determined, manipulation of 
experimental variables relating to mobile phase is typically done to optimize the method. 
Variables in this instance may include the nature and percentage of organic components, 










2.8.3 Citrate Detection Using HPLC 
A review of the literature indicated the use of HPLC for the detection of sildenafil 
citrate, a common pharmaceutical [2]. This study was more focused on sildenafil rather 
than citrate, so the method provided was not determined to be suitable for this study.  
 Dunphy utilized HPLC to evaluate citrate concentrations in bone, but the testing 
parameters of the HPLC and the column used were not clearly defined. A survey of 
columns available for detection of citric acid was done to help get some starting 
parameters from literature provided by the company.   
 
2.9 Research Objectives 
 The overall objective of this thesis was to develop and validate an HPLC 
method for quantitative and qualitative analysis of citrate in bone. In order to achieve this 
objective, experiments were developed to achieve three following three aims.  
 
(1) An HPLC method was developed and tested on a physiologically relevant 
range of citrate standards 
 
 (2) An existing bone specimen processing method was optimized for use with 





(3) Bone samples were prepared and analyzed both qualitatively and 
quantitatively using the HPLC method developed in Aim one and the Bone 
Processing protocol developed in Aim two.  
 
Aim 1 was accomplished through an array of experiments performed on a 
physiologically relevant range of citrate standards (0 to 2.5 mM). In particular, linearity, 
storage time of standards, stock solution pH, and intra-day test method precision 
(repeatability) were examined. Aim 2 was accomplished by designing experiments to 
qualitatively and quantitatively analyze citrate detection in three different bone masses 
(50, 75, and 100 mg). Also, matrix effects were also analyzed through the design and 
execution of standard addition and standard recovery tests. Finally, different types of 
bone (cortical, trabecular, and mixed) were analyzed to determine the optimal type of 
bone and limitations with the HPLC test method. Aim 3 was accomplished by analyzing 
different short term (14 day) storage conditions (hydrated, dehydrated, and room 
temperature), intra-bone factors associated with sampling at different anatomical 
locations (dorsal, central, and ventral), and an analysis of the calculated PMI produced by 
the method described by Schwarcz et al. for all 75 mg cortical only bone samples 







MATERIALS AND METHODS 
 
3.1 Introduction 
The methods established and used throughout this thesis fall into four general 
subsections, namely the preparation of chemical solutions, quantitative and qualitative 
analysis of simple citrate matrices with HPLC, selection and processing of bone 
specimens, and the quantitative and qualitative analysis of citrate in bone with HPLC.  
Subsection 3.2 “Preparation of Chemical Solutions” includes methods for the 
generation of standard solutions, mobile phase for HPLC, and other chemical solutions 
needed throughout the thesis. Subsection 3.3 “Quantitative and Qualitative Analysis of 
Simple Citrate Matrices using HPLC” discusses methods used in the analysis of standard 
solutions comprised of citrate in water including storage time studies, HPLC test 
parameters, and HPLC performance. Subsection 3.4 “Selection and Processing of Bone 
Samples”, provides methods used throughout the selection and preparation of bone 
specimens. This section also includes justification for the use of a porcine model in this 
thesis as well as a discussion of simple quantitative and qualitative methods used to 
optimize the processing protocol of bone specimens. Finally, subsection 3.5 “Quantitative 
and Qualitative Analysis of Citrate Concentration in Bone Using HPLC” discusses 




qualitative and quantitative methods used to further optimize the sample selection and 
analytical technique are discussed. 
 
3.2 Preparation of Chemical Solutions 
 In the section below, methods and materials needed for the chemical 
solutions required in this thesis are provided. Furthermore, the methods and rationale 
used for the preparation of the stock citrate solutions used for standard preparation is 
provided.  Chemicals specific to the processing protocol will be listed in section 3.4.   
 
3.2.1 Chemicals 
Laboratory grade Trisodium Citrate Dihydrate (Na3C6H5O7.2H2O) in granular 
form (S279-500, Thermo Fisher Scientific, Waltham, MA) was used to generate 
calibration standards. Furthermore, it was used throughout standard addition and standard 
recovery tests to spike samples. After use, the container provided by the manufacturer 
was sealed by tightly securing the cap on the container. The container was then left on the 
counter at room temperature (22ºC).  
 Laboratory grade 1N (0.5M) Sulfuric Acid (H2SO4) (SA212-1, Thermo Fisher 
Scientific) was selected for use in this thesis for all solutions requiring sulfuric acid. The 
main uses of this chemical were pH reduction of standard solutions to prevent 
microbiological activity during storage, and the preparation of the 5mM H2SO4 mobile 
phase used in HPLC analysis. Laboratory grade 1N (1.0 M) Hydrochloric Acid (HCl) 




requiring hydrochloric acid. The main uses of this chemical were demineralization of 
bone specimens in order to release citrate into solution. After use, the lid was secured 
tightly onto each bottle provided by the manufacture and stored in an acid storage cabinet 
at room temperature (22ºC) within the lab. 
Unless otherwise designated, all chemical solutions requiring water were prepared 
using ultrapure deionized water (18.2 MOhm-cm resistivity at 25°C, 2ppb TOC) from a 
designated water filtration system (MilliQ, EMD Millipore, Billerica, MA) hereafter 
referred to as deionized water. Fresh water was obtained from the system for each 
preparation of standards as well as all other uses of water throughout this thesis.  
 
3.2.2 Stock Solution Preparation 
In most instances, 100mL of 0.1M stock citrate solution was prepared for each 
run to ensure adequate solution for all experiments. Later on in the study, it became clear 
that 100mL was not necessary, so calculations were adjusted accordingly for 25 and 
50mL volumes. The following calculations are based on 100mL, as this was the most 
often prepared volume.  
 
3.2.2.1 Calculations Used to Prepare Stock Solution 
Stock solutions of 0.1M citrate were prepared by dissolving granular form 
Trisodium Citrate Dihydrate in deionized water. The appropriate mass of Trisodium 
Citrate Dihydrate to be added was calculated using its molar mass of 294.1 g/mole as 














     Eq. 3.1 
 
The subsequent calculation determined the amount of Trisodium Citrate 








∗ 100𝑚𝐿 = 2.941 𝑔                 Eq. 3.2 
 
Based on these calculations, 2.941g of Sodium Citrate Dihydrate powder was 
weighed on a precision (0.0001 grams) balance (Adventurer Pro, Ohaus, Parsippany, 
New Jersey) and placed into a 50mL glass beaker (02-540G, Thermo Fisher Scientific) 
containing approximately 20mL of deionized water. The solution was mixed for 15 
minutes by inserting a clean magnetic stir bar into the solution and placing the beaker 
onto a magnetic stirrer plate (6795-220, Corning).  
Once mixed, the solution was carefully transferred into a 100mL volumetric flask 
with a precision of ±0.1mL (89000-404, VWR). Four of the stock solutions prepared in 
this thesis (1, 2, 6, and 10) were prepared by adding only deionized water to the mark on 
the flask, resulting in a basic stock solution with a pH of approximately 9. The remaining 
stock solutions (3, 4, 5, 7, 8, 9, and 11) were prepared at a pH of 2 in order to match the 
pH of the mobile phase. This was achieved by adding 34mL of 0.5M H2SO4 into a 




added to the volumetric flask until the meniscus was level with the 100mL line of the 
flask using a sterile polypropylene transfer pipette (414004-008, VWR, Radnor, PA). 
A cap was then placed onto the volumetric flask and the solution was further 
mixed by gentle shaking for approximately two minutes. Immediately after, the 0.1M 
stock solution was transferred for storage into a Pyrex 100mL glass container with screw 
top cap (1396-100, Corning, Inc.) and stored at 5°C until use.  
 
3.2.3 Preparation of Citrate Standards 
 This section introduces the methods and materials used to prepare the citrate 
standards used throughout the thesis. In addition, a discussion of the rationale for the 
range of standards used is provided.  
 
3.2.3.1 Concentration Range 
Prior studies have suggested maximum citrate concentrations of approximately 
1.6 wt. % in trabecular bone and approximately 2.0 wt. % in cortical bone [11, 21, 49]. 
An average of these two values was used to generate a theoretical concentration of 1.8 
wt. % within a complete bone specimen that combines equal parts trabecular and cortical 
bone. A simple calculation was then performed to determine the expected mass of citrate 
within a bone specimens containing the maximum wt. % for a given type and mass of 
bone (Eq. 3.3).  
 




Using Equation 3.3, the maximum expected mass of citrate in bone samples 
based on literature values for cortical and trabecular [21, 49] with weights varied from 50 
mg to 100 mg were calculated. A maximum value of 1.5 wt.% for trabecular bone and a 
maximum value of 2.0 wt.% for cortical bone were used. These values were averaged to 
obtain a maximum value of 1.75 wt.% for combined (cortical and trabecular). 
 
Table 3.1: Maximum Expected Mass (mg) of Citrate in Various Weights of Bone Powder 
Bone Type 50 mg 75 mg 100 mg 
Trabecular 0.750 mg 1.125 mg 1.500 mg 
 
Cortical 1.000 mg 1.500 mg 2.000 mg 
 
Combined Trabecular & Cortical 0.875 mg 1.313 mg 1.750 mg 
 
 
Similarly, the expected number of moles of citrate within the different bone 
sample weights and types were calculated using the molar mass of Citrate (189.1 g/mol) 






* Expected mass citrate (mg)=Expected moles citrate (µmol)     Eq. 3.4 
 
The expected number of moles of citrate in bone samples were calculated for the 






Table 3.2: Expected Number of Moles Citrate in Various Weights of Bone Powder 
Bone Type 50 mg 75 mg 100 mg 
Trabecular 3.97 µmols 5.95 µmols 7.93 µmols 
Cortical 5.29 µmols 7.93 µmols 10.58 µmols 
Both 4.63 µmols 6.94 µmols 9.25 µmols 
 
 
The expected number of moles from Table 3.2 were subsequently used to 
determine molar concentrations based on an expected final solution volume of 5 mL as 
seen in the following equation (Eq. 3.5) and applied below (Table 3.3).  
 
𝐸𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑀𝑜𝑙𝑒𝑠 (𝑢𝑚𝑜𝑙𝑠)
𝐸𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝐹𝑖𝑛𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿)
= 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑚𝑀)     Eq. 3.5 
 
Table 3.3 Expected Concentrations of Citrate (mM) in Bone 
Type of Bone 50mg 75mg 100mg 
Trabecular 0.79 mM 1.19 mM 1.59 mM 
Cortical 1.06 mM 1.59 mM 2.12 mM 
Both 0.93 mM 1.39 mM 1.85 mM 
 
 
Overall, a citrate concentration ranging from 0 to 2.5mM was determined to be 
sufficient enough to cover the expected concentrations of citrate in bone based on the 






3.2.3.2 Preparation of Standards 
Seven concentrations of citrate standards were selected and prepared for the 
generation of calibration curves. They were as follows: 0 mM, 0.1 mM, 0.5 mM, 1.0 mM, 
1.5 mM, 2.0 mM, and 2.5 mM, which are hereafter referred to as a set of standard 
solutions. In later work, the 0.1mM solution was not included in some sets as it appeared 
to have no significant impact on the linearity of the calibration curve obtained. However, 
it must be noted that removing the 0.1 mM standard would have an impact on regression 
statistics. 
 The required volume of 0.1M-citrate stock solution required for each 
concentration was calculated using the following process. First the following equation 
(Eq. 3.6) was solved for V1 based on the desired concentration of the standard. 
 
𝐶1𝑉1 = 𝐶2𝑉2                                                      Eq. 3.6 
 
The following values were plugged into the equation to determine V1, the volume 
of stock solution to be added for each concentration. C1 was known to be 0.1M as it was 
the concentration of the stock solution described in section 3.2.2 above. V2, the volume of 
standard solution being prepared, was also known to be 10mL. Inserting these values 










C2 was the concentration of the standard being prepared from 0 - 2.5 mM. Each of 
these concentrations were plugged into an equation (Eq. 3.7) to determine V1 values. This 
process produced the values in the following table (Table 3.4). 
 
Table 3.4 Preparation Volumes Needed for all Concentrations [0-2.5 mM] in a Set of 










0.0  10   0 10.00 
0.1  10  10 9.990  
0.5  10  50  9.950  
1.0  10  100  9.900  
1.5  10  150  9.850 
2.0 10  200  9.800 
2.5 10  250  9.750 
 
 
The calculated volumes of 0.1M-citrate stock solution were then carefully 
pipetted (89133-288, VWR ) from the stock storage container into seven, or six in cases 
when the 0.1 mM solution was not included, individual 10mL glass volumetric flasks 
having a precision of ±0.02mL (89000-398, VWR).  Pipette tips were discarded after a 
single use to prevent cross contamination. Deionized water was subsequently added to 
each volumetric flask until the meniscus was level with the mark on the flask. 
Each of the concentrations were transferred from their volumetric flasks to 15mL 




tubes which were then stored at room temperature (22 C) until use. After all analysis 
was completed, standards were stored in the centrifuge tubes at room temperature (22ºC).   
 
3.2.4 Mobile Phase Preparation 
 A 5 mM (0.005M) H2SO4 mobile phase used was used for all HPLC analysis 
throughout this thesis. Fresh mobile phase was prepared prior to flushing of the column 
on the day of testing using laboratory grade 0.5M sulfuric acid (SA212-1, Thermo Fisher 
Scientific). For the most part, 1L of mobile phase was prepared for each run, as such all 
calculations were for this volume.  
First, filtered, deionized water was degassed by pulling vacuum on a 1L Pyrex 
square base glass bottle (1396-1L, Corning) containing a magnetic stir bar. Each bottle 
was placed on a magnetic stirrer plate set at a speed of approximately 2 for at least 24 
hours before the mobile phase preparation.  
After degassing overnight, the water was carefully transferred into a 1000 mL 
glass graduated cylinder with a precision of ±5 mL (89001-686, VWR). The volume of 
water remaining after degassing was measured to account for volume loss. A calculation 
was used to determine the amount of 1N (0.5 M) H2SO4 solution needed to reach a 
desired solution concentration of 5mM (0.005 M).  
A sample calculation for the preparation of 1000mL of 5 mM H2SO4 solution is 
demonstrated below: 
 




In this instance, C1, C2, and V2 are all known values. C1 is the original 
concentration of the H2SO4 solution or 1N (0.5M). C2 is the desired concentration of the 
final solution or 5 mM (0.005M) H2SO4. V2 is the final volume of the 5 mM H2SO4 
solution, which in this example is 1000 mL. V1, the amount of sulfuric acid to add, was 
determined from this calculation.   
A sample calculation using this method is seen below. First, the known values 
were inserted to simplify the equation. Then simple algebra was used to solve the 
equation for V1. As demonstrated below in Equations 3.9- 3.11 below, to prepare 1L of 
mobile phase, 10 mL of 1N H2SO4 was needed.  
  
0.5𝑀 ∗ 𝑉1 = 0.005𝑀 ∗ 1000 𝑚𝐿                                    Eq. 3.9            
 
0.5𝑀 𝑉1 = 5 𝑀 ∗ 𝑚𝐿                Eq. 3.10 
 
     𝑉1 = 10 𝑚𝐿                                        Eq. 3.11 
 
Once V1 had been obtained from the equation, a corresponding amount of water 
was taken out of the 1000 mL graduated cylinder and discarded using an Eppendorf 
Research Plus 10mL Pipettor (89131-970, VWR) with disposable tip. Immediately after 
this step, the corresponding amount of 1N sulfuric acid was added in order to create a 5 




Runtimes varied due to the number of samples tested, as such, a calculation was 
required to ensure adequate mobile phase had been prepared. As discussed later, for the 
most part each sample was run for approximately 15 minutes at a 0.6 mL/min flow rate. 
In order to calculate the amount of mobile phase needed, a simple method is described 
below. 
First, the number of samples was multiplied by the run time for each sample to 
determine the overall run time, TT. In almost all experimental runs the number of samples 
were approximately 30 and sample run time was usually 15 minutes per sample.  
 
# 𝑠𝑎𝑚𝑝𝑙𝑒𝑠 ∗ 𝑠𝑎𝑚𝑝𝑙𝑒 𝑟𝑢𝑛 𝑡𝑖𝑚𝑒 = 𝑇𝑇                      Eq. 3.12 
 
Then the total overall run time was multiplied by the flow rate, 0.6 mL/min for 
almost all samples to determine the theoretical volume needed (VT) for the HPLC run.  
 
𝑇𝑇 ∗ 𝑓𝑙𝑜𝑤 𝑟𝑎𝑡𝑒 = 𝑉𝑇                                  Eq. 3.13 
 
 Finally a safety volume (VS), typically 250 mL, was added to this number to 
ensure an adequate amount of mobile phase was available for the total time of the run. 
 





 Inserting typical values for number of samples, 35, and sample run time, 15 
minutes, yields a TT = 525 minutes. A flow rate of 0.6 mL/min gives a VT= 315 mL. Then 
using a VS=250 mL, the actual volume one should prepare is 565 mL. This process does 
not account for the mobile phase needed to prepare the column which is typically another 
200 mL. Overall, a good estimate for amount of mobile phase needed for an average 
number of samples is 1L.  
 
3.2.5 Preparation of 1.0M Potassium Hydroxide Solution 
A 1.0M Potassium Hydroxide (KOH) solution was needed for the bone 
processing protocol discussed later. For all KOH solutions prepared in this thesis, 
Potassium Hydroxide in pellet form (P251-500, Thermo Fisher Scientific) was dissolved 
in deionized water.  
A molar calculation was done to determine the weight of KOH pellets needed to 
prepare 100 mL of a 1.0M solution. For all solutions prepared in this thesis, 5.611g of 
KOH pellets were weighed on a precision (0.0001 grams) balance (Adventurer Pro, 
Ohaus) and placed into a 100mL beaker containing approximately 20mL of deionized 
water. A clean magnetic stir bar was then inserted into the beaker and subsequently 
placed onto a magnetic stirrer plate. After 15 minutes of mixing, the solution was 
carefully transferred into a 100mL volumetric flask with an error of ±0.1mL (89000-404, 
VWR). Deionized water was added to the volumetric flask until the meniscus was level 




The KOH solutions were then transferred into two polypropylene 50mL 
centrifuge tubes (89401-562, VWR). Each of the tubes were capped and stored at room 
temperature (22ºC). Each tube was able to provide enough volume for roughly 30 sample 
preparations.  
In total, six main chemical solutions were prepared and utilized throughout the 
entirety of this thesis. In order to better clarify the reference names of the solutions and 
their compositions, a table was prepared. In the table below, the reference name of the 
solution in this thesis is provided, along with their concentration or concentration range, 






Table 3.5 List of Chemical Solutions Used throughout Thesis. Maximum concentrations 
listed for bone solutions are the concentrations determined in Table 3.3. 
 
Reference Name Concentrations Solute Solvent pH Adjustment 
Stock Solution 0.1 M Citrate Powder DI H2O 0.5 M H2SO4 
 
Set of Standards 
 


























1.0 M HCl 
 










1.0 M HCl 
 





0 – 1.85 mM 
 
Ground cortical and 
trabecular bone 
 
1.0 M HCl 
 
1.0 M KOH 
  
 
3.3 Execution of Chemical Analysis using High Performance Liquid Chromatography  
This section will introduce the methods and materials used to analyze samples 
with HPLC. Emphasis will be placed on the HPLC system and software, as well as test 
method parameters. The items discussed in this section will be applicable to all HPLC 
analysis performed in this thesis  
  
3.3.1 High Performance Liquid Chromatography System 
HPLC analyses were carried out using a Waters Breeze 2 HPLC system (Waters 
Corp., Milford, MA). It was comprised of the following components: a model 1525 
Binary HPLC Pump, model 2707 Autosampler, and model 2998 Photodiode Array 







Figure 3.1: Waters Breeze 2 HPLC System Used in this Thesis. In this picture the main 
components of the system are labelled as follows: (A) model 2707 Autosampler, (B) 








3.3.2 Column Selection 
 Columns were investigated in order to identify an appropriate column for the 
specific application of detecting citrate in bone. An appropriate column was defined to be 
one capable of detecting citric acid at approximately pH of 2.  A search of available 
columns indicated that a column dedicated to the detection of organic acids would 
provide the best results for this application. Table 3.6 contains a list of five manufacturers 




Table 3.6: List of Selected Columns for HPLC Analysis of Organic Acids 
 
Manufacturer Column Part Number 
Bio-Rad 
Laboratories 
Aminex HPX-87H 1250140 
 
Thermo Scientific  
 
Acclaim OA, 5 µm 




   
Agilent 
Technologies 
Agilent Hi-Plex H, 
7.7 × 300 mm, 8 µm 
PL1170-6830 
   
Restek Corporation Allure® Organic 
Acids, 5 µm, 300 


















The Aminex HPX-87H by Bio-Rad Laboratories (Hercules, CA) was selected due 
to its successful use in a preliminary study conducted by Dunphy [16]. Furthermore, the 
column advertised a fairly low retention time for citric acid (8.20 minutes), providing for 
a relatively low run time for large sample volumes, which is a practical concern for 
translation to forensic labs [4, 5].   
 
3.3.3 Aminex HPX-87H Organic Acid Column 
All analyses in this study were performed on a single Aminex HPX-87H Ion 
Exchange column obtained from Bio-Rad (Bio-Rad, Hercules, CA) (Figure 3.2). In order 
to minimize costs, an organic analysis kit containing the Aminex HPX-87H column, two 
Cation H+ Micro-Guard Cartridges, and organic acid standard was purchased (125-034, 
Bio-Rad). A standard cartridge holder was also obtained in order to hold and connect 
guard columns to the system (125-0131, Bio-Rad).  
 Literature from the manufacturer stated the column has a maximum flow rate 
between 0.5 and 0.7 mL/min, a maximum operating temperature of 65° C, a pH range of 
1-3, and a maximum operating pressure of 1,500 psi [4, 5]. Furthermore, the shipping 







Figure 3.2 Aminex HPX-87H Column Used in this Thesis 
 
3.3.4 Software 
The built in software of the Waters Breeze 2 System was used to perform data 
acquisition and peak integration. Furthermore, raw data was exported from the Breeze 
software for further analysis using Microsoft Excel (Microsoft, Redmond, WA). Excel 
was also used to analyze the peak areas determined by the system software. Peak 
integration will be discussed further in Section 3.3.5 below.  
 
3.3.5 Test Method Parameters 
A testing method was established and saved in the Breeze 2 system software. The 
parameters of the method were as follows: 35° C, flow rate of 0.6 mL/min, detection at a 
time constant standard 210 nm, wavelength scan from 200-400 nm, and an alarm set at 
1400 psi to ensure max pressure was not passed.  
Pressure was monitored closely as the column was connected in the system to 
ensure the machine was performing adequately. Throughout the majority of this thesis, 




As stated in section 3.3.2, the mobile phase (solvent moving through the column) 
used in this study was a 5 mM (0.005M) H2SO4 solution, as recommended by the 
manufacturer. The stationary phase (one that stays in place in the column) was sulfur 
trioxide, SO3 
–, bound to polystyrene according to the manufacturer (Bio-Rad).   As cost 
was a key consideration in the method development, mobile phase was prepared by 
diluting a stronger concentration rather than purchased directly in the more dilute form. 
  
3.3.6 HPLC sample preparation and disposal 
Glass HPLC vials with pre-slit Teflon septa (Waters Corporation, Milford, MA) 
were used to hold samples for testing. Initial testing was done with 2 mL clear glass vials 
(186000307C, Waters), while later testing was done with amber vials (186007194C, 
Waters) due to concerns of possible photodegradation. Each vial was labeled with 
specimen name including concentration and content, as well as the date of preparation.  
Samples were transferred from 15 mL centrifuge tubes to HPLC vials by a Becton 
Dickinson Tuberculin syringe (14-829-10D, Thermo Fisher Scientific) with the needle tip 
removed for standards, and attached for bone solutions due to smaller volumes of sample.  
Nylon membrane Acrodisc syringe filters from Pall life Sciences (28143-985, 
VWR) were used to filter samples prior to testing. Each syringe tip filter was primed by 
passing a small amount of sample solution, approximately 0.5 mL if possible, through the 
filter into a waste container. Immediately after, the syringe tip filter was placed in the 
opening of the correctly labeled glass HPLC vial. Approximately 1.5 mL of sample 




After the solution had been transferred, a pre-slit cap was screwed onto the vial. 
The syringe and syringe tip filter were discarded, while the vials were loaded onto an 
auto sampler tray and placed into the Waters auto sampler for testing. An example of a 
filled tray can be seen below (Figure 3.3). 
Sample sets were created and saved with the Breeze 2 software to reflect the order 
of the samples placed in the tray by the user. Samples were tested in the order dictated in 
the Breeze 2 software. After each run, samples were kept for two weeks in the event 
further analysis was needed. Beyond this time period, HPLC samples were emptied into 
an appropriate waste container and glass vials were placed into a glass waste container.  
 
 
Figure 3.3: Autosampler tray with vials placed in a specific test order. Each location 
corresponds to a letter and number which is represented in the system software. Test 





3.3.7 Column Preparation and System Equilibration 
Prior to analyzing the samples, the Aminex-HPX87H column was preconditioned 
as advised by the manufacturer. Approximately 20 mL of degassed mobile phase was 
passed through the column at a flow rate of 0.2 mL/min at room temperature. After this 
step, the column was placed into the column heater attached to the Breeze system and 
allowed to slowly heat to the operating temperature of 35ºC at the same flow rate. Once 
heated, the flow rate was increased to 0.6 mL/min over 5 minutes with incremental 
changes taking place. Once the column had a steady pressure with no apparent 
fluctuation, the lamp of the PDA detector was turned on in order to allow the detector to 
equilibrate.  
Mobile phase was allowed to move through the column as the lamp was warming 
up, and a test method saved with the name “citric acid equilibrium” was used to monitor 
the baseline produced by the system. The baseline was monitored in order to determine 
when to begin analysis of the samples. Once the baseline appeared to be stable with little 
fluctuation, the equilibration method was stopped, and analysis of the samples was 
begun. A typical stable baseline obtained at the end of the equilibration process is shown 








Figure 3.4: Baseline capture after one hour of equilibration with mobile phase for 
multiple wavelengths (top) and single wavelength (bottom). These were both considered 
stable as the fluctuation range was less than .001 absorbance units for both baselines. 
 
 
3.3.8 Analysis of HPLC Data 
HPLC results were analyzed using the Waters Breeze 2 Software integrated into 
the Waters Breeze 2 system. The citrate peak in each chromatogram produced was 
integrated using the built in integration capabilities of the Waters Breeze 2 software. A 
straight line was drawn from the start of the citrate peak as indicated by an increase of the 
absorbance units from the baseline level until a return to baseline was evident in the 
chromatogram. When necessary, the zoom functions of the software were used to ensure 
accurate start and stop points for the range of integration. An example of peak integration 






Figure 3.5: Example of peak integration in the Breeze 2 Software for a 0.5 mM standard 
solution. Retention time and Peak area are highlighted in black, while the red lines under 
each peak represent the beginning and end of the peak integration. 
 
Peak area and retention time values were then transferred by copying the data 
from the breeze software and subsequently pasting the data into a Microsoft Excel 
spreadsheet. Each spreadsheet was named with the run date and saved for further 
analysis. Chromatograms were also acquired by either taking screen captures of the 
Breeze 2 Software or by copying the chromatogram from the software and pasting it into 
a Microsoft Word document (Microsoft).  
An export function in the Breeze software was used to export raw data for 
analysis. Each file was exported in .awf format, which was then opened with Microsoft 
Excel. The .awf files were then used to prepare chromatograms for qualitative analysis of 
each sample. Each chromatogram had time on the x-axis and absorbance units, the signal 




3.3.9 Calibration Curve Tests 
Eleven sets of standard solutions containing all seven concentrations from 0.0 to 
2.5 mM were prepared for this experiment. All 11 sets of standards were made from 
0.1M stock solutions prepared on the same day as the standard solutions. Five of the sets 
of standards were prepared at a pH of approximately 9, while the other six were prepared 
at a pH of approximately 2 by adding sulfuric acid to the stock solutions, as described in 
section 3.2.3 above.  
The first six sets were analyzed at two time points to determine the impact of 
storage time on the concentrations of citrate in the simple matrices. In general, a time 
zero measurement was taken followed by a subsequent analysis two to four weeks after 
depending on availability of the HPLC. All sets were stored in a cardboard box at room 
temperature (22°C) with the caps tightly secured on the 15mL centrifuge tubes. The 
concentrations and slopes obtained between time zero analyses and the aged analyses 
were compared to analyze variance over storage time. Furthermore, the concentrations 
and slopes of the different pH values were compared to determine if the stock pH had any 
impact on the observed concentrations of citrate. Standard sets 7-11 were analyzed only 















Linearity is a measure of how well a calibration curve follows a straight line [23]. 
Based on the expected citrate concentrations in bone determined in section 3.4, a 
concentration range of 0 to 2.5 mM was tested. After analysis, the square of correlation 
coefficient (R2) was calculated to measure linearity [23]. The equation used to find R2 is 
shown below (Eq. 3.15).  
 





2                                      Eq. 3. 15 
 
 
In this equation, x̅ is the mean of all x values and y̅ is the mean of all y values. 
The RSQ function in Microsoft excel was used to find all R2 values. RSQ required the 
known x values, concentrations, and the known y values, peak areas. The function 
returned the value of R2.  
 R2 needs to be very close to 1 to represent a linear fit [23]. As the concentrations 
of citrate in bone are very low (less than 2.0 wt.%) in comparison to the main 
components of bone, linearity boundaries were determined by treating citrate as an 
impurity in the sample. As such, an R2 value of 0.98 was deemed acceptable for the range 
of 0.1 to 2 wt.% [23]. 
 Another common metric for linearity is the y-intercept of the curve after the blank 
concentration is subtracted. This method should produce a y-intercept close to 0 [23]. 
Treating the method as an impurity assay means that an acceptable y-intercept should be 
≤ 10% of the response for the 2.5 mM standard. When the y-intercept was negative, the 




3.3.11 Instrument Precision Tests 
Instrument precision or injection precision is the reproducibility observed when 
the same quantity of one sample is repeatedly injected into an instrument (≥ 10 times). 
This is also referred to as intra-day test method precision as the results are obtained under 
the same conditions over a short time interval [52]. Relative standard deviation (RSD) 
was used to assess the results of repeatability tests in this thesis. RSD was determined by 
using the following equation (Eq. 3.16) where s was the standard deviation of the sample 




       Eq. 3. 16 
 
An acceptable precision for our test method was defined to be an RSD ≤ 5% near 
the limit of quantitation [52]. As instrument precision was considered early in the 
development process, 0.5 mM standards were used in this test. In particular, two different 
0.5mM standard solutions, one from set 04_B and the other from set 04_A, were 
prepared for repeatability tests. Ten injections from each vial were performed and 
subsequently analyzed for peak areas of citrate peaks. The standard deviation and mean 
of the injection were obtained for each standard and analyzed to determine if the machine 







3.3.12 Statistical Methods 
 Throughout this thesis, the following statistical tests were used: One way 
ANOVA, Repeated Measures ANOVA, unpaired t-test, and paired t-tests. Each test is 
specifically stated, as is the obtained p-value. When stated, one way ANOVA tests were 
used to compare the differences in group means and were followed by a post-hoc test 
(Tukey’s HSD) for pair-wise comparisons.  Repeated measure ANOVA tests were used 
when populations were related. Two-tailed, unpaired t-tests were done to compare group 
means as stated. Two-tailed, paired t- tests were done when data could be paired. An 
alpha value of 0.05 was employed in all statistical calculations. All statistical analysis in 
this thesis were accomplished with Minitab Statistical Software version 17(Minitab Inc., 
State College, PA). 
  
3.4 Selection and Preparation of Bone Samples Solutions 
 This section addresses the key methods, materials, and rationale used throughout 
the selection and preparation of the bone samples used throughout this thesis. In general, 
this section will address the rationale of the porcine animal model and the methods and 









3.4.1 Animal Model 
Different animal models were investigated for use in this thesis to ensure results 
would be applicable in a forensic anthropology context. Furthermore, the results obtained 
in this thesis needed to have a high degree of translation to human bone. As such, a set of 
criteria was established to ensure the selected model would be acceptable.  
Animal species were evaluated for the following five criteria to determine the 
optimal model for use in this thesis. First, the bone needed to have similar biochemical 
and mechanical properties as human bone. Second, the bones needed to be easily 
acquired and widely available to many researchers to ensure results could be validated by 
others. Third, the bones used needed to be suitable for a lab environment [8]. Namely, 
bones needed to be easy to handle and store in a lab environment, as well as not pose any 
unnecessary risks to researchers. Fourth, the overall gross morphology of bone was 
considered to ensure the size of the bones was easy to work with in this application. 
Finally, the bones needed to have been validated by use in other studies on citrate in 
bone, and in particular studies on citrate in a forensic context. 
 The correlation between the biochemical and mechanical properties of human 
bone and the animal models being considered for use was critical, and as such was the 
first criterion used to screen possible options. The results of this analysis provided two 







Table 3.7. Summary of Four Key Attributes in Terms of Similarity between Animal and 




Canine Sheep/Goat Pig Rabbit 
Bone Composition     
Bone Remodeling     
 least similar,  moderately similar,  most similar. 
 
Porcine morphologic and anatomic characteristics were determined to be more 
comparable to humans than those of canine origin due to bone regeneration rates [56]. 
Porcine bone was also found to be more similar to human bone in mineral density and 
concentrations when compared to canine species [1]. In order to further validate the 
results of the first screening process, the second criterion discussed, ease of use within a 
lab, was evaluated for the porcine and canine animal models. This analysis yielded the 
following: (1) a porcine model was more readily available in large quantities and (2) was 
more suitable for a lab environment due to ease of use and minimal risk posed to 
researchers in comparison to a canine model. A porcine model was further substantiated 
by an evaluation of porcine bone gross morphology that demonstrated an easy to work 
with size for the application in this thesis. Finally, porcine bone models been used in 
similar studies on bone decomposition [1, 29, 49, 60]. As such, it appeared that using a 
porcine model would allow us to produce data that was translational to human bone, as 






3.4.2 Selection of Porcine Ribs 
 Once an adequate animal species had been selected, a set of criteria was 
established to determine the appropriate anatomical location of bone to sample. In 
general, this analysis was done to ensure adequate access to samples, easy to work with, 
and also able to meet our experimental needs. 
Based on our overall objectives, an optimal anatomical bone model was defined 
to be one that was: (1) accessible, (2) easy to section, and (3) translational to human 
bone. Accessible in this thesis was defined as a bone source that was readily available 
and easily obtained for use. This criterion narrowed down the possible anatomical 
locations to ribs, feet, or loin as they are common cuts of meat available in a meat section 
at a grocery. The second criterion narrowed the decision to one location, as porcine rib 
was the only location that was deemed to be easy to section due to adequate bone and an 
easy to work with gross morphology. Finally, this selection was validated by similar 
studies that also selected to work with porcine rib bones as a sufficient model of human 
bone [16, 49].  
 
3.4.3 Sectioning Rib Bones 
In total, six fresh racks (complete set of ribs) were obtained from a local grocery 
story for all bone analysis in this thesis. Each rack consisted of 12 to 13 porcine ribs, and 
in some instances a sternum. All bone analyses were performed on the fresh porcine rib 
bones either immediately after purchase or after storage in a freezer at approximately -




approximately 5°C overnight or at room temperature approximately one hour before 
sample preparation. The racks were numbered in the order they were obtained with Rack 
1 being the first rack and Rack 6 being the last. Each bone specimen was labeled with the 
rack from which is was obtained by including an R with the rack number immediately 
following (R#). 
Bones in each rack were numbered from 1 to 12 or 13 depending on the number 
of ribs present. Numbers were assigned by placing the rack in a cranial to caudal manner 
with the cranial most rib on top (Figure 3.6). Cranial to caudal manner was determined by 
the curvature and gross morphology of each rack of ribs. Each rack contained a very 
small bone that was in all cases the caudal most rib present, and as such was placed on 
the bottom of each set. A profound curve to each rack could be observed to further 
confirm the appropriate direction of each rack of ribs. Numbers were assigned in an 
ascending fashion, such that the small rib on the bottom had the highest number assigned. 
Care was taken to ensure that each rib number was appropriately documented in all 
samples prepared and was recorded for each sample by placing a B with the bone number 
immediately following the rack and rack number (R#B#).  
Each specimen cut from a bone was given a number to help identify the location 
of the specimen along a bone. In general, a 2 mm section was taken off of the dorsal end 
of the bone and removed as it was exposed during the processing of the ribs by the 
grocer. Next, 2-4 mm sections were taken along the bone with each section being given a 
number in an ascending fashion such that the first specimen was number one and the last 




identified by the rack number, bone number and specimen number by placing an S and 
specimen number immediately after the bone number (R#B#S#). This labeling system 
was maintained throughout the entirety of the thesis. 
 
Figure 3.6 Image of Rack of Ribs positioned in a Cranial to Caudal manner. 
 
3.4.4 Defleshing of Porcine Rib Bones 
Bones were defleshed by removing the soft tissue surrounding the porcine ribs 
through mechanical separation with a stainless steel surgical scalpel blade (Figure 3.7). In 
some instances, a large stainless steel kitchen knife was necessary to remove large 
sections of tissue that were too thick to mechanically shear with the scalpel.  After the 
majority of the soft tissues had been removed, forceps were used to remove the final layer 















on each bone, but in some instances, the removal of the cartilaginous regions on the 













Figure 3.7 Images of Bone Pre and Post Defleshing. A stainless steel scalpel was used to 
mechanically remove most of the soft tissues on the bone.  
 
3.4.5 Bone Sectioning 
 Following defleshing, porcine rib bones were sectioned into 2-4 mm specimens 
by a water-cooled band saw (Microedge, Dorn and Hart, Villa Park, IL). An initial 2 mm 
section was taken off the dorsal side of the bone in order to ensure sample analyses was 
not impacted by the bone exposed during the processing of the ribs by the grocer. 






became too short to safely introduce to the blade without posing a risk to the researcher. 
At this point, a pair of stainless steel forceps were used to hold the ventral end of the 
bone and slowly and carefully introduce the bone to the blade. After processing, the band 
saw was cleaned with bleach and tap water to ensure no residual citrate would be present 
in subsequent sections. The remaining parts of bone not sectioned were placed into a 
polypropylene storage container and placed into a freezer at at approximately -18° C.  
 
 
Figure 3.8 Section of Bone Acquired for Analysis. The average section was 2-4 mm in 
width and was obtained using a water-cooled bandsaw. 
 
3.4.6 Bone defatting 
 Bone sections were defatted in a mixture of chloroform and ethanol (1:1). For 
each specimen, a 50 mL Pyrex glass beaker (13912-149, VWR) was obtained and placed 
into a fume hood [49]. Immediately after, one mL of reagent grade chloroform (S25248, 
Fisher Scientific) was added into the beaker under a fume hood. Next, one mL of 





Specimens were then placed into the glass container and allowed to sit in the mixture for 
one hour. Finally, the samples were allowed to air dry for 10 minutes under the hood.  
 
3.4.7 Bone Type Preparation Steps 
After defatting, bone specimens were transferred to a lab bench and allowed to 
dry for an additional 10 minutes. Bone marrow was preserved in all samples to prevent 
potential loss of citrate in processing. When specimens containing both cortical and 
trabecular bone types were desired, specimens skipped the first step and proceeded to the 
bone grinding method. Cortical only specimens were prepared by manually removing 
trabecular bone with a stainless steel scalpel. Trabecular specimens were prepared by 
saving the removed trabecular bone from the above step in a 15mL polypropylene 
centrifuge tube. 
3.4.8 Bone Grinding  
All bone specimens were ground using a mortar and pestle. In this process, each 
specimen was cooled with liquid nitrogen and pulverized by hand using a mortar and 
pestle in order to generate a powder with a particle size <20 um. Bones were ground until 
an adequate amount (approximately half) of the bone was a fine powder (Figure 3.9). All 
steps in this process were done under a hood to prevent unnecessary exposure to the bone 
powder to both researchers and others using the lab. Liquid nitrogen was carefully poured 
onto the bone from an acceptable container, and subsequently left undisturbed for 15 
seconds. The mortar and pestle were then used to grind the bone into a fine powder. On 




grinding. Once an adequate amount of bone was finely ground, all powders were allowed 
to air dry for at least five minutes prior to weighing. Next, the bone powder was weighed 
to ensure enough of the bone specimen had been obtained for all testing, and 
subsequently transferred into a clean 15 mL centrifuge tube until further testing was 
needed. In cases where subsequent processing would not occur for over six hours, 



































Figure 3.9 Images of Bone Pre (A) and Post (B) Grinding with Mortar and Pestle. Bone 
sections were ground with the mortar and pestle until an adequate amount for sampling 







3.4.9 Bone Digestion 
The finely ground bone powder was transferred from the centrifuge tube to a 
clean polystyrene weigh boat (89106-764, VWR). Then 75 mg except where noted was 
weighed and transferred into a clean 15mL centrifuge tube. Care was taken to ensure all 
of the weighed powder was transferred into the tube. In addition, the tube was capped and 
gently tapped to ensure the powder was on the bottom of the tube. Next, 2mL of 1.0M 
HCl was added to each centrifuge tube, which was then placed into a 60°C water bath for 
four hours to demineralize the bone.  
 
3.4.10 Final Processing Steps 
After digestion of the bone, each solution was neutralized with a 1.0 M potassium 
hydroxide solution as described in Section 3.2. Potassium Hydroxide was added until the 
bone solution was determined to have a pH of 2 as indicated by pH test strips with a 
range from pH 0 -2.5 and a 0.3 resolution (Millipore MColorpHast pH-indicator strips 
(non-bleeding), VWR)  The volumes of KOH necessary were estimated using Visual 
MINTEQ equilibrium software as seen below in Table 3.8. The values in the table 
assume 2mL of strong acid (1M HCl), pH adjustments with a strong base (1M KOH), and 












50 mg bone 
digested 
100 mg bone 
digested 
















pH after bone 
digestion 
0.254 0.285 0.480 0.587 0.890 1.225 
 
Milliliters (mL) 






















Immediately after neutralization, sample tubes were centrifuged at 1200xg for 5 
minutes (Sorvall ST 40R, Thermo Scientific). The supernatant was decanted and stored in 
a clean 15mL centrifuge tube. The remaining pellet, consisting of collagen, was saved in 
a labeled tube and stored in a freezer at -18°C. The centrifuge tube containing the 
supernatant was labelled and stored in a refrigerator at approximately 5°C until HPLC 
analyses were performed. An overview of the entire preparation process for porcine rib 









Figure 3.10: Overview of the preparation process of porcine rib bone citrate solutions. 
Modified procedure for the preparation of porcine rib bone specimens for HPLC analysis 
based on protocols by Schwarcz et al. and Kanz et. al [32, 49]  
Deflesh bones mechanically using a scalpel then obtain porcine rib bone section using water 
cooled diamond blade band saw 
Defat bone specimens in a 1:1 Chloroform to Ethanol Mixture in a 50 mL Beaker for one hour 
and allow to air dry for 10 minutes 
Grind bone into a fine powder using a mortar and pestle cooled with liquid nitrogen. Allow to air 
dry for 5 minutes. 
Measure out 75 mg of bone into a 15 mL centrifuge tube and add in 2 mL of 1.0M HCL 
Demineralize each sample in a 60°C water bath for 4 hours 
Centrifuge each sample for five minutes at 1200 x g, then carefully decant supernatant into a clean 
15mL tube 
Prepare each sample for analysis with HPLC 





3.5 Quantitative and Qualitative Analysis of Citrate Concentration in Bone Using HPLC 
A series of 8 tests were developed and executed to optimize translation of the 
HPLC test method to bone samples. In particular, optimal mass of samples were studied 
to determine the best mass of bone to sample. Second, standard recovery and standard 
addition tests were performed to determine potential losses of citrate during the bone 
processing steps as well as the presence of matrix effects [23]. Third, different types of 
bones were analyzed qualitatively and quantitatively to determine the optimal bone type 
with the method. Fourth, different storage environments were evaluated to determine if 
where samples are stored would have an impact on the citrate concentration. Fifth, 
locations along a bone were sampled to determine if the location of a specimen along a 
bone had an impact on the measured concentration of citrate. Sixth, samples filtered with 
molecular weight cutoff centrifuge tubes and unfiltered samples were qualitatively 
analyzed to determine if the extra filtration had a noticeable impact on the peaks observed 
in chromatograms. Seventh, different methods used to obtain concentrations in samples, 
standard addition and calibration curve methods, were compared to determine if any 
significant difference in concentrations was seen between the two populations. Finally, 
different integration fits in the breeze software were qualitatively analyzed to determine 








3.5.1 Optimal Mass Test 
Prior studies on citrate with porcine rib bone all utilized 50 mg samples 
throughout sample preparation [16, 21, 49]. Each of these studies were done with 
enzymatic assay kits in microwell plates requiring small volumes of sample for analysis. 
As such, large masses of bone were not considered, as they offered no obvious advantage 
with the analytical technique. With HPLC, larger volumes of samples can be prepared 
and analyzed as the only limitation to sample volume is the volume of the vial containing 
the solution.  
As discussed in Section 3.2, 50, 75, and 100 mg samples have expected 
concentrations of 1.06 mM, 1.59 mM, and 2.00 mM respectively for cortical only 
solutions (Table 3.3). Using a 50mg sample with the calibration curve range selected 
would cause all results to be in the lower range of concentrations, which would not be 
desired. The larger masses should produce larger peaks, and also provide concentrations 
in the upper range of the calibration curve. Overall, each of these masses were tested to 
determine if the HPLC method was impacted by the mass of bone in the solution 
prepared and analyzed. In order to determine whether or not the mass of bone prepared 
for analysis has an impact on the concentration of citrate detected, three different weights 
of bone (50mg, 75mg, and 100mg) were processed and analyzed using HPLC.   
The method used for this analysis is as follows. Two porcine rib bones (R3B5 and 
R3B6) were prepared and sectioned into 18 bone sections, 12 sections from R3B5 and 6 
sections from R3B6, as outlined in section 3.4. The 18 bone sections were subsequently 




sections. Group 1 was comprised of sections 1-6 from R3B5. Group 2 was comprised of 
sections 7-12 from R3B5. Group 3 was comprised of sections 1-6 from R3B6.  The 6 
sections for each group were then ground together into a large pile of bone powder using 
the method described in section 3.4.8. The piles for each of the 3 groups of bone were 
then used to prepare a solution for each of the three different masses (50, 75, and 100 
mg). Solutions were then labeled based on the mass of bone present and the group from 
which the bone was obtained. For example, the 50 mg sample from group 1 was labeled 
as bone solution OM 50-1.  
The bone samples were then run through the final steps of the sample preparation 
method listed in section 3.4.10 with two main differences between mass groups. First, the 
amount of 1.0M KOH solution added after digestion was varied, as the higher masses 
required less base to reach a pH of 2 due to higher initial pH. Second, 50 mg samples 
were digested for one hour, 75 mg samples were digested for two hours, and 100 mg 
samples were digested for four hours in order to ensure adequate demineralization 
occurred. The volumes added to each mass can be found in Section 3.4.10 (Table 3.8).  
Samples were then analyzed qualitatively and quantitatively to determine the 
impact of mass on citrate detection. Qualitatively, chromatograms were analyzed for peak 
resolution and separation. Quantitatively, peak areas were obtained as described in 
Section 3.3.8. A calibration curve was then used to determine the molar concentration of 
the samples that were normalized into wt. % and compared using the statistical 





3.5.2 Standard Addition Tests 
Standard addition tests were designed and executed to screen the digested, pH2-
adjusted bone solutions for matrix effects at the analytical stage. Matrix effects were 
defined to be any signal change caused by anything in the sample other than analyte [23]. 
In this test, three bone solutions were prepared using the method defined above and 
subsequently prepared as outlined below. 
First, a single bone solution was transferred into a 10mL graduated cylinder and 
the volume of the sample was recorded. As each specimen was prepared in the same 
manner, it was assumed that this volume was equivalent in all samples prepared. In 
general, the volume of recovered solution was approximately 3 mL. This volume was 
subsequently divided by the number of additions being prepared, typically 3 additions, in 
order to determine the amount of sample to transfer to a microcentrifuge tube. In general, 
800 µL was transferred into each of the microcentrifuge tubes. It was critical to ensure at 
least 500 µL was transferred into each tube, as the HPLC autoinjector required this 
volume in each injection for complete analysis of the sample.  
Once the solution had been appropriately divided into the microcentrifuge tubes, 
calculations were performed in a manner similar to section 3.2.3.2 in order to determine 
the appropriate volume of the 0.1M stock solution to add to each microcentrifuge tube to 







3.5.3 Standard Recovery Tests 
Standard recovery tests (also referred to commonly as fortification tests) were 
done to evaluate the impact of the bone processing method on citrate concentrations in 
bone samples. Prior to demineralization of the bone samples, known amounts of citrate 
were added to each individual sample in order to calculate the recovery of additional 
citrate in each sample. A range of concentrations was determined for the study based 
upon the theoretical citrate concentrations established in Table 3.2. The selected 
concentrations were 0mM, 0.5mM, 1.0mM, 1.5mM, and 2.0mM. Each of these 
concentrations was converted into an expected mass value based upon an assumed an 
approximate final volume of bone solution of 5mL. The concentrations of citrate in each 
sample were then compared to the calibration curve concentrations to determine the % 





         Eq. 3.17 
 
Percent recovery was used to determine if citrate was being lost during bone 
demineralization and/or subsequent processing steps. A high percentage of recovery 
implied no losses or matrix effects were present, while a lower percent recovery indicated 
the loss of citrate throughout the processing of the samples or analytical technique. 
Furthermore, percent recovery was expected to be approximately the same in each 




to have a similar percent recovery in all samples was taken to indicate the presence of 
matrix effects in the samples.  
In order to test standard recovery, ten bone samples from varying locations and 
different porcine ribs were then combined into one pile of bone powder to minimize the 
variance in sample testing. Both trabecular and cortical bone were tested in this 
experiment in order to ensure the most complex matrix. It was assumed that trabecular 
and cortical matrices would be less complex than both combined. Presence of matrix 
effects in the mixed sample was taken to mean matrix effects were present in cortical 
only or trabecular only samples as well, and as such as strategy would need to be adopted 
to overcome the interferences.  
75 mg of bone powder was weighed using a precision scale (0.0001 mg) 
(Adventurer Pro, Ohaus) and subsequently transferred into a clean 15mL centrifuge tube. 
Trisodium Citrate Dihydrate in granular form was then added based on the calculated 
values corresponding to the desired concentrations of citrate to be examined. The bone 
processing protocol then proceeded as normal. This process was repeated three times for 
and each set was analyzed to determine percent recovery. 
 
3.5.4 Analysis of Citrate Concentrations in Various Bone Types 
Previous studies on citrate content in bone have used either cortical or trabecular 
only samples of porcine rib bone [21, 49]. No direct comparison between the types of 
bone and their impact on the analytical technique or obtained concentrations appeared to 




and quantitative differences between types of bone (cortical, trabecular, and a mixture of 
both) using HPLC. The main objectives of this experiment were to determine limitations 
of the HPLC method developed in regards to bone type, as well as analyze the 
concentrations observed in the different bone types. Overall, it was believed that each 
bone type analyzed would have no significant impact on the output of the HPLC analysis. 
The methods used for this experiment are as follows. A total of six 2-4 mm 
sections of bone were obtained from two fresh porcine rib bones prepared using the 
method described in section 3.4.3. After sectioning the bones were defatted using the 
chloroform and ethanol solution described in section 3.4.6. Immediately after defatting, 
trabecular and cortical bone from the specimens were differentiated by both the color and 
structure of bone. Trabecular bone was subsequently removed with a stainless steel 
scalpel and placed into a clean 15 mL polypropylene centrifuge tube. The remaining 
cortical bone was inspected to insure the trabecular bone was completely removed by 
visual inspection with and without magnification, then placed into a separated 15 mL 
centrifuge tube. The mixed cortical and trabecular samples analyzed were prepared as 
part of the optimal mass testing protocol and were included only for comparison 
purposes. Each of the cortical, trabecular, and combined samples were prepared for 
HPLC analysis using the preparation method described in section 3.3.6.  
 Samples were then analyzed qualitatively and quantitatively to determine the 
impact of mass on citrate detection. Qualitatively, chromatograms were compared for 
peak resolution and separation. Quantitatively, peak areas were normalized into wt. % 




3.5.5 Analysis of Environmental Storage Conditions on Citrate 
Schwarz et al hypothesized that water content has an impact on citrate 
concentration within bone, but provided no further justification [49]. As such, exposure 
to water in a lab environment was considered to be a potential risk in the preservation of 
citrate within samples being prepared for analysis. Thus, this study was done to evaluate 
the impact of possible storage environments, in particular a wet environment, within a 
forensic lab to which samples may be exposed for a period of up to two weeks. Overall, 
three different storage environments (dry, moist, and atmospheric) were evaluated to 
determine if storage environment presents a major risk to the measured concentrations of 
citrate in bone samples. 
The methods used for this experiment are as follows. Three fresh porcine ribs 
were prepared and sectioned into three 2-4 mm specimens using the preparation 
procedure described in section 3.4.3. One specimen from each bone was then placed 
under differing conditions. The first was left at room temperature and atmospheric 
conditions. The second specimen was submerged in deionized water and kept under 
vacuum. The third specimen was immediately placed in a Fisher IsoTemp 281A vacuum 
oven (281A, Fisher) at 110°C for 4 hours, removed, and left at room temperature covered 
by a towel. After 14 days, the specimens were immediately prepared for HPLC analysis 
as described in section 3.3.6. The water in one of the flasks evaporated after 10 days in 
one of the water specimens. As it was later in the process, it was still analyzed as it was 




Samples were then analyzed qualitatively and quantitatively to determine the 
impact of storage conditions on the detection of citrate. Qualitatively, chromatograms 
were compared for peak resolution and separation. Quantitatively, peak areas were 
normalized into wt. % and compared using the statistical techniques described in section 
3.3.12 when possible. 
 
3.5.6 Analysis of Citrate Content in Dorsal, Central, and Ventral Regions 
A key concern in using citrate concentration in bone for the estimation of PMI is 
if the anatomical location of a sample would have an impact on the concentration of 
citrate detected. Prior studies have suggested an even distribution of citrate along a bone, 
but no mention of the location of samples tested is provided in these studies [16, 49]. As 
such, a need was realized for more information on the concentration of citrate in different 
regions along a porcine rib bone. The objective of this experiment was to sample 
different anatomical regions (dorsal, central, and ventral) to determine if the location of 
the specimen obtained had a significant impact on the concentration of citrate detected.  
The methods used for this analysis are as follows. First, three fresh porcine ribs 
were defleshed using the preparation procedure described in section 3.4.3. Then, the 
length of each bone was measured in mm with a ruler and recorded. Next, each bone was 
divided into three equal length sections (ventral, central, and dorsal) based on the total 
length of the bone and anatomical landmarks (Figure 3.11). Ventral sections were defined 
as the third of the bone where cartilage was attached. Central sections were defined as the 




bone. The midpoints of each of the three sections were measured with a ruler and marked 
on the bone. Each midpoint was then used as a guide to obtain a section of bone from 
each of the regions. Cortical only samples were then prepared for HPLC analysis using 
the method in Section 3.3.6.  
 
Figure 3.11 Image of Bone with Midpoints Marked and Anatomical Regions Identified. 
 
3.5.7 Comparison of Molecular Weight Cutoff Filtered and Unfiltered Samples 
Initial chromatograms of bone samples had a substantial unknown peak prior the 
elution of citrate. Additional filtering was tested in order to evaluate if the unknown peak 
could be removed from the sample. Molecular weight cutoff tubes (MWCO) appeared to 
be an appropriate method of filtration for this particular application. As citrate had a 
molecular weight of 189.1 Da, the two smallest molecular weight cutoffs available in the 
Pall Microsep™ Molecular weight centrifuge cutoff tubes were acquired. The cutoffs 







the first peak in bone chromatograms was due to a larger biomolecule, in particular a 
protein that would be eliminated from the sample when MWCO tubes were utilized to 
filter the samples.   
The methods used for this analysis are subsequently described. First, three bones 
were defleshed as described in Section 3.4.4 then sectioned into 16 2-4 mm bone 
specimens as described in section 3.4.4 Three different populations of bone were then 
prepared by grinding and mixing five of the specimens together using the process 
described in section 3.4.8. Three samples were then prepared, one for each of the filtering 
methods (unfiltered, 1K, 3K) from each population of bone specimens by weighing out 
75 mg of the cortical only bone and placing it into a new 15 mL centrifuge tube labeled 
with the type of filtration. The preparation protocol was then the same for each filtration 
method until after the supernatant had been removed after centrifugation of samples for 5 
min at 1200 x g. At this point, unfiltered samples were considered ready for the HPLC 
sample preparation process, while the MWCO samples required further treatment.  
Both the 1K and 3K samples were transferred into the 1K and 3K MWCO tubes 
respectively. After transfer, the caps were tightly secured to each of the tubes and placed 
into a centrifuge (Sorvall ST 40R, Thermo Scientific). In order to ensure adequate 
filtration of the samples, the instructions provided by the manufacturer were analyzed for 
ultrafiltration. This analyses demonstrated that setting the centrifuge at 4500 x g for 90 
min would be sufficient to ensure ultrafiltration. After centrifugation was complete, the 
upper reservoir containing the filter and all of the compounds too large to pass through 




was then transferred into a clean 15 mL centrifuge tube for storage until preparation for 
HPLC analysis. Once the lower reservoir was cleared, the top reservoir was placed back 
into the tube and sealed for storage.  
Samples were analyzed qualitatively to determine the impact of filtration on the 
appearance of the unknown peak in chromatograms. Qualitatively, chromatograms were 
compared for peak height of the unknown peaks and separation between the citrate peaks 
and unknown peaks.  
 
3.5.8 Integration Fit 
 Throughout the thesis, citrate peaks did not consistently elute after the completion 
of the unknown peak. As such, the method of integrating the area of the citrate peak was 
evaluated to determine the optimal fit of integration. Three primary fits were evaluated 
(computer, exponential, tangential skim) to determine differences in the calculation of 
area between them, and also to determine which appeared to fit the peak most accurately. 
Each of the fits was acquired using the built in breeze software data analysis functions. 
The computer fit was obtained by using the built in integration function of the computer. 
Exponential fits were obtained by setting up an exponential fit using he system software 
and having it extend from the beginning of the peak to the end of the peak. Each of the 
sections were magnified using the zoom functions of the software and evaluated to 
determine the start and stop points. Start and stop time for peak integration could be 
programmed into the software to limit the area of peak integrated. Tangential skim fits 




line could be made more accurate by using the built in functions to set a start and stop 
time for integration. Peak areas obtained by each fit were compared to determine the 
most appropriate fit for each of the citrate peaks produced in the study. Furthermore, each 
fit was reviewed in a more general sense to determine the most appropriate fit across all 
integrations performed in this study. 
 
3.5.9 Standard Addition Compared to Calibration Curve 
 Two main methods were used to obtain concentrations of citrate in bone samples 
throughout this thesis, namely, standard addition and calibration curve methods. From a 
practical perspective, the calibration curve technique requires less time and resources and 
as such is more desirable for this method. However, calibration methods are prone to 
error in the presence of matrix effects in samples [55]. As both methods were adequately 
tested in this thesis, a comparison of the concentrations obtained with each method were 
performed using results in this thesis, to determine if a significant impact was observed in 
the concentrations of citrate detected based on the method of determining concentration. 
Statistical tests as described in section 3.3.12 were performed on the location and storage 
condition study concentrations with the concentrations obtained from each method to 
determine if each method had an impact on the normalized citrate concentration 







3.5.10 Calculation of PMI Using Schwarcz Model 
 Postmortem interval estimates produced in this thesis were obtained by using the 
equation developed by Schwarcz et al. [49]. In this equation, the normalized citrate 
concentration (wt. %) were used in the following equation to obtain a PMI estimate in 
years (Eq. 3.18).  
 
𝐶(𝑡) =  −0.673 ∗ log(𝑡) + 3.021                                      Eq 3.18 
 
In this equation, C(t) is the detected normalized concentration (wt.%) of citrate in each 
sample, and t is the time in days. The number of days was then divided by the typical 
number of days in a year, 365, to obtain PMICALC, or the estimated postmortem interval in 










The results in this chapter are divided into five general subsections, namely HPLC 
Method and System Performance, Validation of Method Acceptability with Standard Solutions, 
Analysis of Citrate Peaks in Bone Solution Chromatograms, Applied Tests with Method, and 
Performance of HPLC.  
Subsection 4.2 “HPLC Method and System Performance” includes results related to the 
system parameters observed in this thesis. Subsection 4.3 “Validation of Method Acceptability 
with Standard Solutions” provides results related to the linearity of calibration curves, tests on 
calibration curve variance in time and stock solution pH, as well as intra-day assay precision 
(repeatability) studies. Subsection 4.4 “Analysis of Citrate Peaks in Bone Solution 
Chromatograms”, provides results related to bone chromatograms including characteristic peaks 
and injection dependence. Subsection 4.5 “Applied Tests with Method” provides results related to 
tests done to characterize citrate concentrations in bone. Finally, subsection 4.6 “Performance of 
HPLC” provides results related to the general performance of the HPLC method and system over 
the thesis. 
4.2 HPLC Method and System Performance 
 This section addresses the overall performance of the HPLC system, as well as 
method parameters that varied throughout the thesis. Results are presented to demonstrate 




4.2.1 Retention Time 
 Retention times for citrate standards were carefully monitored throughout the 
thesis. Analysis of the test chromatogram provided with the column used for all analysis 
in this thesis listed a retention of 7.50 minutes with the same temperature and flow rate 
selected for use in the test method. Further information available from the manufacturer 
indicated a retention times of citrate of 7.8 and 8.2 minutes [4, 5]. The average retention 
times for standards prior to the introduction of bone solutions into the column was 7.86 ± 
0.24 minutes. After the introduction of bone samples into the column, average retention 
time for standards increased to 8.62 ± 0.14 minutes. Statistical analysis was completed to 
determine if the introduction of the bone samples was a factor in the observed retention 
times for citrate standards. Introduction of the bone solutions was determined to be a 
significant factor in the retention times of citrate standards (unpaired t-test, p < 0.05), 
indicating that the performance of the column was altered by the introduction of bone 
solutions through the column. Example chromatograms of 2.5 mM standards from set 05, 
before the introduction of bone solutions (Figure 4.1), and set 10, after the introduction of 











Figure 4.1 Chromatogram of 2.5mM standard solution prior to introduction of bone 
solutions into column. Retention time of citrate peak was determined to be 7.97 minutes 




Figure 4.2 Chromatogram of 2.5mM standard solution after the introduction of bone 
solutions into column. Retention time of citrate peak was determined to be 9.55 minutes 













































4.2.2 Mobile phase 
 As stated in Chapter 3 (Section 3.3.3), 5mM (.005M) sulfuric acid, pH 2, was 
used as the mobile phase in all analyses. Blank sample chromatograms contained no 
peaks and demonstrated a stable baseline (Figure 4.3).  This was witnessed in all blank 
solutions analyzed in this thesis, as such, 5 mM H2SO4 was deemed to be an acceptable 
mobile phase for use with this test method and the Waters Breeze 2 HPLC system. 
 
 
Figure 4.3: Chromatogram produced by blank standard through Column [0 mM]. No 
peaks and a stable baseline are present. 
 
4.2.3 Operating Pressure  
 As stated in Chapter 3 (3.3.5), the Aminex HPX-87H column was kept at a 
constant temperature of 35ºC by the column heater attached to the Waters HPLC system. 
The pressures observed at this temperature were below the maximum operating pressure 





















psi. The maximum pressure, PMAX, observed in testing was 1176 psi and the minimum 
pressure, PMIN, was 565 psi. PMAX was observed in the first run of the column during the 
conditioning stages; no samples were analyzed at this pressure. PMIN occurred after a total 
of 450 injections comprised of both standards and bone samples. It was hypothesized that 
changes in pressure would have no qualitative impact on the quantitative analysis of both 
citrate standards and citrate peaks in bone solutions.  
 Chromatograms of 2.5 mM standards analyzed at PNORM (Figure 4.1) and PMIN 
(Figure 4.2) were obtained using the chromatogram processing method described in 
Chapter 3 (Section 3.3.8). Peak height, time of elution, and retention times were then 
compared to gauge the impact of the change in operating pressure of the column on 
citrate standards. This analysis was subsequently repeated on bone solution 
chromatograms obtained at PNORM (Figure 4.4) and PMIN (Figure 4.5). As with the 2.5 
mM standard solutions, peak height and retention times of citrate peaks were 
qualitatively analyzed to evaluate the impact of the change in operating pressure on 











Figure 4.4 Chromatogram of 75mg Cortical Only Bone Sample Obtained at PNORM. 
(Sample: RT2 from Short Term Storage Study) 
 
 
Figure 4.5 Chromatogram of 75mg Cortical Only Bone Sample Obtained at PMIN. This is 
from the MWCO data set. 75mg Group 2 Unfiltered. Citrate is the third peak on the 












































 Analysis of the 2.5 mM standards demonstrated a large decrease in peak height 
when the column was operating at PMIN (.005 absorbance units) compared to PNORM (.01 
absorbance units). Despite the difference in peak heights, the area under each peak was 
approximately the same. This was due to an increase in the elution time of citrate at PMIN 
(2 minutes) compared to PNORM (1 minute). Finally, an increase in retention time was seen 
at PMIN (9.55 minutes) compared to PNORM (7.97 minutes). Overall, the decreased pressure 
impacted the peak height, time of elution, and retention time of the 2.5 mM citrate 
standards. 
Analysis of bone solutions at PMIN and PNORM demonstrated three main 
differences. At PMIN, a total of three peaks were observed, while only two were present at 
PNORM. Similar to the trend observed in the 2.5 mM standards, retention time of citrate 
was increased at PMIN (9.75 minutes) compared to PNORM (8.75 minutes) In addition, the 
citrate peak began to elute approximately one minute later on the PMIN (9.25 minutes) 
compared to PNORM (8.25 minutes). Also, the height of the citrate peak at PMIN (0.0025 
absorbance units) was approximately 0.5x the peak height of the citrate peak in the PNORM 
chromatogram (.005 absorbance units). As these were not the same sample, a direct 
quantitative comparison of the citrate peak heights was not appropriate. Overall, 
operating pressure did not have a significant impact on the ability to qualitatively and 
quantitative analyze citrate peaks in bone sample chromatograms. 







 As stated in Chapter 3 (3.3.5), all sample analyses were analyzed at both a time 
constant standard wavelength of 210 nm and over a range of wavelengths, 190 – 300 nm, 
using the 3D wavelength scan capabilities of the HPLC system. 3D data were primarily 
used to analyze UV-Vis spectra of chromatogram peaks when identification of citrate 
peaks was necessary. When changes in retention time were observed, UV-Vis spectra of 
citrate peaks in bone solution were compared to the UV- Vis spectra of citrate standards. 
Examples of UV-Vis spectra for four citrate standards [1.0, 1.5, 2.0, 2.5 mM] are 
provided below (Figure 4.6). Analysis of the spectra demonstrated maximum response in 
absorbance units for the citrate peak at 190 and 210 nm. The time constant standard 
channel was set at 210 nm as bone samples contained an unknown peak with a 










Figure 4.6 UV-Vis Spectra of Four Citrate Standards. Include four of the standard 
concentrations [1.0, 1.5, 2.0, and 2.5 mM]. The response in absorbance units is shown for 






Figure 4.7 UV-Vis Spectra of Unknown Peak and Citrate Peak.  The response in 
absorbance units is shown for across the wavelength range scanned. The unknown peak 


















































4.3 Validation of HPLC Method Acceptability with Standards 
 This section addresses the ability of the HPLC method to detect citrate in simple 
matrix standard solutions. Results were analyzed both qualitatively and quantitatively to 
ensure the test method provided acceptable linearity over the concentration range selected 
for the calibration curve [0 – 2.5 mM]. Furthermore, standards were analyzed to evaluate 
degradation in calibration curve response and linearity over time. Finally, intra-day test 
method precision (repeatability) was analyzed to evaluate the precision of the test 
method.  
 
4.3.1 Linearity and Range 
As described in Chapter 3, section 3.3.9, a total of 11 sets of standards were 
prepared in this thesis and analyzed for linearity. An R2 > 0.98 and y – intercept value ≤ 
10% of the 2.5mM response were deemed acceptable degrees of linearity. All analysis 
was performed as described in Section 3.2.3. 
For complete clarity, an example of the data and results obtained from this 
technique is presented below. Chromatograms for each of the standard concentrations 
were produced and analyzed (Figure 4.8). The peak area values for each of the 
concentrations in Standard Set 08A at time t= 0 weeks (Table 4.1) were then determined 
by integration of peaks and entered into Excel in order to generate a first-order (straight 
line) fit calibration curve with a forced y intercept at 0 (Figure 4.9). Excel was also used 
to find the y-intercept value when the calibration curve was not forced through the origin 













0.00 0.000 0 
0.50 8.610 26394 
1.00 8.618 52725 
1.50 8.611 80585 
2.00 8.610 107607 




Figure 4.8 Chromatograms of Each Standard Solution Concentration Analyzed in Set 



































Figure 4.10: Calibration Curve produced by Set of Standards 4A without being forced 











































 The first-order (straight line) fit calibration curve of standard set 4A at t=0 had an 
R2 of 0.9992 and y-intercept of 246.3 Area Units when the calibration curve was not 
forced through the origin. When compared to the response of the 2.5 mM standard, the y-
intercept obtained was determined to be ≤10% of the response, 0.19%. Also, the R2 value 
is greater than 0.98. As such, the calibration curve obtained for standard set 4A has an 
acceptable degree of linearity for this analysis. This process was repeated for each set of 
standards in order to ensure acceptable linearity was obtained. A summary of this data is 






Table 4.2: Determination of Linearity for All Analyses of Citrate Standards Based on R2 








Slope R2 y-int 




1 01_A 7 0 47899 0.9863 -5785.50 4.67 yes 
1 01_A 5 4 52283 0.9920 8560.50 8.46 yes 
2 02_A 7 0 46653 0.9937 2685.50 2.40 yes 
2 02_A 5 4 40189 0.9897 2738.00 3.53 yes 
3 03_A 7 3 51539 0.9990 -2805.70 2.17 yes 
3 03_A 6 6 47338 0.9967 -3040.70 2.55 yes 
4 04_A 7 0 50996 0.9991 246.30 0.19 yes 
4 04_A 7 3 46203 0.9970 -2473.20 2.07 yes 
4 04_B 7 0 46343 0.9935 -4529.30 3.81 yes 
5 05_A 7 0 52677 0.9981 1374.70 1.04 yes 
5 05_A 7 3 46202 0.9995 160.11 0.14 yes 
6 06_A 7 0 56016 0.9933 -4803.80 3.29 yes 
6 06_A 5 2 58037 0.9926 -3949.60 2.79 yes 
7 07_A 6 0 53188 0.9968 2146.40 1.64 yes 
8 08_A 6 0 53162 0.9996 200.80 0.15 yes 
9 09_A 6 0 49776 0.9995 -498.20 0.40 yes 
10 10_A 6 0 46400 0.9996 279.8 0.24 yes 
11 11_A 7 0 49534  0.9985  1675.8  1.34  yes  
 
a Cmax for all but two of the sets, 01_A, t=4wks, and 02_A, t-4wks, was 2.5mM. Cmax for 











 All sets tested had R2 values greater than 0.98 as well as y-int ≤ 10% of the 
maximum concentration tested. Thus, all sets tested in this study had acceptable linearity 
based on the criteria defined for linearity. Furthermore, the results indicate that using six 
concentrations [0, 0.5, 1.0, 1.5, 2.0, 2.5 mM] of standards is sufficient to provide an 
acceptable linear calibration curve over a range of 0 to 2.5 mM.  
 
4.3.2 Analysis of Intra-day Method Precision (Repeatability) 
Repeatability (intra-day assay precision) was assessed to evaluate how results 
varied over a short time interval under the same conditions [52]. As stated in section 3.5 
in Chapter 3, two 0.5mM solutions from two different sets of standards (set 04_A in 
study one and set 04_B in study two) prepared from the same stock solution (stock 4) 
were injected 10 times on the same day, under the same experimental conditions. The 
results of the first repeatability study (Tables 4.3) and the second (Table 4.4) are found 



















1 7.904 23460 
2 7.909 22374 
3 7.924 24122 
4 7.912 23227 
5 7.909 22569 
6 7.905 22179 
7 7.907 22075 
8 7.920 23015 
9 7.911 23665 
10 7.923 22337 
Mean 7.9124 22902.3 
SD 0.007 664.521 
RSD (%) 0.09 2.90 
 
 







1 7.925 14927 
2 7.910 14461 
3 7.922 15040 
4 7.921 15900 
5 7.913 15343 
6 7.903 16058 
7 7.919 14887 
8 7.902 14789 
9 7.901 14621 
10 7.921 16093 
Mean 7.9137 15211.9 
SD 0.009 573.675 





Relative Standard Deviation (RSD) was used to evaluate the instrument precision 
of this method. As the low concentrations of citrate are best approximated by an impurity 
model, the precision criterion for the method was set at ≤ 5%. That is, the RSD value 
obtained for the retention times and peak areas demonstrated acceptable precision of the 
instrument so long as the RSD obtained were ≤ 5%.     
In the first set of ten replicate injections, an RSD of 0.09% for retention time and 
an RSD of 2.90% for the peak areas were obtained. The second set of replicate injection 
provided an RSD of 0.11% for retention time and an RSD of 3.77% for the peak areas. 
All of these values were within our acceptable criteria for instrument precision, RSD ≤ 
5%. This indicated that the test method had a high degree of repeatability under normal 
operation at the level of intra-day assay precision.  
 
4.3.3 Concentration Variation over time in standards 
As described in section 3.3.9 (Ch. 3), four of the 11 sets of standards prepared in 
this thesis were analyzed at two time points (to = 0 weeks and tf = 2-4 weeks) depending 
on the availability of the HPLC. Set 03_A was not analyzed at t=0 due to the HPLC 
system being offline for maintenance, but was analyzed at t=3 weeks which was included 
in the aged population. The number of samples for each standard as well as the mean and 
standard deviation for each concentration of both to (Table 4.5) and tf (Table 4.6) 

















0.0 0 0 - 4 
0.1 4460.67 320.13 7.18 3 
0.5 27791 1602.16 5.77 3 
1.0 49975 2478.21 4.96 4 
1.5 76464.25 3082.83 4.03 4 
2.0 100749.7 1659.32 1.65 3 


















0mM 0 0 - 4 
0.1mM 2692.33 288.25 10.71 3 
0.5 mM 23419.4 2881.01 12.30 3 
1.0 mM 47928.6 2855.04 5.96 4 
1.5 mM 68621 6068.84 8.84 4 
2.0 mM 97487.2 15440.8 15.84 3 














Table 4.7 p-Values Obtained from paired t-tests of peak areas of fresh (t=0 weeks) and 








0.1 mM 0.00 Yes 
0.5 mM 0.37 No 
1.0 mM 0.27 No 
1.5 mM 0.05 No 
2.0 mM 0.05 No 
2.5 mM 0.66 No 
Slopes 0.15 No 
 
 
Statistical analysis was performed to assess whether time was a factor in the 
concentration of citrate detected in the standards over a two to four week time period.  
This analysis showed a significant difference (paired t-test, p < 0.05) only in the 0.1 mM 
concentration. Otherwise, all samples had no significant difference in the standard 
concentrations between the freshly prepared and aged standards (Table 4.7).   
 
 










(t ≤ 4 weeks) 
Number of 
Standards Used 
Sf % of Si 
02_A 46653 5 40189 5  86 
04_A 50996 7 46203 7 90 
05_A 52677 7 46202 7 88 





 In general, the slopes obtained from the aged standards were 10% lower than the 
fresh standards (Sf % of Si, Table 4.8). Set 06_A had a higher slope which was caused by 
an overestimation of the areas for the higher concentrations [2.0, 2.5 mM] due to an error 
in the preparation of the standards. A paired t-test was performed on the slopes and 
showed no significant difference (paired t-test, p=0.15) in the slopes of the fresh and aged 
standards.  
 While no statistical significance was present in the fresh and aged standards, all 
subsequent analysis used only fresh standards as slight changes in calibration curve 
slopes would impact the observed concentration of citrate in bone samples. Due to the 
low concentrations present, a slight change in the obtained concentration would impact 
PMI estimation greatly. For example, a bone solution with a low citrate concentration, 
peak area of 25000 Area units, would have a molar concentration of 0.49 mM at to and 
0.54 mM at tf using the calibration curve slopes for set 04_A at to and tf. Assuming a 75 
mg sample, these would become 0.42 and 0.46 wt. % respectively. When these values are 
used in the equation provided by Schwarcz, PMI estimates are 20.1 and 17.3 years 
respectively. Thus, the slight change in slope causes a difference of 3 years in the PMI 
obtained for the same sample. If only aged standards are available, the investigator must 








4.3.4 Analysis of Stock Solution pH on Standards 
 Four of the 11 stocks prepared in this thesis were prepared with only water that 
resulted in a pH of 9 (Table 4.9). The remaining six stocks were prepared with sulfuric 
acid mixed in to lower the pH to 2. This was done to inhibit microbial growth, as well as 
have the standards at the same pH as the bone solutions (Table 4.10). Stock 3 was not 
included in this analysis as no time = 0 weeks data was available for analysis. 
The different pH populations were qualitatively compared to determine if the pH 
of the standards had an impact on the linearity of the calibration curve and quantitatively 
compared to determine if the pH had an impact on the peak areas of the each standard 
concentration [0, 0.5, 1.0. 1.5, 2.0, 2.5 mM]. It was hypothesized that the pH of the 
solution would not impact linearity of the calibration curve. Furthermore, it was 
hypothesized that pH would not be a significant factor in the detected peak area for each 




















1 01_A 47899 0.9863 40 H2O 9 Yes 
2 02_A 46653 0.9937 50 H2O 9 Yes 
6 06_A 56016 0.9933 50 H2O 9 Yes 
10 10_A 46400 0.9996 50 H2O 9 Yes 
 
 













4 04_A 50996 0.9991 50 H2SO4 / H2O 2 Yes 
5 05_A 52677 0.9981 50 H2SO4 / H2O 2 Yes 
7 07_A 52093 0.9996 50 H2SO4 / H2O 2 Yes 
8 08_A 53162 0.9996 50 H2SO4 / H2O 2 Yes 
9 09_A 49776 0.9995 50 H2SO4 / H2O 2 Yes 
11 11_A 49534 0.9985 50 H2SO4 / H2O 2 Yes 
 
  
All of the sets analyzed had an acceptable degree of linearity (R2 > 0.98) as shown 
in Section 4.3.1. As such, no further analysis was done to evaluate linearity, and all 
subsequent analysis focused on the impact on peak areas for each concentration.  
 Set 01_A standards were injected at a lower volume, 40 µL, compared to all other 
samples, but were included in the analysis, as the peak areas were within the range seen 
in all other samples. The areas for five of the concentrations [0.5, 1.0, 1.5, 2.0, and 2.5 
mM] were used for statistical comparison, as not all populations had sufficient samples of 






Table 4.11 Peak Areas of Standard Concentrations prepared from pH 2 Stock Solutions 










0.50 26854.17 1842.08 6.86 6 
1.00 51941.33 2827.42 5.44 6 
1.50 78015.33 3857.43 4.94 6 
2.00 102287 3357.21 3.28 6 
















0.5 22629 2377.62 10.51 3 
1.0 48423 2363.41 4.88 4 
1.5 70870.5 5969.71 8.42 4 
2.0 95997.33 2801.04 2.92 3 
2.5 124387.25 13198.1 10.61 4 
 
 
Table 4.13: Results of Unpaired t-test Analysis of Citrate Peak Areas for Standards 
Prepared with pH 2 and pH 9 Stock Solutions 
 
Concentration 
t-test   p 
value 
Significance 
0.5 mM 0.06 No 
1.0 mM 0.10 No 
1.5 mM 0.07 No 
2.0 mM 0.04 Yes 







As seen above (Table 4.13), a significant difference (unpaired t-test, p< 0.05) was 
seen in the peak areas of 2.0 mM standards prepared from stock solutions of different pH. 
Also, the standard deviations seen in the pH 9 stock solution standards were much higher 
than in the pH 2 populations. Some of this may attributed to a larger population of pH 2 
standards, as it was the preferred method of preparing the stock solutions. Another cause 
may have been the inclusion of two early sets of standards, 01_A and 02_A, which may 
have been impacted by a lack of experience in the preparation of the standards.  
  
4.4 Analysis of Citrate Peaks in Bone Solution Chromatograms  
This section will seek to address some of the general observations made 
throughout the entirety of testing in regards to the performance of the HPLC with bone 
samples. Results will include both qualitative and quantitative analysis when possible.  
 
4.4.1 Chromatogram Peaks 
 The chromatograms produced by bone solutions were consistent throughout the 
entire thesis. In general, each chromatogram contained a large peak preceding citrate with 
a retention time in the 6.5 to 7 minute time range. Each chromatogram also contained a 
citrate peak with retention times ranging from 8.0 in early studies to 9.25 minutes in later 
studies. The increased retention time in later analyses suggested that the column was 
altered over the course of the thesis. The citrate peak occurred slightly later in bone 
samples than in the simple citrate matrices, but was confirmed using spiked samples. In 




however, as the study progressed, the separation between the two peaks diminished. 
Despite this loss of resolution, the beginning and end of the citrate peak were still easily 
identified, and sufficient enough for integration to determine peak area. A typical 
chromatogram, as well as a spiked chromatogram of the same sample produced in this 
study are demonstrated in Figure 4.11 below. 
 
 
Figure 4.11: Chromatograms of Cortical Only Bone Sample Obtained from the Dorsal 
Region of a Porcine Rib Bone both spiked with 1.63 mM citrate and unspiked. Spiked is 






























4.4.2 Integration of Citrate Peaks in Bone Samples 
In general, citrate peaks in bone solutions analyzed in this study had clearly 
defined boundaries. As such, areas under citrate peaks were well approximated with a 
simple tangential skim fit using the method described in Section 3.5.8, Chapter 3 (Figure 
4.12). Initial points for the integration were obtained through the use of the computer 
integration fit, but corrections were necessary in most instances as the computer 
overestimated the area. Corrections were made by zooming into the citrate peaks and 
determining the point at which the citrate peak began to steadily increase. End points for 
integration were determined based upon a return to baseline.  
 
 
Figure 4.12 Representative Image of Tangential Skim Integration to Determine Area 
under Citrate Peak in Chromatogram [Specimen: 75-1 Injection 2] 
 
 Over the life of the column, peak resolution decreased in bone chromatograms. 
While the boundaries of citrate peaks continued to be apparent, a lack of baseline return 
meant that a tangential skim fit for integration would underestimate the area under the 




integration were investigated in order to determine how extensive of an impact column 
degradation had on the ability to quantify citrate concentrations in the samples. The fits 
used were the computer fit or how the computer determined the best fit, a tangential fit or 
straight line drawn from start to bottom, and an exponential fit. An example of each of 
the fits on a single sample with an uneven baseline (Figure 4.13). The areas obtained by 
each method are listed below (Table 4.14). The computer method overestimated the true 
area of the peak, and there was no difference between the exponential and tangential skim 
fits. The tangential skim integration fit was utilized in all data analysis as it best 





Table. 4.14 Peak Areas of Citrate Peak in 75 mg Cortical Only Bone Solution Using 
Different Fits of Integration from Waters Breeze Software. Each fit is for bone solution 
[R4B7 Ventral] 
 
Fit Type Area 
Computer 209311 
Exponential 34929 










Figure 4.13 Screen captures of Breeze 2 Integration Fits. (A) Computer Fit, (B) 


















































































4.4.3 Injection Dependence 
 The initial bone sample analyzed in each HPLC run produced a larger first, 
unknown, peak when compared to subsequent injections (Figure 4.14). The unknown 
peak in the first injection had a peak height twice as large as the unknown peak in the 
second injection of the same sample; citrate peaks did not exhibit the same trend. Peak 
resolution was the same in each of the injections, as was the retention time of the citrate 
peaks.  
 
Figure 4.14 Overlaid Chromatograms of Three Consecutive Injections of a Mixed Bone 







































  First injections of three 50 mg mixed (cortical and trabecular) bone samples 
through the column were compared with second and third injections to determine if the 
injection number was a significant factor in the detected concentration of citrate (wt. %). 
It was hypothesized that no significant difference would be observed in subsequent 
injections. Table 4.15 below lists the values for three consecutive injections. 
 
Table 4.15: List of Citrate Concentrations (wt.%) for Three Consecutive Injections of 
Mixed Bone Specimens 
 
 Injection 1 Injection 2 Injection 3 
Sample wt.% wt.% wt.% 
OM-50-1 1.067 0.970 0.943 
OM-50-2 0.879 0.917 0.919 
OM-50-3 0.954 0.871 0.865 
Mean 0.967 0.919 0.909 
STD 0.077 0.041 0.033 
 
 
 Statistical analysis was completed to determine if injection number (1, 2, or 3) 
was a factor in the measured wt. % concentration of citrate. Injection number was not a 
significant factor in the average concentrations measured in the three bone samples 
(Repeated Measures ANOVA, p=.26), indicating no significant difference in the detected 
citrate concentrations (wt. %).  Thus, the larger peak witnessed in the first bone sample 
injected through the column in a run has no impact on the detected citrate concentration 






4.5 Applied Tests with Citrate HPLC Method  
A series of 8 applied tests were performed to evaluate the HPLC test method 
developed in this thesis on the detection of citrate in bone samples. In particular, optimal 
mass of samples were studied to determine the best mass of bone to sample. Second, 
standard recovery and addition tests were performed to determine the presence of matrix 
effects [23]. Third, different types of bones were analyzed qualitatively and quantitatively 
to determine the limitations of the method with various bone types. Fourth, different 
storage environments were evaluated to determine if where short term storage 
environment of samples would have an impact on the citrate concentration. Fifth, three 
regions of bone were sampled to determine if the location of a specimen along a bone had 
an impact on the measured concentration of citrate. Sixth, samples filtered with molecular 
weight cutoff centrifuge tubes and unfiltered samples were qualitatively and 
quantitatively analyzed to determine if filtration had a noticeable impact on the peaks 
observed in chromatograms and detected citrate concentrations. Seventh, different 
methods used to obtain concentrations in samples, standard addition and calibration curve 
methods, were compared to determine if any significant difference in concentrations was 
seen between the two populations. Finally, the results of each of these studies were 
pooled and estimated PMI were calculated using the equation developed by Schwarcz et 







4.5.1 Optimal Mass Study 
 As described in section 3.5.1 (Ch. 3), nine bone solutions consisting of three 
samples for three different mass groups (50, 75, and 100 mg) were prepared and 
analyzed. Each of these samples were qualitatively analyzed for citrate peak height and 
resolution and quantitatively analyzed for citrate concentration. In this experiment, it was 
hypothesized that the mass of bone analyzed would not have an impact on the normalized 
concentration, wt. %, of citrate detected.    
 
Qualitative Analysis 
Chromatograms for each of the three mass groups were evaluated to determine the 
impact of mass on peak heights and separation. Figure 4.15 below contains the raw 
chromatograms overlaid. Citrate peaks were then normalized by setting the first 
absorbance measurement to zero by adding or subtracting the measured value. This value 
was then used as a constant and added or subtracted from each absorbance measurement. 
This process was repeated for the 50, 75, and 100 mg bone solution citrate peaks. The 
normalized citrate peaks, as well as the overall chromatograms for each sample were 
qualitatively analyzed to ensure peak areas and heights scaled with increased mass. An 








Figure 4.15: Chromatograms of 50, 75, and 100 mg Mixed Bone Samples from Optimal 





























Figure 4.16 Citrate Peaks of 50, 75, and 100 mg Mixed Bone Samples from Optimal 
Mass Group One Normalized and Overlaid. Citrate peaks were normalized by setting the 
first measurement to zero absorbance units and using the difference as a constant that was 



























Analysis of the raw chromatograms showed clearly defined citrate peaks in each 
of the three mass groups occurring between 8 and 9 minutes. Furthermore, each 
chromatogram had an unknown peak beginning around 6 minutes and ending at shortly 
after 7 minutes (Figure 4.13). The normalized citrate peaks demonstrated increasing areas 
as mass was increased (Figure 4.14).  Each mass group also produced citrate peaks that 
were easily integrated and quantified. No clear distinction was evident in the 
chromatograms, so quantitative analysis was necessary to further test the impact of mass 
on citrate analysis.  
 
Quantitative Analysis 
 As stated in Section 3.5.1, a total of 27 analyses, 3 injections for each of the 3 
mass populations comprised of three samples each, were performed. The peak processing 
method described in section 3.3.8 (Ch. 3) was used to determine citrate concentration in 
each of the bone samples. Table 4.16 shows the molar concentration (mM) as well as the 
normalized concentration obtained by using the wt. % processing procedure outlined in 










Table 4.16: Average Peak Areas and Concentrations (mM and wt. %) of Citrate in 50, 










50-1 0.78 1.020 
50-2 0.71 0.918 
50-3 0.74 0.961 
   
75-1 1.20 0.967 
75-2 1.22 0.982 
75-3 1.22 0.980 
   
100-1 1.86 1.057 
100-2 1.82 1.030 
100-3 1.68 0.947 
 
  
Statistical analysis was completed to determine if different bone mass (50, 75, and 
100 mg) was a factor in the measured wt. % concentrations. Bone mass was not a 
significant factor in the average wt. % concentrations (ANOVA, p=0.48), indicating no 
detectable difference between the various bone mass samples (Tukey post-hoc multiple 
comparison, p>0.05).  Thus, the mass of bone used in the sample preparation process had 
no impact on the determined concentration of citrate present in the bone when normalized 
into weight percent. All subsequent analysis in this thesis used 75mg bone samples as the 
average molar concentration obtained in this study at this mass was 1.21 mM. This 





4.5.2 Analysis of Matrix Effects 
 As described in Chapter 3 (Sections 3.5.2 and 3.5.3), experiments were designed 
to evaluate the presence of matrix effects in the analytical method. Results below are 
provided for standard addition and recovery tests. It this experiment, it was hypothesized 
that matrix effects were not present in the analytical method.   
 
4.5.2.1 Standard Addition Tests  
Standard Addition Tests with Mixed Bone Samples 
 Standard addition tests were performed on a total of three mixed bone samples 
using the standard addition method described in Chapter 3 (Section 3.5.2). The additions 
were approximately 50% 150%, and 300% times the maximum concentration, 2 wt. %, 
listed in literature [49]. Volumes for additions were calculated based on a final total 
volume of 5 mL, but each bone sample only produced 3.5 mL. As such, the 
concentrations tested were higher than initially calculated. Qualitative analysis was done 
on the chromatograms obtained to ensure that the additions of citrate were enlarging the 
citrate peak. Quantitative analysis was performed to determine if matrix effects were 
present as evidenced by a loss of linearity of the curve produced by the additions 
compared to the calibration curve produced by standards.  
 Standard addition tests were first performed on mixed bone samples as it was 
theorized that matrix effects would be most prevalent in the complex matrix of all bone. 
Calibration curve results were compared with equally divided bone solutions containing 




and similar response factors would be observed between the standard addition and 
calibration curves.  
 
Qualitative 
Prior to quantitative analysis, chromatograms of the additions were overlaid to 
ensure that as amount of citrate added increased, the area of the citrate peaks increased 
proportionally. An example showing this output for the additions of Standard Addition 









Figure 4.17 Chromatograms of Original Bone Sample and Three Additions Overlaid. 
Each curve corresponds to a volume of 0.1M stock solution added to a 600 µL aliquot of 
solution. [Standard Addition Set One] 
 
Quantitative 
 Peak areas for each of the additions were obtained using the post-processing 
method described in Chapter 3 (Section 3.3.8). It was hypothesized that the curve 
produced by the additions would have acceptable linearity as defined by Chapter 3 
(Section 3.3.10). Furthermore, it was hypothesized that no significant difference in 
concentration in wt. % would be found between the use of a calibration curve and the 
standard addition methodology. The areas and calibration curves obtained for each set of 













































Figure 4.18 First-order (Straight line) fit of the Peak Areas Obtained in Standard 
Addition Set One. The slope of the standard calibration curve was similar, and as such no 
matrix effects appeared to occur. 
  













































Figure 4.19 First-order (straight fit) line of the Peak Areas Obtained in Standard 
Addition Set Two. Slope was similar to that of the standard calibration curve, indicating 
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Figure 4.20 First-order (Straight line) fit of the Peak Areas Obtained in Standard 
Addition Set Three. Not enough sample volume was available of the 0 mM standard, so 


































Table 4.20 Slope and R2 Values Obtained in All Mixed Bone Standard Addition Sets 
Tested 
 







SA1 51201 0.9980 1.1 0.17 
SA2 51151 0.9984 1.01 0.15 
SA3 52351 0.9998 1.25 0.05 
Mean 51567.667 0.999 1.120 0.12 
SD 554.276 0.001 0.099 0.05 
    
  
 Acceptable linearity for the standard addition curves was an R2 >0.98. All of the 
first-order (straight line) fits generated in this analysis had acceptable linearity. The 
unspiked aliquot of bone sample in standard 3 did not contain enough volume to test due 
to loss of solution in transfer, but the linearity of the curve is unaffected.  
 The results support the hypothesis that matrix effects are not present in the 
samples. Linearity is maintained in all three analysis and as the citrate concentration 
increases, the peak areas increase in a linear manner. Furthermore, the slopes of all three 
curves are within an acceptable 20% of the slope of the calibration curve obtained in this 






Figure 4.21 Comparison of Standard Addition Set 1 Curve with Standards set 05_A (t=0) 
forecasted forward. The lines appear to be parallel over the range of data indicating an 
equivalent slope. The R2 values also both indicate high degrees of linearity. 
 
Standard Addition of Cortical Only Bone Solutions 
 Standard addition tests were subsequently performed with cortical bone solutions 
once a cortical only sampling procedure was adopted. These analyses were performed to 
confirm the absence of matrix effects in the analytical procedure as determined with the 
mixed bone solutions. Additions in these tests were done at lower concentrations, as a 
more accurate final volume of bone solutions was used in calculations for additions. In 
this section, three of the addition tests performed throughout the thesis will be provided 
(Figure 4.22), however, Appendix D contains a complete database of calibration curves 




y = 51201x + 56414
R² = 0.998






























 Figure 4.22 First-order (Straight line) fits of three Standard Additions performed on 75 
mg Cortical Only Bone Solutions and Calibration Curve of Set 08 A. (A) Solution: VAC 
2, (B) RT 2, (C) H2O 2, (D) Calibration Curve [Set 08A] 
 















































































Figure 4.23 First-order (Straight line) fits of three Standard Additions performed on 75 
mg Cortical Only Bone Solutions adjusted and compared to Calibration Curve of Set 08 
A. Additions were adjusted by subtracting the peak area of the unspiked sample (0 mM) 
from the subsequent additions. The calibration curve is the first curve in the figure. 
 
 
 In contrast to the mixed bone solutions, the standard addition tests of cortical only 
bone solutions demonstrate the presence of matrix effects in the analytical procedure 
(Figure 4.23). Also, the effects appear to vary from each sample which were taken from a 
single bone. Overall, the effects appear to best resemble a translational matrix effect, such 
that as more citrate is spiked into bone solutions, the peak area response decreases 
y = 53162x
R² = 0.9996
y = 39811x + 820.4
R² = 0.9995
y = 49297x + 760.3
R² = 0.9997
























proportionally [55]. The difference between mixed and cortical solutions may be due to 
the high concentrations of additions performed in the mixed bone solutions that may have 
biased the outcomes of the tests. 
 
4.5.2.2 Standard Recovery 
 As described in section 3.5.3 (Ch. 3), three standard recovery tests were 
performed with combined cortical and trabecular bone solutions. Using a complete bone 
specimen ensured that the maximum number of components possible in a sample were 
present throughout analysis. Furthermore, it was hypothesized that matrix effects present 
in the combined matrix would be present in either cortical only or trabecular only 
matrices. One cortical only standard recovery test was performed later in the thesis, when 
a cortical only sampling protocol was adopted. 
  Peak areas were obtained for each of the four concentrations in each standard 
recovery set, as well as the unspiked bone solution. Areas were then converted into molar 
concentrations using the calibration curve obtained from standards set 06 which were 
analyzed under the same operating conditions. First-order (straight line) fits were 
generated for both raw and processed bone solution data. A calibration curve for the bone 
samples was created by subtracting the peak area from each of the spiked samples. The 
standard calibration curve as well as the adjusted and non-adjusted matrix calibration 
curves for each set were produced to determine the presence or absence of matrix effects. 
Each of the non-adjusted and adjusted calibration curves for bone solutions analyzed 





Figure 4.24 Non-adjusted Standard Recovery Calibration Curve for Standard Recovery 
Set One Solutions Compared to Standard Calibration Curve. This curve has the raw data 





Figure 4.25 Adjusted Standard Recovery Calibration Curve for Standard Recovery Set 
One Solutions Compared to Standard Calibration Curve. This curve has the processed 
data points for the spiked bone solutions and the unspiked sample is included as the 
origin [Sample: SR1]. 
 




















Linear (SR 1) Linear (Calibration Curve)
y = 52034x - 6423.3
R² = 0.981


























Figure 4.26 Non-adjusted Standard Recovery Calibration Curve for Standard Recovery 
Set Two Solutions Compared to Standard Calibration Curve. This curve has the raw data 





Figure 4.27 Adjusted Standard Recovery Calibration Curve for Standard Recovery Set 
Two Solutions Compared to Standard Calibration Curve. This curve has the processed 
data points for the spiked bone solutions and the unspiked sample is included as the 
origin [Sample: SR2]. 
 
 
























Linear (SR 2) Linear (Calibration Curve)
y = 47878x - 2079.4
R² = 0.9746

























Figure 4.28 Non-adjusted Standard Recovery Calibration Curve for Standard Recovery 
Set Three Solutions Compared to Standard Calibration Curve. This curve has the raw 




Figure 4.29 Adjusted Standard Recovery Calibration Curve for Standard Recovery Set 
Three Solutions Compared to Standard Calibration Curve. This curve has the processed 
data points for the spiked bone solutions and the unspiked sample is included as the 
origin [Sample: SR3]. 
























Linear (SR 3) Linear (Calibration Curve)
y = 45327x + 2853.6
R² = 0.9711





























 Only one out of the three, set one, bone matrix calibration curves produced had 
acceptable linearity, R2 > 0.98.  Also, only set one had a bone matrix slope that was 
parallel to the standard calibration curve. Despite the slopes being equal, the y- intercepts 
of the bone matrix of set one and standard calibration curves were not equal. This is best 
characterized as a translational matrix effect, meaning that the loss of citrate or change of 
signal was independent of the concentration of the citrate spiked into the bone solutions 
[55]. The bone matrix calibration curves obtained in sets two and three are best 
characterized by a rotational matrix effect. This type of matrix effect displays as a loss of 
citrate or the change of signal proportional to the concentration of the citrate spiked into 

























 Further confirmation of matrix effects was seen by calculating the % recovery of 
citrate in each of the spiked bone solutions (Table 4.21). Percentage of citrate recovered 
in each of the solutions varied from 59% to 103%.  
 
Table 4.21 List of % Recovery for Each 75mg Mixed Bones Samples spiked With Citrate 








1 0.450 0.264 58.737 
 0.930 0.582 62.617 
 1.500 1.511 100.714 
  2.770 2.614 94.362 
Mean 79.108 
SD 18.617 
2 0.590 0.581 98.505 
 1.290 1.008 78.130 
 1.640 1.298 79.138 
  2.350 2.251 95.776 
Mean 87.887 
SD 9.310 
3 0.710 0.666 93.775 
 1.180 1.006 85.221 
 1.760 1.826 103.744 











Cortical Only Standard Recovery Tests 
 A single standard recovery test was performed with cortical bone once a cortical 
only sampling procedure was adopted (Figures 4.31-4.32). All methods used on mixed 
bone solutions were repeated except for the use of a 0.1M citrate stock solution instead of 
citrate crystals.  
 
 
Figure 4.31 Non-adjusted Standard Recovery Calibration Curve for Cortical Only 
Sample Compared to Standard Calibration Curve. This curve has the raw data points for 
the unspiked and spiked bone solutions. [Sample: SR 75C] 
 





























Figure 4.32 Adjusted Standard Recovery Calibration Curve for Cortical Only Sample 
Compared to Standard Calibration Curve. This curve has the processed data points for 




Table 4.22 Percent Recovery of Citrate Based on Adjusted Concentrations of Citrate in 







0.50 0.521 104.30 
1.00 0.892 89.150 
1.39 1.175 84.582 
2.50 2.238 89.532 






























The curve that was obtained had a linear response indicating that as citrate was 
added to the samples, the response of the system increased proportionally, R2 > 0.98. In 
addition, the cortical only standard recovery curve demonstrated rotational matrix effects 
much likes sets two and three in the mixed bone recovery tests [55]. This confirmed the 
hypothesis that matrix effects present in mixed solutions would be translational to all 
samples analyzed with this technique.  
 
4.5.2.3 Strategy for Reducing Matrix Effects in Bone Sample Analysis 
 The presence of matrix effects in the standard recovery tests indicated the need 
for a strategy to reduce matrix effects. Three following three general approaches were 
considered for all subsequent tests: matrix matched standards, standard addition, or 
mathematical compensation [55]. Each of the methods were analyzed for feasibility and 
ease of implementation with the HPLC method. This analysis led to the adoption of a 
standard addition methodology, as it was determined to be the easiest strategy to 
implement and was also feasible with the bone samples. All subsequent quantitative 
analysis utilized standard addition strategies to compensate for matrix effects in the bone 
solutions. 
 
4.5.3 Comparison of Trabecular, Cortical, and Mixed Bone Samples  
 One of the key questions to arise from a review of literature is whether citrate 
concentrations vary in different types of bone (cortical versus trabecular). Data were 
analyzed to determine qualitative differences in chromatograms, as well as quantitative 




section 3.5.4 (Ch. 3), samples of cortical bone only, trabecular bone only, and mixed 
(cortical and trabecular) bone were compared. In total, nine cortical only, six trabecular 
only, and three mixed solutions were tested. Each of the cortical only and trabecular only 
samples discussed here utilized the standard addition method described in Section 3.5.2 
and all were 75mg. The mixed samples analyzed in this experiment were taken from the 
75 mg standard addition tests discussed in section 4.4.1 (Ch. 4).  
 
Qualitative Comparison 
The chromatograms for all three bone types [cortical, trabecular, and both] were 
analyzed for separation of peaks, retention time, and peak height. Figures 4.33-4.35 








Figure 4.33 Chromatogram of 75mg Cortical Only Bone Sample from Dorsal Region of 
Porcine Rib Bone. [Specimen: R4B6DC] 
 
 
Figure 4.34 Chromatogram of 75mg Trabecular Only Bone Sample from Dorsal Region 
of Porcine Rib Bone. [Specimen: R4B6DT] 
 
 
Figure 4.35 Chromatogram of 75mg Mixed Bone. Solution from Standard Addition 





































































Two main peaks, unknown and citrate, appeared in all of the samples, and an 
extra peak with a retention time of 12.5 minutes appeared in all of the mixed solutions. 
Citrate peaks had normal retention times of 9 minutes in cortical only, 9.5 minutes in 
trabecular only samples, and 8.5 minutes in mixed samples. UV-Vis spectra of the citrate 
peaks were compared to spectra of standard solutions to verify that peaks were citrate. 
Furthermore, the cortical and trabecular citrate peaks elute over a longer period of time, 
1.75 minutes compared to the one minute elution time of mixed samples.  
The bone samples used to generate the cortical and trabecular chromatograms 
were taken from the same rib section and analyzed under the same operating conditions. 
Mixed samples were tested at a higher operating pressure of the column, and as such 
were not directly compared for peak height or separation with the cortical only and 
trabecular only chromatograms. When the cortical and trabecular chromatograms are 
compared, the citrate peak in the cortical only sample has a higher peak and better 
separation as the unknown peak decreases to .002 absorbance units before the citrate peak 
begins. In the trabecular only sample, the citrate peak begins while the unknown peak 
still produces a signal of approximately .004 absorbance units. Furthermore, the cortical 
only sample has a higher peak height, 0.002 absorbance units, compared to the trabecular 
only, 0.001 absorbance units. Although the cortical chromatograms demonstrated better 
peak height and separation compared to the trabecular samples, a quantitative analysis 
was necessary to determine if there was a difference in the citrate concentrations in the 







 Four of the six trabecular samples tested did not have peaks that could be 
integrated, while all of the cortical only samples and two of the three mixed samples did. 
One of the two trabecular only samples that was capable of integration had a very low 
citrate concentration, 0.23 wt. %, while the other had a larger, 0.83%, but still somewhat 
low concentration compared to the cortical only bone samples from the same specimen 
(Table 4.23). The variance in the two trabecular only samples represents a range of 
approximately 33 years when using the Schwarcz equation. Mixed samples also had 
lower concentrations when compared to the cortical only samples. Cortical only samples 
provided the highest concentrations of citrate and also had the lowest PMI estimates, less 
than one year, with the Schwarcz equation (Table 4.23).  
 
Table 4.23 Citrate Concentrations and Estimated PMI for Trabecular, Cortical, and 
Mixed Samples Analyzed With HPLC Test Method. Cortical and Trabecular Samples 











R4 B5 CEN Trabecular 0.95 0.83 4.9 
R4 B6 DORS  Trabecular 0.26 0.23 38.4 
R4 B5 CEN Cortical 1.87 1.62 0.3 
R4 B6 DORS Cortical 1.64 1.42 0.7 
SA 1  Mixed 0.86 0.73 6.9 








The inability to consistently detect citrate and the low concentrations obtained in 
the two samples that had adequate peaks, demonstrated a limitation of the HPLC 
analytical method with trabecular only samples. In addition, the inclusion of trabecular 
bone in mixed samples was deemed to be a potential risk with the use of mixed bone 
samples. This was further substantiated by the lower concentrations of citrate detected in 
the mixed samples. As such, cortical only samples were deemed to be the optimal bone 
type for use in this analytical method. All subsequent analysis in this thesis utilized 
cortical only samples.  
 
4.5.4 Analysis of Bone Storage Conditions on Citrate Concentrations 
This experiment was developed to evaluate whether the storage conditions of a 
bone specimen over a short time period, 14 days, would have any significant impact on 
the detected concentration of citrate. The methods and materials used for this experiment 
are provided in section 3.5.5 (Ch. 3).  Results in this section include the qualitative 
analysis of chromatograms produced by the bones in the different storage environments 
and quantitative analysis comparing the normalized citrate concentrations between the 
three test populations. It was hypothesized that storage environment would have no 
significant impact on the normalized concentration of citrate in bone over the short time 







Qualitative Analysis  
 As described in Section 3.5.5 (Ch. 3), chromatograms of each of the three storage 
environments were overlaid and compared (Figure 4.36). The areas under each of the 
peaks were similar despite the room temperature sample having a higher peak. Also, the 
size of the unknown peak preceding citrate had no impact on the citrate peaks produced, 
as the room temperature unknown peak was substantially larger for this bone. 
Quantitative analysis was needed to test if storage conditions had an impact on the 








Figure 4.36 Chromatograms of Three Different Storage Conditions Overlaid. Only six 




























Quantitative Analysis  
 Citrate peaks in each of the chromatograms were integrated using the chromatogram 
post processing method to determine the peak area and retention time. Areas were then 
converted into molar concentrations by using the standard addition method described in 
Section 3.5.2 (Ch. 3). Concentrations were the normalized into wt. % concentrations for 
statistical analysis (Table 4.24). 
 
Table 4.24 Calculated wt. % Values of Citrate in Bone Solutions after Short Term (14 
days) Storage in Varied Environments 
 
Sample H2O (wt. %) VAC (wt. %) RT (wt. %) 
1 1.478 1.399 1.171 
2 1.361 1.336 1.259 
3 1.372 1.302 1.362 
Mean  1.40 1.35 1.26 
SD 0.05 0.04 0.08 
 
 
Statistical analysis was completed to determine if the storage environment (H2O, 
VAC, and RT) was a factor in the measured wt. % concentrations. Storage environment 
was not a significant factor in the average wt. % concentrations (ANOVA, p=0.14), 
indicating no detectable difference between the various storage environments (Tukey 
post-hoc multiple comparison, p>0.05). This demonstrates that, over the 14 days of 
storage in the three environments, the manner in which a bone specimen is stored prior to 





4.5.5 Analysis of Specimen Location on Citrate Concentration 
 As described in section 3.5.6 (Ch. 3), three bones from a single rack of ribs were 
divided into three distinct anatomical regions (Dorsal, Central, and Ventral). The 
midpoint of each region was identified and a specimen was sectioned for analysis. 
Qualitative analysis was done to determine peak height, retention time, and resolution. 
Quantitative analysis was performed to determine if the anatomical location of a 
specimen was a factor in the detected concentration of citrate.  
 
 Qualitative Analysis 
 The peaks for the three locations along the length of the bone had two main peaks, 
with the largest one preceding the citrate peak. This run was the first run in which the 
peak preceding citrate did not return to a baseline prior to the start of the citrate peak. 
Thus, the citrate peak began before the unknown peak had finished eluting and could be 
considered to be a rider peak [31]. This was constant in all of the chromatograms from 
bone tested in this study, as such it was not believed to be specific to a particular location 
on the bone. The peak areas did appear to be different, but quantitative analysis was 
necessary to determine if the peak areas were significantly different. The chromatogram 








Figure 4.37 Close in View of Citrate Peaks in Different Locations of the Same Bone. All 

























Quantitative Analysis   
 Wt. % values for each of the samples were then determined using the processing 
method described in Section 3.3.8 (Ch. 3). This allowed for statistical analysis using the 
One-Way ANOVA method described in Section 3.3.12 (Ch. 3). While the values were 
pooled, it must be noted that bone samples from rack six were analyzed as the column 
performance began to decline due to the drop in operating pressure discussed earlier in 
this chapter. The values for wt. % are seen below (Table 4.25).  
 
 
Table 4.25 Calculated Normalized Concentrations (wt. %) of Citrate in Three 










R4B5 2.071 2.391 1.183 
R4B6 1.598 1.028 0.825 
R4B7 1.945 2.457 1.469 
R6B4 0.631 0.596 0.315 
R6B5 0.588 0.461 0.241 
R6B6 0.621 0.364 0.096 
Mean 1.242 1.216 0.688 
SD 0.645 0.879 0.510 
RSD (%)  51.93 72.29 74.13 
 
  
Statistical analysis was completed to determine if the anatomical location of a 
specimen (Dorsal, Central, and Ventral) was a factor in the measured wt. % 
concentrations. Anatomical location of a bone specimen was not a significant factor in 
the average wt. % concentrations (ANOVA, p=0.39), indicating no detectable difference 




comparison, p>0.05). This demonstrates that anatomical location of bone samples tested 
has no impact on the detected normalized citrate concentration (wt. %). 
The standard deviation when adjusted for the mean, RSD, values obtained for 
each of the locations indicates a wide degree of variance in the citrate contents in the six 
bone samples. The ventral samples had the highest degree of variance as evidenced by an 
RSD of 74.13%, while the dorsal had the lowest with an RSD of 51.93%. Citrate content 
across bones appears to be highly variable in each of the three regions. Further analysis 
was done to determine the impact of concentration variance on the PMI calculated using 
the method described in Section 3.5.10. The Calculated PMI for all samples is provided 
below (Table 4.26).  
 
Table 4.26 Estimated PMI Values of Bone Samples Using the Schwarcz Citrate 
Degradation Model49 in Three Anatomical Regions along a Porcine Rib Bone 
 









R4B5 0.071 0.024 1.475 
R4B6 0.357 2.507 5.020 
R4B7 0.109 0.019 0.554 
R6B4 9.741 10.983 28.747 
R6B5 11.292 17.428 37.025 
R6B6 10.075 24.341 60.822 
Mean 5.27 9.22 22.27 
SD 5.12 9.25 22.16 






Subsequent statistical analysis was completed to determine if the anatomical 
location of a specimen (Dorsal, Central, and Ventral) was a factor in the PMI estimation 
(years) obtained from the Schwarcz equation. Anatomical location of a bone specimen 
was not a significant factor in the PMI estimation (ANOVA, p=0.17), indicating no 
detectable difference between the various anatomical locations of bone samples (Tukey 
post-hoc multiple comparison, p>0.05). This demonstrates that anatomical location of 
bone samples tested has no significant impact on the estimated PMI (years).  
RSD values of PMI (years) obtained for each of the locations indicates a very 
large degree of variance in the estimated PMI for the three regions of the six bone 
samples. The central samples had the highest degree of variance as evidenced by an RSD 
of 100.32%, while the dorsal had the lowest with an RSD of 97.15%.  
 
4.5.6 Analysis of Additional Filtering on Chromatograms 
 More rigorous filtering of bone samples was considered towards the end of this 
thesis in order to eliminate the unknown peak that begins at 6 minutes. One of the 
common views held throughout early testing was that the large peak preceding citrate in 
the chromatograms of bone samples was caused by some type of protein remaining in the 
samples after using syringe tip filters. As such, it was believed that using a cutoff filter 
that allowed low molecular weight elements within the solution through, while filtering 
out large molecular weights would help to achieve the desired clean samples. In order to 
test this hypothesis, both a 1000 Dalton (Da) and 3000 Da cutoff filter were used in 




citrate molecule (189.1 Da) to pass through while filtering out the larger molecules 
believed to be the root cause of the preceding peak.  
 Chromatograms for the three filtration methods (unfiltered, 1K, 3K) of 75mg 
bone samples were overlaid and qualitatively analyzed (Figure 4.38). The peak height of 
the unknown peak did not decrease significantly in any of the three filtration methods. 
This demonstrated that the compound eluting prior to citrate had a molecular weight 
below 1kDa. Thus, the extra filtering had no significant impact on the peak height of the 





Figure 4.38 Chromatograms from MWCO Group One of 75mg Bone Overlaid. There is 
no significant difference in the size of the first peak in the three samples indicating that 




























Quantitative Analysis  
 Citrate peaks were processed with the peak processing protocol as outlined in 
section 3.3.8 (Ch. 3). Peak areas were converted into normalized concentrations of 
citrate, wt. %, for each of the three samples (unfiltered, 1K, 3K) in the three groups 
(Table 4.27). Concentrations were compared to determine if the filtering process 
produced any change in the detected citrate concentration.  
 
Table 4.27 Detected Concentration of Citrate (wt. %) Using Three Different Filtering 
Methods. 1K and 3K represent the molecular weight (kDa) of particles that are filtered 









Group 1 0.614 0.612 0.582 
Group 2 0.564 0.466 0.423 
Group 3 0.572 0.478 0.492 
Mean 0.583 0.519 0.499 
SD 0.022 0.066 0.065 
 
Statistical analysis was performed to determine if the type of filtration of a sample 
(unfiltered, 1K, and 3K) was a factor in the measured citrate concentration (wt. %). Type 
of filtration of a bone sample was not a significant factor in the average wt. % 
concentrations (ANOVA, p=0.34), indicating no detectable difference between the 
various filtration methods (Tukey post-hoc multiple comparison, p>0.05). This 
demonstrates that filtration of bone samples had no impact on the detected normalized 





4.5.7 Comparison of Standard Addition and Calibration Curve Concentrations 
 Concentrations obtained by the calibration curve and standard addition method 
were compared to evaluate if methodology had an impact on the concentration observed 
in bone specimens. Uncertainties associated with each Standard Additon measurement 
are reported, but were not considered in this analysis as it was intended to be a first order 
approximation of the differences between the two methods in order to determine how the 
method used to obtain a concentration would impact the obtained value. Two sets of test 
data (location and storage condition) were pooled for analysis. It was hypothesized that 
methodology of calculating the concentration in a bone sample would not have a 
significant impact on the normalized concentration, wt. %, of citrate detected in each 
bone sample. 
 Calibration curve concentrations were obtained by finding the concentration 
(mM) associated with the peak area obtained. Standard addition values were obtained by 
back extrapolation of the standard addition curve and taking the absolute value of the 
concentration on the negative x axis. Uncertainties of x-intercept values were determined 
using the following equation (Eq. 4.1) [23].  
 









2     Eq. 4.1  
 






Table 4.28: Comparison of Concentrations Obtained by Calibration Curve and Standard 

















Location R4B5D 1.789 2.071 0.12 
Location R4B5C 1.623 2.391 0.08 
Location R4B5V 1.016 1.183 0.11 
Location R4B6D 1.421 1.598 0.07 
Location R4B6C 0.678 1.028 0.31 
Location R4B6V 0.657 0.825 0.06 
Location R4B7D 1.455 1.945 0.21 
Location R4B7C 1.564 2.457 0.16 
Location R4B7V 1.166 1.469 0.06 
Storage RT1 1.352 1.380 0.01 
Storage RT2 1.365 1.473 0.02 
Storage RT3 1.393 1.594 0.03 
Storage VAC1 1.316 1.399 0.06 
Storage VAC2 1.161 1.336 0.03 
Storage VAC3 1.182 1.302 0.06 
Storage H2O1 1.493 1.478 0.03 
Storage H2O2 1.332 1.361 0.01 
Storage H2O3 1.331 1.372 0.03 
Mean 1.294 1.537 0.08 
SD 0.283 0.417 0.07 











Statistical analysis was performed on the obtained concentrations to determine if 
the methodology of obtaining the citrate concentration (standard addition or calibration 
curve) had a significant impact on the normalized citrate concentration, wt. %, measured 
in each sample. Method of obtaining the normalized concentration (calibration curve, 
standard addition) was a significant factor in the average concentrations measured (paired 
t-test, p<0.05), indicating a significant difference between the concentrations obtained 
with the two methods.  This demonstrates that the method of obtaining the normalized 
concentration, wt. %, was significant in the detected citrate concentration for all samples 
when uncertainty of x was not accounted for in standard addition population. A more 
complete analysis could be performed using the uncertainty values provided in Table 
4.28.   
 Overall, the concentrations obtained with the standard addition methodology were 
higher compared to the calibration curve concentrations in all of the samples except for 
one (H2O 1). It was unclear how the difference in the concentrations would factor into 
PMI estimates, so further analysis was performed to obtain PMI estimates using the 






Table 4.29 Comparison of calculated PMI (years) for Standard Addition and Calibration 











Location R4B5D 0.186 0.071 
Location R4B5C 0.327 0.024 
Location R4B5V 2.608 1.473 
Location R4B6D 0.654 0.356 
Location R4B6C 8.304 2.504 
Location R4B6V 8.916 5.013 
Location R4B7D 0.582 0.109 
Location R4B7C 0.401 0.019 
Location R4B7V 1.562 0.555 
Storage RT1 0.827 0.752 
Storage RT2 0.791 0.547 
Storage RT3 0.719 0.361 
Storage VAC1 0.936 0.704 
Storage VAC2 1.590 0.874 
Storage VAC3 1.480 0.982 
Storage H2O1 0.511 0.538 
Storage H2O2 0.886 0.802 
Storage H2O3 0.889 0.773 
Mean 1.787 0.914 
SD 2.478 1.148 









The standard deviation in both methods was large compared to the mean as 
indicated by the large RSD values obtained. The standard addition method provided a 
more accurate estimation of the PMI. Statistical analysis was performed to determine if 
the differences in PMI estimation were significant. Method of obtaining citrate 
(calibration curve or standard addition) was found to be significant (paired t-test, p < 
0.05) on the calculated PMI (years). The lower RSD for the standard addition group 
indicated the need for a standard addition methodology in the sampling protocol.   
 
4.5.8 Analysis of Calculated PMI for Citrate Concentrations Obtained in Study 
 As the primary motivation for this thesis was to investigate the potential of a 
citrate based method for prediction of PMI, all cortical only samples were analyzed to 
determine the calculate PMI (years) obtained by the Schwarz equation (Tables 4.30-4.33; 
Figures 4.39-4.41). It was hypothesized that all samples should return a PMI close to 0, 












Table 4.30 Calculated PMI Using Schwarcz Citrate Degradation Model49 for all Bone 
Specimens Tested in the Storage Condition Study 
 
Storage Condition Study 
Sample  wt.% 
PMICALC 
(Years) 
VAC1 1.40 0.70 
VAC2 1.34 0.87 
VAC3 1.30 0.98 
H2O1 1.48 0.54 
H2O2 1.36 0.80 
H2O3 1.37 0.77 
RT1 1.17 1.54 
RT2 1.26 1.14 
RT3 1.36 0.80 
Mean 1.34 0.90 




Figure 4.39 Plot of PMI and Concentration of Bone Samples in Storage Condition Study. 

















Table 4.31 Calculated PMI Using Schwarcz Citrate Degradation Model49 for all Bone 
Specimens Tested in the Location Study 
 
Location Study  
Sample  wt.% 
PMICALC 
(Years) 
R4B5 DOR 2.07 0.07 
R4B5 CEN 2.39 0.02 
R4B5 VEN 1.18 1.47 
R4B6 DOR 1.60 0.36 
R4B6 CEN 1.03 2.50 
R4B6 VEN 0.83 5.01 
R4B7 DOR 1.94 0.11 
R4B7 CEN 2.46 0.02 
R4B7 VEN 1.47 0.55 
R6B4 DOR 0.63 9.74 
R6B4 CEN 0.60 10.98 
R6B4 VEN 0.31 28.75 
R6B5 DOR 0.59 11.29 
R6B5 CEN 0.46 17.43 
R6B5 VEN 0.24 37.03 
R6B6 DOR 0.62 10.07 
R6B6 CEN 0.36 24.34 
R6B6 VEN 0.10 60.82 
Mean 1.05 12.25 




Figure 4.40 Plot of PMI and Concentration of Bone Samples in Location Study. Blue bars 














Table 4.32 Calculated PMI Using Schwarcz Citrate Degradation Model49 for all Bone 
Specimens Tested in the Filter Method Study 
   
Filter Method Study 




MWG1 UN 0.61 10.33 
MWG1 1K 0.61 10.40 
MWG1 3K 0.58 11.53 
MWG2 UN 0.56 12.28 
MWG2 1K 0.47 17.17 
MWG2 3K 0.42 19.88 
MWG3 UN 0.57 11.95 
MWG3 1K 0.48 16.45 
MWG3 3K 0.49 15.67 
Mean 0.53 13.96 




Figure 4.41 Plot of PMI and Concentration of Bone Samples in Filtration Method Study. 























MEAN 1.12 7.93 
SD 0.63 13.72 
RSD 56.64 173.05 
 
 
The storage condition study provided the least variation in PMI, 0.90 ± 0.27 
years, while the location study had the most 12.25 ± 15.93 years. This indicates that the 
model provided by Schwarcz is unable to compensate for variation in citrate content 
within bone. The wide variance in all bone samples, 56.64 RSD over the whole thesis, 
demonstrates citrate concentrations in porcine rib bone vary. The mean wt % obtained in 
this thesis is the same as that reported by Froome et al. (1.12 wt. %) [20]. Also, only three 











The overall objective of this thesis was to develop and validate an HPLC method 
for quantitative and qualitative analysis of citrate in bone. In order to achieve this 
objective, experiments were developed to achieve three main aims. First, an HPLC 
method was developed and tested on a physiologically relevant range of citrate standards. 
Second, an existing bone specimen processing method was tested and optimized to 
ensure the proper preparation and sampling of bone using HPLC. Third, bone samples 
were prepared and tested to evaluate the qualitative and quantitative analysis provided by 
the HPLC method developed in aim one.  
Aim 1 was accomplished through an array of experiments performed on a 
physiologically relevant range of citrate standards (0 to 2.5 mM). In particular, linearity, 
storage time of standards, stock solution pH, and intra-day test method precision 
(repeatability) were examined. Aim 2 was accomplished by designing experiments to 
qualitatively and quantitatively analyze citrate detection in three different bone masses 
(50, 75, and 100 mg). Also, matrix effects were also analyzed through the design and 
execution of standard addition and standard recovery tests. Finally, different types of 
bone (cortical, trabecular, and mixed) were analyzed to determine the optimal type of 




different short term (14 day) storage conditions (hydrated, dehydrated, and room 
temperature), intra-bone factors associated with sampling at different anatomical 
locations (dorsal, central, and ventral), and an analysis of the calculated PMI produced by 
the method described by Schwarcz et al. [49] for all 75 mg cortical only bone samples 
analyzed throughout this thesis.  
This chapter is divided into six subsections. Subsection 5.2, “HPLC Test Method 
Development and Validation on Standards (Aim 1)”, discusses experiments related to 
Aim one in this thesis. Subsection 5.3, “Selection and Preparation of Bone Specimens 
(Aim 2)”, addresses the experiments performed to accomplish aim two. Subsection 5.4, 
“Utilization of Bone Preparation Protocol and HPLC Method for Qualitative and 
Quantitative Analysis of Citrate Content in Bone (Aim Three)”, addresses the 
experimental results obtained to accomplish aim three. Subsection 5.5, “General 
Observations on HPLC Performance”, briefly discusses the performance of the HPLC 
system throughout this thesis. Subsection 5.6, “Overview of Expenses”, addresses the 
costs associated with the HPLC method. Finally, subsection 5.7, “Future Work”, 
discusses potential areas of future research.   
 
5.2 HPLC Test Method Development and Validation on Standards (Aim 1) 
Aim 1 was accomplished through an array of experiments performed on a 
physiologically relevant range of citrate standards (0 to 2.5 mM). In particular, linearity, 
storage time of standards, stock solution pH, and intra-day test method precision 




5.2.1 Mobile Phase 
 Laboratory grade sulfuric acid was used for mobile phase throughout the entirety 
of this thesis. At the outset of the project, it was unclear as to the necessary purity and 
grade of chemicals needed to obtain optimum results. Due to a desire to minimize 
expenses with this analytical technique in regards to translation to forensic labs, non-
HPLC grade chemicals were used throughout testing to determine impact on sample 
resolution and overall quality of the method. No testing was done with HPLC grade 
sulfuric acid, and as such it is unclear whether or not chemical grade had an impact on 
chromatogram shape or retention times.  
 
5.2.2 HPLC Method Parameters 
 As with mobile phase, HPLC method parameters [temperature, pressure, 
wavelength, injection volume, and flow rate] were based on operating conditions 
suggested by the manufacturer. This thesis was focused on practical optimization of 
HPLC analysis of bone samples, as such certain aspects of HPLC method were not fully 
investigated. For the purposes of this thesis, the conditions provided by the manufacturer 
produced acceptable results, and as such were deemed acceptable for this method. This 
section will discuss the range of testing on method parameters. 
 In this thesis, a singular flow rate of 0.6mL/min was used for all analysis in order 
to minimize stress on the column. When the column pressure dropped after 400 
injections, flow rate was increased to 0.7 mL/min. Chromatograms produced at this flow 




flow rate of either 0.6 mL/min or 0.7 mL/min would provide acceptable chromatograms 
for qualitative or quantitative analysis with this method. 
 Initial analysis of standards were done with a 40 µL injection volume based on 
the manufacturer’s suggested test method. Chromatograms at this injection volume had 
small citrate peaks and as a result low areas of citrate. In subsequent analyses, injection 
volume was increased to 50 µL which resulted in larger citrate peaks and peak areas that 
were more easily integrated. All subsequent analyses were done with injection volumes 
of 50 µL. The HPLC system had a max injection volume in the sample loop of 100 µL. In 
samples with in which citrate concentration is expected to be difficult to quantify, larger 
injection volumes could be used to increase the response of the system. No need was 
evident throughout testing for greater injection volumes with the method as all sample 
were fresh and as a result expected to have high concentrations of citrate.  
 As demonstrated in section 4.2.4 (Ch. 4), analysis of standards and bone samples 
was performed with two channels. The first was a time constant standard channel with a 
wavelength of 210 nm, which was used in parallel with channel that performed a 
wavelength scan from 200-400 nm. Analysis of UV-Vis spectra of citrate standards 
demonstrated two wavelengths where citrate had a high response in absorbance units, 190 
nm and 209.6 nm (210 nm). Analysis of the unknown peak in bone solution 
chromatograms demonstrated a dominant response at 190 nm that was muted at 210 nm, 
as such the time constant standard wavelength was fixed at 210 nm. As the main point of 
interest of this thesis was citrate, no further analysis was performed on the unknown first 




spectra were consistent in each sample, and may be worth investing the potential of doing 
a background subtraction when suspected interference with a citrate peak occurs. The 
wavelength scan channel was adjusted to scan from 190 nm to 300 nm to allow for 
analysis of citrate at 190 nm if desired.  
 As demonstrated in section 4.2.3 (Ch. 4), pressure in the column varied 
throughout the thesis, but did not have an impact on the ability to quantify citrate. 
However, during the final 50 sample injections performed in this thesis, a noticeable drop 
in pressure (200 psi) occurred after storing the column for one month at 2ºC. The 
manufacturer hypothesized that the drop was due to a change in the chemistry of the 
column caused by the high salt content of the bone samples. Column regeneration was 
attempted using the protocol suggested by the manufacturer, namely, a 25 mM H2SO4 
mobile phase solution was run through the column overnight at a flow rate of 0.1 
mL/min. After this treatment, pressure and chromatograms were unchanged from the 
lower pressure conditions, and as such regeneration of the column was not successful.  
  
5.2.3 Linearity and Range 
 All of the standards analyzed in this thesis provided acceptable linearity as 
documented in section 4.3.1 (Ch. 4). This indicated that the response (i.e. absorbance) of 
the HPLC increased in proportion to the increased citrate concentration in standard 
solutions. Furthermore, a physiological citrate concentration range (0 to 2.5 mM) was 
linear over the entire range. All citrate measured from bone samples in this thesis were 




method developed was appropriate for the detection of citrate in standards as well as bone 
solutions. 
 
5.2.4 Intra –Day Test Method Precision (Repeatability)  
 Overall, the HPLC method is suitable for low concentrations of citrate that may 
be expected from degraded bone samples in forensic anthropology applications. As 
shown in section 4.3.2 (Ch. 4), intra –day test method precision (repeatability) of the 
HPLC method and Waters Breeze 2 HPLC system was acceptable based on ten 
consecutive injections of the 0.5 mM standard. The 0.5 mM standards used in this test 
were analogous to a 75 mg bone solution with a normalized concentration of 0.43 wt. % 
which is approximately half of the concentrations seen in fresh bone samples analyzed. It 
is believed that a similar result would be obtained were this analysis repeated on bone 
solutions based on an analysis of samples for which three injections were performed. 
Other aspects of precision (inter day variation, reproducibility) were considered for 
testing, but time and resource constraints prevented completion of those experiments.  
 
5.3 Selection and Preparation of Bone Specimens (Aim 2) 
 The second aim of this thesis was to develop and optimize a specimen processing 
protocol for HPLC analysis of bone. The bone specimen processing method described by 
Schwartz, et al. was evaluated and modified to allow for more efficient processing of 
bone samples. Next, bone samples were analyzed with HPLC in order determine 




dependence on the detected citrate concentrations, and the ability of the Breeze system 
software to integrate citrate peaks. Furthermore, HPLC analysis were performed on three 
different bone masses of bone to determine if mass of bone prepared for analysis was a 
factor in the detected citrate concentrations in bone samples. Matrix effects were also 
analyzed to determine if the processing method required a strategy for the reduction of 
matrix effects. Finally, different bone types (cortical, trabecular, and mixed) were 
analyzed to determine if the type of bone prepared in this process was a factor in the 
detected citrate concentration.    
 
5.3.1 Modifications to Schwarcz et al. Bone Processing Method  
  An analytical approach was used to develop both a more efficient and easier to 
use processing method for bone analysis in this thesis. Also, changes to the Schwarcz 
method were needed in order to optimize the prepared samples for HPLC analysis [49]. 
This section will address two main changes made to the processing method, namely an 
increased digestion time for larger masses of bone and a defined sample neutralization 
procedure.  
 
5.3.2 Digestion Times 
Overall, the time of digestion of samples in this thesis was increased from one 
hour to four hours to ensure adequate time for the demineralization reaction to occur. As 
demonstrated in Section 4.5.1, mass of bone prepared and analyzed was not a factor in 




in this thesis for subsequent analysis was the use of 75 mg samples. Although mass was 
not a factor in the citrate concentration detected, a key concern with the use of larger 
masses of bone is ensuring that all of the citrate is extracted from the sample.  
As the demineralization reaction is rate limited, the concentration of the acid, 
time, and temperature at which demineralization occurs will impact the citrate extracted 
from the process [18].  Furthermore, it has been shown that increased concentrations of 
acid do not impact the demineralization reaction proportionally [18]. In the optimal mass 
study, the three masses were digested for different times (one hour for 50 mg, two hours, 
for 75mg, and four hours for 100 mg), thus, it was demonstrated that the increased 
digestion times had no negative impact on the detection of citrate. While the two hour 
digestion of 75 mg samples in the optimal mass study appeared to be appropriate, it was 
unclear whether a 150% increase in bone mass used would be sufficiently mineralized 
with only an additional hour of digestion time. As a result, four hours was selected in 
order to allow for adequate time of demineralization process to occur. Since the 100 mg 
samples at four hours showed no loss in the detected citrate concentrations, four hours 
was deemed to be suitable for the 75 mg samples. In all samples processed at four hours, 
chromatograms provided adequate peaks for integration. Further research is needed to 








5.3.3 Sample Neutralization 
As described in section 3.4.10 (Ch. 3), samples were neutralized to a pH 2 rather 
than a pH 5 as written in the Schwarcz protocol [49]. This was done to ensure 
precipitation of citrate did not occur prior to analysis of samples, as observed by Gibbs at 
pH 5 [21]. Also, a 1.0 M KOH solution was used rather than a 0.5 M solution. This 
change required less volume of KOH solution to neutralize the bone sample to pH 2. 
Furthermore, an analytical approach was used to standardize the volume of 1.0 M KOH 
solution added to each sample, allowing for more efficient processing in a laboratory 
setting when compared to a dropwise addition as written in Schwarcz [49]. The amount 
of 1.0M KOH needed to reach pH 2 was equivalent in all bone solutions, as long as the 
same source of 1.0M KOH was used. As sample volume was lost in the confirmation of 
pH, the preparation of an extra sample for quality control purposes was found to be useful 
throughout this process. 
 
5.3.4 Chromatogram Peaks 
 As demonstrated in section 4.4.1 (Ch. 4), chromatograms produced by bone 
samples contained two prominent peaks, a large unknown peak that begins to elute 
around 6 minutes and a citrate peak immediately following that begins to elute around 8 
minutes. In most analysis, each of these two peaks were clearly defined, with the 
unknown peak being 5x as large as the citrate peak in terms of both area and peak height. 
Analysis of the test chromatogram provided with the Aminex HPX-87H column showed 




investigated in literature, but it appeared that the concentrations reported in bone were 
less than those of citrate [25]. Thus, the peak was not oxalic acid, but rather another 
analyte that reacts with the ions in the column. A list of compound retention times 
provided by the manufacturer was studied to try and determine the actual compound 
eluting in the samples.  
    Using the retention times of the unknown peak and citrate in reference to lactic 
acid, it was determined that at the operating parameters of the method, two compounds 
have relative retention times of approximately six minutes. The two compounds and 
relative retention times were Glucosamine, 6.10 min, and 1-Hexanesulfonic acid, 6.13 
min. Glucosamine appeared to be the more likely compound in this application, as 
glucosamine is found in the bone extracellular matrix [54]. Furthermore, Glucosamine 
has a molecular weight close to citrate (179.17 g/mol) that would be able to pass through 
the 1K and 3K molecular weight cutoff filter tubes as evidenced by the preservation of 
the peak in chromatograms (Section 4.4.1,Ch. 4). As the unknown peak did not interfere 
with the citrate peak, no further investigation occurred in this thesis; however, the 
compound causing the peak should be identified and if possible reduced in order to make 
the HPLC method more suitable for bone samples with low, < 0.25 wt. %, citrate 
concentrations.   
 
5.3.5 Peak Integration 
The built in integration capabilities of the Breeze 2 software were sufficient to 




approach when correcting integration in order to prevent the introduction of error in the 
processing of the data. Namely, in instances where the beginning and end of peaks were 
unclear, peaks were magnified with the software and start and stop points were identified 
based on a consistent increase in the baseline (start) and a return to the baseline (end).  As 
demonstrated in section 4.4.2 (Ch. 4), the tangential skim fit described in section 3.3.8 
was the most appropriate fit for all analysis as it allowed for correct approximation of the 
area under citrate peaks.  
 
5.3.6 Injection Dependence 
As shown in section 4.4.3 (Ch. 4), the first injection of bone solutions through the 
HPLC system produced larger unknown peaks when compared to subsequent injections. 
Statistical analysis demonstrated that the injection number had no significant impact on 
the measured concentration of citrate in bone solutions (Repeated Measure ANOVA, 
p=0.26). While the unknown peak size in the first injection had no significant impact on 
the detected concentration of citrate, an extra bone sample could be prepared and 
introduced into the column prior to the necessary analysis of bone solutions as a quality 
control measure.  
 
5.3.7 Optimal Mass 
 As demonstrated in Section 4.5.1 (Ch. 4), mass of bone prepared for analysis was 
not a significant factor in the detected concentrations of citrate. Previous methods of 




suitability with larger masses of bone [16, 49]. The results shown in section 4.5.1 (Ch. 4) 
demonstrated that greater masses of bone caused proportional increases in the area under 
the citrate peaks. As such, any mass of bone in the range of 50 to 100 mg could be 
analyzed using the HPLC method developed in this thesis as the mass of bone prepared 
for analysis (50, 75, and 100 mg) was not a significant factor in the detected 
concentration of citrate when normalized (wt.%). As stated in section 4.5.1 (Ch.4), 75 mg 
was selected for the HPLC bone sample processing method as the theoretical 
concentrations of citrate at this mass were within the middle of the concentration range 
used in the calibration curve.  
The success of the 100mg mass samples was not important with fresh bone 
samples analyzed in this thesis, but would be important with aged samples containing 
reduced concentrations of citrate. Forensic samples 50 years or older would be expected 
to have low concentrations of citrate that may approach the Limit of Quantitation (LOQ) 
and Limit of Detection (LOD) of the HPLC method. The use of a larger mass of bone is 
one possible way to generate enough signal for peak integration. The success of this 
method at higher mass groups shows promise of being able to overcome the problem of 
low concentrations in aged samples. 
 
5.3.8 Matrix Effects 
As demonstrated in Section 4.5.2 (Ch. 4), standard addition and standard recovery 
tests were performed to determine whether or not matrix effects were present in either the 




recovery tests, but not in the standard addition tests. Section 5.3.8.1 will address what 
was demonstrated by the presence of matrix effects in standard recovery, but not standard 
addition tests. Section 5.3.8.2 will address the nature and extent of matrix effects in the 
standard recovery data. Finally, section 5.3.8.3 will discuss the strategy for reducing 
matrix effects adopted in subsequent analysis (Section 4.5.2, Ch. 4).  
 
5.3.8.1 Analysis of Matrix Effects in Standard Recovery and Standard Addition 
 As seen in section 4.5.2 (Ch. 4), matrix effects were present in standard recovery 
tests, but not standard addition tests performed on mixed bone solutions. Analysis of 
these results indicated that matrix effects were present in the processing protocol of bone 
rather than the analytical method.  
Standard addition calibration curves had slopes equivalent to the calibration curve 
slopes in all three of the standard addition tests performed with mixed bone solutions. 
Also, the maintenance of linearity (R2 > 0.98) indicated that matrix as citrate was spiked 
into the bone solutions, the detected citrate concentration increased in proportion. This 
indicated that no loss of citrate was occurring in bone solutions spiked with either high or 
low concentrations of citrate. As the spiking of the solutions was done after processing of 
the specimens, this indicated that no matrix effects exist in the analytical technique 
utilized for detection of citrate content in bone solutions. Further testing with lower 
spiked concentrations is needed to determine if standard additions on cortical only 
solutions with additions in a range of up to 3x the concentration reported in this thesis, 




As seen in section 4.5.2 (Ch. 4), matrix effects were present in standard recovery 
tests of all three mixed bone samples analyzed. Matrix effects were evidenced by a loss in 
linearity of two of the three mixed bone solutions tested (R2 < 0.98), as well as both 
translational and rotational effects in the standard recovery calibration curves when 
compared to the standard calibration curve.  This indicated that as citrate was added, the 
analyte signal was not increasing proportionally in each of the bone samples. As no 
matrix effects were seen in standard addition tests, it was determined that degradation in 
the detection of citrate occurred in the final steps of bone sample processing. Only two 
steps occurred after citrate was spiked into samples, namely the demineralization process 
and sample neutralization. As citrate is known to form a precipitate in the presence of 
calcium and phosphate, the demineralization process may be the most likely site of 
matrix effects in the bone samples [35].  Another potential explanation for the presence 
of matrix effects in standard recovery data but no standard addition data was the 
introduction of error in the measurement of citrate spiked into the bone samples. As the 
target concentrations of citrate were low [0.5, 1.0, 1.5, and 2.0 mM], small masses of 
citrate, in some cases single crystals, were weighed and added into the samples prior to 
the demineralization process.  If error were introduced by amount of citrate added, the 
low concentrations should have been consistently scattered, while the high concentrations 
should have demonstrated a high degree of stability. All of the concentrations appeared to 
be equally scattered in the three recovery tests, and as such it was concluded that error in 
the measurement of citrate crystals added was not a cause of the matrix effects realized in 




5.3.8.2 Nature of Matrix Effects Seen in Standard Recovery Data 
 As shown in section 4.5.2 (Ch. 4), both translational and rotational matrix effects 
were observed in the three sets of standard recovery tests performed in this thesis. It was 
unclear why set one was the only to demonstrate a translational matrix effect, meaning 
the citrate lost was independent of the amount of citrate added [55]. The other two sets, as 
well as the standard recovery test on a cortical only sample, demonstrated a rotational 
matrix effect, indicating that as the amount of citrate spiked was increased, a loss of 
signal increased. When citrate recovery in set one, 79.2 ± 19%, is compared to sets 2 and 
3, 87.9 ± 9% and 91.4 ± 8%, it can be determined that the translational matrix effect 
causes a greater loss in citrate within these samples. Further analysis is needed to 
determine whether or not both type and extent of matrix effects are varied between 
different bones and individuals. 
 
5.3.8.3 Strategy for Reducing Matrix Effects in Bone Sample Analysis 
 As detailed in section 4.5.2 (Ch. 4), three strategies for reducing matrix effects 
were considered: (1) matrix matched standards, (2) standard addition, and (3) 
mathematical compensation. As bone composition is expected to vary between bones, a 
matrix matched standard was found to be too challenging to implement within a 
laboratory setting, as such a matrix matched standards strategy was not utilized. As the 
sample size for matrix effects across bone samples is still small, the adoption of a 




strategy was the easiest to work with and most feasible given the current database of 
knowledge. 
The adoption of a standard addition strategy was not a small decision. This 
method required more sample preparation and subsequent analysis for the determination 
of a single value. As a result, both longer run times and increased resource requirements 
were experienced compared to a calibration curve methodology.  In order to reduce the 
overall costs of the standard addition method, only three additions were used for each 
bone sample for a total of four measurements. As standard addition requires the back 
extrapolation of a first-order (straight line) fit of the data to the x-axis, the uncertainty in 
x was calculated using a cortical only bone sample in which standard addition was used. 
Standard deviation of the x-intercept in x was calculated using the following equation 
(Eq. 5.1).  
 









2                        Eq. 5.1 
 
 Sy
 is the standard deviation of y, |m| is the absolute value of the slope, n is the 
number of data points for the calibration line, y is the absorbance of the unknown,  ?̅? is 
the mean value of y (area units) for all of the points on the calibration, xi are the 
individual values of x for the points on the calibration line, and ?̅? is the mean value of x 
for all points on the calibration line [23].  
  A calculation was done with sample R4B5 Dorsal, a cortical only sample from the 




obtained standard deviation in x was 0.135 mM. Translating this into wt % of 75 mg 
samples yields a standard deviation of 0.12 wt. %. Ultimately, the error in the x – 
intercept of a sample with four additions translates into an error in the PMI estimation 
with the Schwarcz equation, as such, the standard addition method adopted in this thesis 
needs to be improved. One possible way to accomplish this is to increase the number of 
additions performed for each bone sample. Further analysis is needed to balance the 
resource and time requirements of additional concentrations with the required accuracy 
and precision of the assay.  
 
5.3.9 Analysis of Citrate Concentration in Bone Types 
As demonstrated in Section 4.5.3 (Ch. 4), HPLC analyses were performed on 
three bone types (cortical, trabecular, and mixed) to determine the most suitable type of 
bone for use with the HPLC method. Cortical chromatograms showed better peak 
resolution and larger peak heights compared to the corresponding trabecular samples. In 
addition, only two of the six trabecular samples analyzed in this experiment provided 
peaks that were quantifiable in the system software. Also, the two that were quantified 
had low concentrations, 0.23 wt. % and 0.83 wt. %, compared to the corresponding 
cortical bone samples, 1.62 and 1.42 wt. % respectively.  The wide variance between 
cortical and trabecular citrate concentrations seemingly impacted the mixed samples as 
the two analyzed had concentrations of 0.73 and 0.71 wt. %.  
The data indicates no advantage to using a mixed bone solution in terms of 




to depressed detection of citrate in bone. It was unclear whether this was a limitation of 
the HPLC detection method or variation in citrate concentrations between cortical and 
trabecular regions. In a prior study by Gibbs, the successful quantitation of citrate in 
trabecular bone specimens using an enzymatic assay method for citrate detection was 
reported In this study, trabecular samples provided an average concentration of 1.5 wt.% 
[21].  All other studies on citrate in bone have utilized cortical only samples, and as such 
the selection of cortical only samples in this thesis can be validated through literature [16, 
20, 27, 32, 49].  
As of now, no apparent disadvantage is known with the use of a cortical only 
samples for the detection of citrate in bone. Conceivably, the only reason trabecular bone 
analysis would be desired is a more rapid degradation of citrate in cortical bone compared 
to trabecular bone within a forensic context.  Overall, it appears that the HPLC test 
method developed in this thesis was most suitable for cortical only bone sample, not 
suitable for trabecular analysis, but was suitable for cortical only sample analysis.   
 
5.4 Utilization of Bone Preparation Protocol and HPLC Method for Qualitative and 
Quantitative Analysis of Citrate Content in Bone (Aim 3)  
In prior sections, it has been demonstrated that the HPLC method was suitable for 
use to qualitatively and quantitatively analyze citrate in standard solutions (Aim 1). Also, 
experiments had been completed to optimize the bone sampling protocol for use with 
HPLC (Aim 2). This section will address experiments that utilized both the HPLC 
method and optimal bone sampling protocol to qualitatively and quantitatively analyze 




Overall, three experiments were designed to achieve this aim. First, bone samples 
were exposed to three different short term (14 day) storage conditions (hydrated, 
dehydrated, and room temperature) and subsequently analyzed to determine if short term 
storage environment was a factor in the concentration of citrate detected. Next, intra-bone 
factors associated with sampling at different anatomical locations (dorsal, central, and 
ventral) were evaluated to determine whether or not anatomical location was a significant 
factor in the observed concentration of citrate. Finally, the equation produced by 
Schwarcz et al. was utilized to determine the calculated PMI (years) for the cortical only 
bone samples analyzed throughout this thesis [49].  
 
5.4.1 Storage Condition 
As shown in Section 4.5.4 (Ch. 4), bone specimens were exposed to three 
different short term (14 day) storage environments (H20, VAC, and RT) in order to 
determine whether or not the short term storage environment was a factor in the detected 
citrate concentration in bone. In one of the specimens stored in water, the water was 
pulled out of the flask by the vacuum. This occurred after 10 days. The sample was 
included in the study as this occurred shortly before testing. Overall, no significant 
difference was observed in either chromatograms or detected concentrations of citrate 
between the three short term storage environments analyzed. The bone specimens left out 
at room temperature had the lowest concentrations of the three populations, 1.26 ± 0.08, 
while the samples stored in deionized water under vacuum had the highest concentrations 




exposure of bone specimens to water would lead to degraded levels on citrate in bone 
specimens [49]. One possible explanation is that deionized water was used in this study 
rather than tap or ground water.  As such, it did not contain microbial organisms that may 
be found in other water sources. Thus, the degradation of citrate in bone when exposed to 
water may be the result of microorganisms rather than hydration of the sample in water. 
In general, these three conditions were selected in order to provide a range of storage 
conditions available in all laboratories. Based on the data, either the storage of bone 
specimens in deionized water or dehydration in a vacuum oven would be better than 
leaving the samples at room temperature. Further analysis is needed to determine how 
these methods work over longer periods of time.  
 
5.4.2 Intra-bone factors associated with sampling at different anatomical locations 
As shown in section 4.5.5 (Ch. 4), the anatomical region from which a bone 
specimen was obtained (Dorsal, Central, Ventral) was not a significant factor in the 
detected concentration of citrate (wt. %). Six sections representing each region were 
analyzed. The ventral regions had the highest relative standard deviation, 72.3%, while 
the dorsal region had the lowest, 51.9%. These variances suggest that inter-bone 
variations can impact results. The wide range of variances also caused a large variation in 
the calculated PMI. Each of the three regions had RSD values greater than 95% 
indicating a great deal of uncertainty with the calculated PMI. The ventral specimens in 
particular provided satisfying low accuracy with the PMI method, 22.3 ± 22.2 years. This 




determine if these variations are universal or unique to the porcine rib model analyzed in 
this thesis.    
 
5.4.3 Standard Addition Compared to Calibration Curve 
As documented in section 4.5.7, the method of obtaining the citrate concentration 
(calibration curve or standard addition) was a significant factor (p < 0.05) in the detected 
citrate concentration (wt.%). The standard addition method had a slightly higher variance, 
RSD = 27.2 %, compared to the calibration method, RSD = 21.8%. Furthermore, the 
concentrations obtained by the standard addition method provided calculated PMI with 
less variance, 0.914 ± 1.1 years, compared to the calibration curve concentrations, 1.79 ± 
2.5 years. Although, this data indicates that standard addition methodologies provide 
more accurate concentrations, it must be noted that the standard deviations in the x- 
intercept (standard addition concentration) were reported but not included in analysis. 
Overall, the adoption of a standard addition methodology to overcome matrix effects in 
samples appears to be necessary for this HPLC method. 
 
5.4.4 Analysis of Calculated PMI for Citrate Concentrations Obtained in Study 
 As demonstrated in Section 4.5.8, the concentrations of citrate in 75 mg cortical 
only bone samples were converted into PMI estimates. Overall, the average concentration 
in all samples was 1.12 ± 0.63 wt. %, which translated into an average calculated PMI of 
7.93 ± 13.7 years. The large standard deviation indicates a lack of accuracy with this 




should have provided a calculated PMI near 0 years. Only two of the samples analyzed 
had PMI of < 0.05 years. Ultimately, a better model is needed to fit the data, as the 
current level of accuracy would not be useful in forensic investigations. 
 
5.5 General Observations on HPLC Performance  
 Overall, the HPLC performance throughout this thesis was highly reliable with 
the standard solutions, but inconsistent with the bone sample analysis. Throughout this 
thesis, the Aminex HPX-87H column was exposed to a total of 460 injections. About half 
of these injections were standards with the other half being bone samples. Over time, the 
performance of the column, in particular, appeared to degrade as evidenced by an 
increase in retention time for all samples, including standards, and a decreased operating 
pressure in the system. Although no changes, other than increased retention time, were 
apparent in standards, citrate peaks in bone sample chromatograms began to elute prior to 
a return to baseline. However, qualitative and quantitative analysis of the samples was 
still possible. 
One potential cause of the change in column performance was the binding of 
calcium from the bone samples to the solid phase of the column causing a chemistry 
change in the column. Typically, Aminex HPX-87H columns should be able to handle a 
minimum of 1000 injections without degradation in performance, so a loss of selectivity 
after 500 injections was not expected. A better cleaning method after sample processing, 
namely the use of a 25 mM H2SO4 left allowed to run through a reversed column with a 





5.6 Overview of Expenses  
 One of the key considerations throughout this thesis was the translation of any 
analytical techniques or methods developed in this paper into a forensics lab. As such, 
key attention was given to minimizing costs of the HPLC equipment and consumables 
needed, while maximizing the performance of the technique. This section will discuss the 
supplies and associated cost as of the writing of this thesis (2015) of materials used 
throughout the thesis. Below is a list all of the equipment not including chemicals needed 






Table 5.1 List of Equipment and Associated Costs Needed for HPLC Method 



















HPLC Glass Vials 186007194C, Waters $60.00 100 






As with most other HPLC applications, the greatest expense in this thesis was the 
column needed for sample separation. Having not had previous HPLC equipment, a 
column, guard column, and cartridge holder for the guard column were needed. All 
equipment was obtained from Bio-Rad Laboratories (Hercules, CA). A review of the 
invoices from this process showed an expense of roughly $2000 for these parts.  
 The cartridge holder for the guard columns has no interaction with the samples 
and was considered to be a one-time purchase. The cartridge holder was $600. As the 
column and guard column cartridges are directly exposed to bone samples, performance 




analysis kit was purchased containing the column, and two guard column cartridges for 
approximately $1500.  
 Overall, the costs associated with this method should not prohibit the use of the 
method in an applied setting. When averaged over the total number of injections done in 
this thesis, 620, the column and guard cartridge could be averaged out to roughly $2.50 
per injection. The cartridge holder is purely an upfront expense and will not be limited by 
the number of injections, as such it is not to be accounted in an estimate of the cost per 
sample. 
 Consumables used in HPLC analysis included syringe tip filters, glass HPLC 
vials, and syringes. Each of these items were sold in packs of 100 and were consumed 
simultaneously with each sample preparation. Analysis of invoices demonstrated that the 
most expensive of these items were the syringe tip filters, followed by the HPLC vials, 
and finally the syringes. 
 At the time of this thesis, the syringe tip filters made by Pall life sciences were 
approximately $300 per 100 count pack. This was by and far the largest recurring 
expense in our method. HPLC vials were purchased from Waters and averaged 
approximately $60 per 100 count pack. Syringes averaged about $25 per 100 count pack. 
Overall, the recurring expenses were $385 per 100 samples. The total number of samples 
in this thesis was approximately 400, so it can be estimated that these supplies needed to 
be purchased a total of four times, for a total of approximately $1600.00. On average, 




increased to $16.00 when the standard addition methodology was adopted as four of each 
consumable were necessary for each bone sample. 
 When the cost per injection in the column and guard column is added to the cost 
of HPLC consumables, the total cost of supplies per injection in this thesis was $6.50. A 
sample done with standard addition, 4 injections, would require $26.00 in supplies. 
  
5.7 Future Work   
A key limitation in this thesis was the lack of experimentation with the parameters 
selected for the HPLC method. There was no available literature to reference in regards 
to the method, and as such, this thesis required testing of the method and bone samples. 
The results in this thesis provide an extensive reference on the optimal samples for testing 
and use with the method described in this test. Using these results, further testing can be 
done to better tune the method for citrate detection. The rest of this section will address 
some of the areas that may have an impact on the outcomes of the method.  
 One of the more apparent avenues for investigation is the column. In this study, a 
single column was used for all experimentation with mixed results. Early tests showed 
clear resolution of the peaks and good separation, while later analysis showed less 
resolution and poor separation. As of now, it is unclear whether these results are due to 
variances between porcine rib racks, or may be the result of degraded column 
performance. Repetition of the test setup in this thesis may allow for the method to be 




 Another recommendation for future study is investigating the impact of test 
method parameters on the chromatograms obtained for each sample. The results obtained 
by the test method described in this thesis appeared to be sufficient for our needs. 
Varying temperature, flow rate, and injection volume, would be useful to determine if 
any significant changes are observed as a result.  
 
5.7.1 Processing Protocol 
Grinding of the bone using a mortar and pestle proved to be the most time 
consuming aspect of the processing protocol. Identifying an acceptable alternative for 
bone digestion would decrease the time required for processing, and help to make this 
method more practical. A few alternative methods were investigated briefly in this thesis 
(mechanical grinding, freezing) but none of these showed any promise. A search of 
literature at the end of the project, produced a simple method for the demineralization of 
bone. 
The alternative method being considered only requires the placement of a bone 
specimen in 1N HCl, for five days. In theory, this demineralization process should allow 
citrate to become suspended in solution once the mineral structure was broken down. A 
preliminary study demonstrated that bone dissolved in 1N HCl, with the rubbery collagen 
maintaining its structure. No further testing was done in this thesis, as it was unclear how 
to proceed once the citrate was in solution. Further investigation into this method may 
yield a more practical and less time consuming method of processing the samples, which 




Another suggestion for future experiments, is the investigation of bone from other 
anatomical locations. As of now, most of the research on postmortem interval estimation 
by citrate concentrations have used only porcine cortical rib bone [16, 49]. Future testing 
should focus on the use of other types of bones from different anatomical locations. 
While these bones will be harder to obtain, the results obtained from these studies would 
help to determine the success of these analytical techniques on bone in general rather than 
the small subset these porcine rib bones represent. Furthermore, other species should be 
evaluated, including humans, to ensure that the results are not being influenced, 
negatively or positively, by the use of a porcine rib model.  
 
5.7.2 HPLC Method Applied to Bone 
 As the majority of the work on this thesis focused on the application of the HPLC 
method to bone samples, this section will provide the most important recommendations 
for future study. Overall, relatively little research in this field has been done on 
quantitative and qualitative analytical techniques, as such much was unknown at the start 
of this project. Below are a list of three major recommendations for future studies.  
 First, matrix effects were evaluated in this study only for the sake of determining 
their existence. As of now, it is unclear how matrix effects vary from sample to sample 
and individual to individual, as well as from species to species. Variations in bone 
chemistry across species and individuals should be expected to have an impact on these 
matrix effects, and should be mitigated by the adoption of an analytical technique to 




chemistry was too complex to accurately mimic due to the complex biomolecules and 
cellular components of the bone matrix. One hypothesis is that the phosphorous and 
calcium present in bone would be expected to account for the majority of matrix effects. 
This was not tested, but a set of standards with a physiologically ratio of calcium, 
phosphorous, and citrate may be one solution to test this hypothesis. In general, these 
matrix effects warrant further study to better understand the reactions which cause the 
reduction of the analyte signal.   
 Second, the standard addition method used to compensate for matrix effects 
should be explored further to ensure the results seen in this thesis are consistent 
throughout all samples. Furthermore, the number of additions performed should be 
optimized to minimize over and under estimation of citrate concentrations when the curve 
is extrapolated.  
 Third, all of the experiments in this study used time zero bone, freshly sectioned 
and immediately processed and analyzed. The effects of aging through either natural 
degradation or artificial exposure in a bioreactor were not evaluated. In order to ensure 
this method works on samples similar to those found in a forensic context, aging studies 
should be performed to trace the degradation in the samples, as well as the ability of the 








SUMMARY AND BROAD SIGNIFICANCE 
 
6.1 Summary 
The overall objective of this thesis was to develop and validate an HPLC method 
for quantitative and qualitative analysis of citrate in bone. In order to achieve this 
objective, experiments were developed to achieve three main aims. First, an HPLC 
method was developed and tested on a physiologically relevant range of citrate standards. 
Second, an existing processing method was tested and optimized to ensure the proper 
preparation and sampling of bone samples using HPLC. Third, bone samples were 
prepared and tested to evaluate the qualitative and quantitative analysis provided by the 
HPLC method developed in aim one.  
Chapter 1 introduces the motivation for the work performed in this thesis. Namely 
the need for better quantitative measures for Post Mortem Interval of Skeletal Remains. 
Chapter 2 presents a comprehensive overview of the current research on citrate in bone. 
A review of the literature demonstrated the need for better testing methods, as most of the 
research to date has relied on the unreliable enzymatic assay kits. Chapter 3, presents a 
comprehensive list of the methods and materials used throughout the thesis in order to 
achieve the aims of this thesis. Chapter 4 presents the results associated with each of the 





Overall, aim one was achieved through an array of experiments performed on a 
physiologically relevant range of citrate standards (0 to 2.5 mM). In particular, linearity, 
storage time of standards, stock solution pH, and intra-day test method precision 
(repeatability) were examined. Aim two was accomplished by designing experiments to 
qualitatively and quantitatively analyze citrate detection in three different bone masses 
(50, 75, and 100 mg). Also, matrix effects were also analyzed through the design and 
execution of standard addition and standard recovery tests. Finally, different types of 
bone (cortical, trabecular, and mixed) were analyzed to determine the optimal type of 
bone and limitations with the HPLC test method. Aim three was accomplished by 
analyzing different short term (14 day) storage conditions (hydrated, dehydrated, and 
room temperature), intra-bone factors associated with sampling at different anatomical 
locations (dorsal, central, and ventral), and an analysis of the calculated PMI produced by 
the method described by Schwarcz et al. [49]. 
In aim one experiments, simple matrix analysis with HPLC demonstrated 
acceptable linearity in all of the standard sets tested. HPLC output acquired from theses 
samples allowed for both qualitative and quantitative analysis of citrate in the 
concentration range expected in bone. Also, time was also shown to not have a 
statistically significant impact on the calibration curves produced by standards. 
Furthermore, stock solution pH was shown to have a significant difference in 2.0 mM 
standards when compared. Overall, the results from these tests demonstrated a successful 




 In aim two experiments, a specimen processing protocol for HPLC analysis of 
bone was developed and optimized. The bone specimen processing method described by 
Schwartz, et al. was modified by keeping samples at a lower pH, increasing the mass of 
bone to 75 mg, and increased digestion time to ensure demineralization was complete in 
the sample [49]. Next, bone samples chromatograms were shown to have two dominant 
peaks, a unknown peak preceding citrate and the citrate peak. Also, bone solutions were 
analyzed to determine if injection order (1, 2, or 3) was a significant factor in the detected 
citrate concentration. Furthermore, HPLC statistical analysis of citrate concentrations in 
three masses of bone showed that mass of bone prepared for analysis was not a factor in 
the detection of citrate, validating the use of 75 mg samples in the processing protocol. 
Matrix effects were detected in standard recovery tests, but not standard addition tests 
indicating a matrix effect in the demineralization or neutralization steps of the bone 
processing protocol. A standard addition strategy was adopted to reduce the impact of 
matrix effects on the detected concentration of citrate. Finally, qualitative and 
quantitative analysis of different bone types (cortical, trabecular, and mixed) led to the 
adoption of citrate only samples in the processing protocol, as trabecular peaks were 
unreliable. At the conclusion of these experiments, an optimal sample processing 
protocol for the detection of citrate in bone samples was documented, accomplishing aim 
two.  
In aim three experiments, bone solutions were prepared using the optimized 
method from aim two, and the analyzed with the validated HPLC method developed in 




storage conditions (hydrated, dehydrated, and room temperature) over a short time period 
(14 days) were performed to determine if storage condition was a factor on citrate content 
in bone. Statistical analysis showed that storage conditions over a 14 day time period 
were not a factor in the detected concentration of citrate in 75 mg cortical only porcine 
rib samples. Furthermore, intra-bone factors associated with sampling at different 
anatomical locations (dorsal, central, and ventral) showed no statistical difference in 
citrate content along the bone. Finally, citrate concentrations obtained in earlier 
experiments were used to estimate PMI (years) using the method described by Schwarcz 
et al [49]. This analysis provided an average concentration in all samples of 1.12 ± 0.63 
wt. %, which translated into an average calculated PMI of 7.93 ± 13.7 years. Overall, it 
appeared that the HPLC method from aim one and the optimal bone processing protocol 
developed in aim two were able to provide qualitative and quantitative data on bone 
samples, accomplishing aim three. 
 This thesis represents one of the first analysis of citrate in bone using HPLC for 
the analytical method. In general, the outcomes shown in this thesis demonstrate that the 
HPLC method developed was shown to be reliable in the qualitative and quantitative 
analysis of citrate in bone. While the results obtained throughout this work mark progress 
in this field, there still exists a great need for further analysis and optimization of the 







6. 2 Broad Significance 
A major challenge throughout this thesis was knowing what concentrations of 
citrate should be expected in bone. The average concentration of citrate in bone obtained 
in this thesis was 1.12 ± 0.63 wt. %. Compared to the value listed by Schwarcz, 2.0 wt. 
%, our method only detected 56 % of the citrate in the cortical bone samples. When 
compared to the average concentration value listed in literature of 1.457 ± 0.31wt. % as 
found in Section 2.4 (Ch. 2), the method utilized in this thesis detected 77% of the 
expected citrate concentration. The range of concentrations observed was 0.66 wt. % to 
1.79 wt. %. In order to have a reliable method for postmortem interval estimation, a 
better understanding of the variance of citrate concentrations in bone samples is needed. 
Were the values obtained in this thesis to be plugged into the Schwarcz equation for PMI 
estimation, the maximum weight percent would return a PMI estimate of 67 days, while 
the minimum would yield 8.8 years (3222 days). As both of these samples were time 0 
samples, the equation provided by Schwarcz does not appear to work with the wide 
variance of citrate concentrations seen in the porcine ribs sampled. One possible 
explanation is that the porcine rib bones used were not fully mineralized as the slaughter 
age of pigs is analogous to a five year old human.  
While research on citrate has been evolving since the 1940’s, a wide gap of 
knowledge still exists. Modern analytical methods have provided more insight over the 
last five years, but still relatively little is known and understood. Over the last two years, 
new evidence has emerged that citrate is produced by osteoblasts rather than derived 




to the use of a citrate based technique for the estimation of PMI, as the use of a citrate 
model would require a stable citrate concentration in all individuals in order to provide 
accurate estimations of PMI.  As of now, no studies have been conducted on citrate 
concentrations in bone where high osteoblast activity would be expected, such as an 
actively remodeling bone or in certain bone diseases. As osteoblasts have been shown to 
produce citrate, it is reasonable to assume that an increase in citrate concentration would 
be observed where increased osteoblast activity was present.  
 Another interesting consideration with citrate is its potential use in bone implants. 
In a recent study by Guo et al. the potential of citrate based polymers for use as biphasic 
scaffolds to fill bone voids was investigated [22]. The goal of this study was to replicate 
the architecture of native tissue to improve functionality of the implants. The utilization 
of a biomimetic scaffold made from a citrate based polymer to replicate both the 
architecture and composition of bone tissue was evaluated for biocompatibility and 
integration into the host tissue. The hypothesis was that the citrate based scaffold would 
induce faster healing of the bone and degrade as native tissue regrew due to the similar 
composition of bone tissue.  
The scaffolds demonstrated excellent mechanical and histological attributes, 
leading to the realization that scaffolds made of this polymer would be suitable as off the 
shelf implants to provide structural support to large bone defects [22]. Overall, this study 
showed promise on the ability to utilize citrate within the chemical composition of 




thesis would provide quantitative data on the citrate concentrations to determine if citrate 
concentrations increase with these implants.  
Overall, citrate is a small but important part of bone biochemistry. Prior to 2010, 
interest in citrate within bone had waned after the promising initial wave in the early 
1950’s. One of the leading reasons for this appears to have been the need for better 
techniques of analysis for both quantitative and qualitative studies. The method 
developed in this thesis should be utilized to help improve the understanding of citrate’s 




















































List of Materials Used Throughout Thesis  
 
Chemicals 









































































High Performance Liquid Chromatography Equipment 





Acid Column  
Bio-Rad 125-0234 $1485.00 1 
 
Micro-Guard 
Cation H Refill 


























High Performance Liquid Chromatography Disposables 





Waters 186007194C $52.00 100 
 




























 Peak Area and Retention Time for All Standard Solutions Used for Calibration Curve 
Linearity Analysis in Chapter 4  
 









0.00 0.00 0.00 0 
0.10 0.00 0.00 0 
0.50 0.00 7.12 19772 
1.00 0.00 7.20 50718 
1.50 0.00 7.24 61773 
2.00 0.00 7.29 97903 





















0.00 0.00 0.00 0 
0.10 0.00 0.00 0 
0.50 0.00 0.00 0 
1.00 0.00 7.205 45263 
1.50 0.00 7.242 72180 
2.00 0.00 7.292 98052 






















0.00 0.00 0.00 0 
0.10 0.00 7.972 2423 
0.50 0.00 7.96 23022 
1.00 0.00 7.964 50934 
1.50 0.00 7.964 77578 
2.00 0.00 7.969 103165 






















0.00 0.00 0.00 0 
0.10 0.00 7.99 4104 
0.50 0.00 7.959 27661 
1.00 0.00 7.967 51985 
1.50 0.00 7.965 74239 
2.00 0.00 7.971 101878 
























0.00 0.00 0.00 0 
0.10 0.00 7.893 3170 
0.50 0.00 7.909 14981 
1.00 0.00 7.917 46236 
1.50 0.00 7.928 70161 
2.00 0.00 7.916 90689 






















0.00 0.00 0.00 0 
0.10 0.00 7.965 4970 
0.50 0.00 7.97 30119 
1.00 0.00 7.963 51964 
1.50 0.00 7.966 80949 
2.00 0.00 7.971 102319 






















0.00 0.00 0.00 0 
0.10 0.00 7.951 4308 
0.50 0.00 7.966 25593 
1.00 0.00 7.976 50688 
1.50 0.00 7.97 78489 























0.00 0.00 0.00 0 
0.50 0.00 8.476 24669 
1.00 0.00 8.457 57071 
1.50 0.00 8.443 83423 
2.00 0.00 8.441 104901 

























0.00 0.00 0.00 0 
0.50 0.00 8.61 26394 
1.00 0.00 8.618 52725 
1.50 0.00 8.611 80585 
2.00 0.00 8.61 107607 

























0.00 0.00 0.00 0 
0.50 0.00 8.819 24907 
1.00 0.00 8.801 47965 
1.50 0.00 8.8 76047 
2.00 0.00 8.8 99881 






















0.00 0.00 0.00 0 
0.50 0.00 9.551 22522 
1.00 0.00 9.549 47023 
1.50 0.00 9.546 71040 
2.00 0.00 9.553 92037 

























0.00 0.00 0.00 0 
0.50 0.00 8.18 27375 
1.00 0.00 8.165 50208 
1.50 0.00 8.178 72849 
2.00 0.00 8.169 97136 

















Mass of Bone, Peak Area, Retention Time, Bone Type, and Citrate Concentrations (mM 
and wt.%) of all Bone Solutions Examined in Thesis 
Aim Two Experiments 














50-1 49.9 1 8.089 42793 0.81 1.067 
50-1 49.9 2 8.076 38916 0.74 0.970 
50-1 49.9 3 8.076 37824 0.72 0.943 
50-2 50.2 1 8.076 35470 0.67 0.879 
50-2 50.2 2 8.106 36975 0.70 0.917 
50-2 50.2 3 8.122 37092 0.70 0.919 
50-3 49.9 1 8.125 38262 0.73 0.954 
50-3 49.9 2 8.129 34913 0.66 0.871 
50-3 49.9 3 8.162 34683 0.66 0.865 
75-1 75.1 1 8.166 54431 1.03 0.837 
75-1 75.1 2 8.184 52143 0.99 0.801 
75-1 75.1 3 8.201 54863 1.04 0.843 
75-2 75.2 1 8.214 63142 1.20 0.969 
75-2 75.2 2 8.209 64334 1.22 0.987 
75-2 75.2 3 8.242 60710 1.15 0.932 
75-3 75.3 1 8.235 60309 1.14 0.924 
75-3 75.3 2 8.234 62531 1.19 0.958 
75-3 75.3 3 8.248 63335 1.20 0.971 
100-1 99.8 1 8.263 98482 1.87 1.068 
100-1 99.8 2 8.27 90557 1.72 0.982 
100-1 99.8 3 8.288 91833 1.74 0.996 
100-2 100.2 1 8.291 89692 1.70 0.969 
100-2 100.2 2 8.3 93320 1.77 1.008 
100-2 100.2 3 8.315 90040 1.71 0.972 
100-3 100.6 1 8.311 83347 1.58 0.896 
100-3 100.6 2 8.309 84168 1.60 0.905 





























SA1 0 75.50 8.54 48161 Mixed 0.914 0.779 
SA1 1.64 75.50 8.53 146859 Mixed 2.788 2.374 
SA1 4 75.50 8.53 267805 Mixed 5.084 4.329 
SA1 7.69 75.50 8.54 445347 Mixed 8.454 7.199 
SA2 0 74.90 8.54 46696 Mixed 0.886 0.761 
SA2 1.64 74.90 8.53 136245 Mixed 2.586 2.220 
SA2 4 74.90 8.53 265900 Mixed 5.048 4.333 
SA2 7.69 74.90 8.54 440006 Mixed 8.353 7.170 
SA3 0 75.30 - Not enough to test Mixed 0.000 0.000 
SA3 1.64 75.30 8.55 153037 Mixed 2.905 2.480 
SA3 4 75.30 8.55 272671 Mixed 5.176 4.420 






























SR S1 0.00 75.10 1 8.32 47576 Mixed 0.903 0.773 
SR S1 0.00 75.10 2 8.35 48538 Mixed 0.921 0.789 
SR S1 0.00 75.10 3 8.35 48709 Mixed 0.925 0.792 
SR S1 0.45 74.70 1 8.35 87165 Mixed 1.655 1.424 
SR S1 0.93 75.30 1 8.36 117368 Mixed 2.228 1.902 
SR S1 1.50 76.20 1 8.38 159585 Mixed 3.029 2.556 
SR S1 2.77 76.40 1 8.39 208555 Mixed 3.959 3.332 
SR S2 0.00 74.20 1 8.39 60555 Mixed 1.150 0.996 
SR S2 0.00 74.20 2 8.41 61752 Mixed 1.172 1.016 
SR S2 0.00 74.20 3 8.41 60338 Mixed 1.145 0.992 
SR S2 0.59 76.20 1 8.42 91498 Mixed 1.737 1.466 
SR S2 1.29 75.30 1 8.42 113976 Mixed 2.164 1.847 
SR S2 1.64 76.30 1 8.44 129252 Mixed 2.454 2.068 
SR S2 2.35 75.90 1 8.44 162893 Mixed 3.092 2.619 
SR S3 0.00 75.00 1 8.50 61126 Mixed 1.160 0.995 
SR S3 0.00 75.00 2 8.51 60754 Mixed 1.153 0.989 
SR S3 0.00 75.00 3 8.51 60881 Mixed 1.156 0.991 
SR S3 0.71 75.00 1 8.51 95994 Mixed 1.822 1.562 
SR S3 1.18 75.80 1 8.53 113895 Mixed 2.162 1.834 
SR S3 1.76 75.90 1 8.53 157107 Mixed 2.982 2.526 
SR S3 2.70 76.70 1 8.53 178780 Mixed 3.394 2.845 
SR75 0.00 73.10 1 8.70 70941 Cortical 1.334 1.173 
SR75 0.50 73.00 1 8.70 98140 Cortical 1.845 1.625 
SR75 1.00 73.40 1 8.70 119670 Cortical 2.250 1.971 
SR75 1.40 74.10 1 8.70 135919 Cortical 2.555 2.217 

































VAC1 75.1 0.000 8.91 69301 Cortical 3 1.316 1.115 1.399 
VAC1 75.1 0.815 8.94 108337 Cortical 3    
VAC1 75.1 1.630 8.96 137375 Cortical 3    
VAC1 75.1 2.445 8.95 175572 Cortical 3    
VAC2 74.2 0.000 8.95 61184 Cortical 3 1.161 0.996 1.336 
VAC2 74.2 0.815 8.97 95864 Cortical 3    
VAC2 74.2 1.630 8.98 126530 Cortical 3    
VAC2 74.2 2.445 8.99 159115 Cortical 3    
VAC3 75.9 0.000 8.98 62289 Cortical 3 1.182 0.992 1.302 
VAC3 75.9 0.815 9.01 90476 Cortical 3    
VAC3 75.9 1.630 9.00 127651 Cortical 3    
VAC3 75.9 2.445 9.02 156934 Cortical 3    
H2O1 75.1 0.000 8.82 78636 Cortical 3 1.493 1.265 1.478 
H2O1 75.1 0.815 8.84 113021 Cortical 3    
H2O1 75.1 1.630 8.85 152060 Cortical 3    
H2O1 75.1 2.445 8.87 187165 Cortical 3    
H2O2 75.7 0.000 8.85 70177 Cortical 3 1.332 1.120 1.361 
H2O2 75.7 0.815 8.88 105079 Cortical 3    
H2O2 75.7 1.630 8.89 139497 Cortical 3    
H2O2 75.7 2.445 8.89 176020 Cortical 3    
H2O3 74.6 0.000 8.88 70126 Cortical 3 1.331 1.136 1.372 
H2O3 74.6 0.815 8.92 103440 Cortical 3    
H2O3 74.6 1.630 8.92 141600 Cortical 3    
H2O3 74.6 2.445 8.93 175036 Cortical 3    
RT1 75 0.000 8.73 71212 Cortical 3 1.352 1.147 1.171 
RT1 75 0.815 8.76 113808 Cortical 3    
RT1 75 1.630 8.77 155495 Cortical 3    
RT1 75 2.445 8.78 156383 Cortical 3    
RT2 74.5 0.000 8.77 71879 Cortical 3 1.365 1.166 1.259 
RT2 74.5 0.815 8.79 113637 Cortical 3    
RT2 74.5 1.630 8.79 153634 Cortical 3    
RT2 74.5 2.445 8.80 192471 Cortical 3    
RT3 74.5 0.000 8.79 73395 Cortical 3 1.393 1.190 1.362 
RT3 74.5 0.815 8.81 108838 Cortical 3    
RT3 74.5 1.630 8.83 144660 Cortical 3    
RT3 74.5 2.445 8.83 184839 Cortical 3       































Dorsal R4B5 74.5 0 8.929 108394 Cortical 4 2.039 1.789 2.071 
Dorsal R4B5 74.5 0.815 8.975 137331 Cortical 4    
Dorsal R4B5 74.5 1.63 8.98 183376 Cortical 4    
Dorsal R4B5 74.5 2.445 8.979 214997 Cortical 4    
Central R4B5 75.4 0 8.967 99554 Cortical 4 1.873 1.623 2.391 
Central R4B5 75.4 0.815 8.994 127977 Cortical 4    
Central R4B5 75.4 1.63 9.003 153230 Cortical 4    
Central R4B5 75.4 2.445 9.003 186713 Cortical 4    
Ventral R4B5 74.5 0 8.977 61590 Cortical 4 1.159 1.016 1.183 
Ventral R4B5 74.5 0.815 9.024 87550 Cortical 4    
Ventral R4B5 74.5 1.63 9.014 133013 Cortical 4    
Ventral R4B5 74.5 2.445 9.017 162818 Cortical 4    
Dorsal R4B6 75.5 0 9.003 87252 Cortical 4 1.641 1.421 1.598 
Dorsal R4B6 75.5 0.815 9.026 120722 Cortical 4    
Dorsal R4B6 75.5 1.63 9.045 155230 Cortical 4    
Dorsal R4B6 75.5 2.445 9.056 198725 Cortical 4    
Central R4B6 75.1 0 9.076 41407 Cortical 4 0.779 0.678 1.028 
Central R4B6 75.1 0.815 9.075 110571 Cortical 4    
Central R4B6 75.1 1.63 9.079 139464 Cortical 4    
Central R4B6 75.1 2.445 9.083 157432 Cortical 4    
Ventral R4B6 75.1 0 9.071 40137 Cortical 4 0.755 0.657 0.825 
Ventral R4B6 75.1 0.815 9.111 72077 Cortical 4    
Ventral R4B6 75.1 1.63 9.116 112160 Cortical 4    
Ventral R4B6 75.1 2.445 9.146 139773 Cortical 4    
Dorsal R4B7 74.9 0 9.177 63804 Cortical 4 1.667 1.455 1.945 
Dorsal R4B7 74.9 0.815 9.176 91781 Cortical 4    
Dorsal R4B7 74.9 1.63 9.21 110302 Cortical 4    
Dorsal R4B7 74.9 2.445 9.211 136890 Cortical 4    
Central R4B7 75.2 0 9.19 95666 Cortical 4 1.800 1.564 2.457 
Central R4B7 75.2 0.815 9.19 113849 Cortical 4    
Central R4B7 75.2 1.63 9.213 148440 Cortical 4    
Central R4B7 75.2 2.445 9.226 173226 Cortical 4    
Ventral R4B7 75.7 0 9.177 71806 Cortical 4 1.351 1.166 1.469 
Ventral R4B7 75.7 0.815 9.237 104047 Cortical 4    
Ventral R4B7 75.7 1.63 9.27 134642 Cortical 4    
Ventral R4B7 75.7 2.445 9.281 174202 Cortical 4       
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(min) 















Dorsal R6B4 75.5 0.00 8.29 30992 Cortical 6 0.626 0.542 0.631 
Dorsal R6B4 75.5 0.82 8.30 62110 Cortical 6    
Dorsal R6B4 75.5 1.63 8.30 92397 Cortical 6    
Dorsal R6B4 75.5 2.45 8.31 129882 Cortical 6    
Central R6B4 74.9 0.00 8.31 20354 Cortical 6 0.411 0.359 0.596 
Central R6B4 74.9 0.82 8.31 50322 Cortical 6    
Central R6B4 74.9 1.63 8.31 77492 Cortical 6    
Central R6B4 74.9 2.45 8.30 98686 Cortical 6    
Ventral R6B4 74.75 0.00 8.32 9713 Cortical 6 0.196 0.171 0.315 
Ventral R6B4 74.75 0.82 8.32 36599 Cortical 6    
Ventral R6B4 74.75 1.63 8.35 62133 Cortical 6    
Ventral R6B4 74.75 2.45 8.32 83010 Cortical 6    
Dorsal R6B5 74.5 0.00 8.35 24293 Cortical 6 0.490 0.430 0.588 
Dorsal R6B5 74.5 0.82 8.36 46046 Cortical 6    
Dorsal R6B5 74.5 1.63 8.37 87418 Cortical 6    
Dorsal R6B5 74.5 2.45 8.35 103696 Cortical 6    
Central R6B5 74.8 0.00 8.36 13911 Cortical 6 0.281 0.245 0.461 
Central R6B5 74.8 0.82 8.36 39194 Cortical 6    
Central R6B5 74.8 1.63 8.40 65367 Cortical 6    
Central R6B5 74.8 2.45 8.39 82873 Cortical 6    
Ventral R6B5 74.8 0.00 8.42 7768 Cortical 6 0.157 0.137 0.241 
Ventral R6B5 74.8 0.82 8.36 27911 Cortical 6    
Ventral R6B5 74.8 1.63 8.42 51838 Cortical 6    
Ventral R6B5 74.8 2.45 8.40 71730 Cortical 6    
Dorsal R6B6 75.4 0.00 8.43 21719 Cortical 6 0.438 0.380 0.621 
Dorsal R6B6 75.4 0.82 8.45 47970 Cortical 6    
Dorsal R6B6 75.4 1.63 8.45 74654 Cortical 6    
Dorsal R6B6 75.4 2.45 8.46 96636 Cortical 6    
Central R6B6 74.5 0.00 8.43 15062 Cortical 6 0.304 0.267 0.364 
Central R6B6 74.5 0.82 8.47 33842 Cortical 6    
Central R6B6 74.5 1.63 8.47 58842 Cortical 6    
Central R6B6 74.5 2.45 8.48 87253 Cortical 6    
Ventral R6B6 75.9 0.00 8.48 5746 Cortical 6 0.116 0.100 0.096 
Ventral R6B6 75.9 0.82 8.46 27341 Cortical 6    
Ventral R6B6 75.9 1.63 8.49 52316 Cortical 6    
Ventral R6B6 75.9 2.45 8.48 83067 Cortical 6       







Standard Addition Calibration Curves Produced in Aim Three Bone Solutions  
 
Short Term (14 Days) Storage Condition Tests  
Compare to Calibration Curve of Standard Set 08 
 































































































































Room Temperature (RT) Samples 
RT 1 
 
*Top contains curve without 2.445mM addition, as an error was made in preparation 
 
RT 2  
 



































































Location Test Set 1 Sample Standard Addition Calibration Curves 

































Location Test Set 2 Sample Standard Addition Calibration Curves 
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